NCT05224791 A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy https://clinicaltrials.gov/study/NCT05224791 RECRUITING Laparoscopic Sleeve Gastrectomy

NCT06528691 Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors https://clinicaltrials.gov/study/NCT06528691 RECRUITING High Grade Glioma

NCT05587491 HybridAPC for Gastric Mucosal Ablation in Obese Patients. https://clinicaltrials.gov/study/NCT05587491 RECRUITING Obesity

NCT04804891 Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation https://clinicaltrials.gov/study/NCT04804891 RECRUITING Intestinal Transplantation BIOLOGICAL: Cell Therapy Columbia University Ossium Health, Inc.

NCT06614491 SCOPE - Single-Point Classification Observational Peristomal Evaluation https://clinicaltrials.gov/study/NCT06614491 NOT_YET_RECRUITING Ileostomy

NCT06120491 Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents https://clinicaltrials.gov/study/NCT06120491 RECRUITING Metastatic Castration-Sensitive Prostate Cancer DRUG: Saruparib

NCT06536491 EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema https://clinicaltrials.gov/study/NCT06536491 NOT_YET_RECRUITING Diabetic Macular Edema DRUG: EC-104 high dose

NCT05740891 AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma https://clinicaltrials.gov/study/NCT05740891 RECRUITING Multiple Myeloma DRUG: BCMA CAR-T cells injection Zhejiang University Yake Biotechnology Ltd.

NCT06674291 Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) https://clinicaltrials.gov/study/NCT06674291 NOT_YET_RECRUITING Tuberculosis, Multidrug-Resistant DRUG: No intervention (observational study) Korea Otsuka Pharmaceutical Co., Ltd.

NCT06029491 The Pivotal Study of RapidPulseTM Aspiration System https://clinicaltrials.gov/study/NCT06029491 NOT_YET_RECRUITING Acute Ischemic Stroke DEVICE: RapidPulseTM Aspiration System RapidPulse, Inc

NCT04732962 Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement https://clinicaltrials.gov/study/NCT04732962 RECRUITING Osteoarthritis, Knee DEVICE: AposHealth

NCT06478862 Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy https://clinicaltrials.gov/study/NCT06478862 RECRUITING Cancer of Ovary

NCT06714591 A Multicenter, Open-Label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of BL-M11D1 in Patients with Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06714591 NOT_YET_RECRUITING Relapsed/Refractory Acute Myeloid Leukemia DRUG: BL-M11D1 SystImmune Inc.

NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) https://clinicaltrials.gov/study/NCT06134362 NOT_YET_RECRUITING HIV Infections DRUG: CAB LA ViiV Healthcare GlaxoSmithKline

NCT06521762 Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis https://clinicaltrials.gov/study/NCT06521762 NOT_YET_RECRUITING Immune Checkpoint Inhibitor-Related Diarrhea and Colitis DRUG: Etrasimod

NCT05290662 Registry of Patients Having Received oNKord® https://clinicaltrials.gov/study/NCT05290662 RECRUITING AML DRUG: oNKord®

NCT05366062 ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab https://clinicaltrials.gov/study/NCT05366062 NOT_YET_RECRUITING Glioma, Malignant DRUG: ERC1671

NCT04738162 Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors https://clinicaltrials.gov/study/NCT04738162 RECRUITING Brain Tumor, Pediatric DRUG: 5-Aminolevulinic Acid Hydrochloride, Oral Universität Münster photonamic GmbH & Co. KG

NCT04873362 A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy https://clinicaltrials.gov/study/NCT04873362 RECRUITING Breast Cancer DRUG: Atezolizumab

NCT06035991 First Clinical Evaluation of Heart Transplantation With Grafts Preserved Using an Ex-vivo Extended Perfusion System https://clinicaltrials.gov/study/NCT06035991 NOT_YET_RECRUITING Heart Transplantation PROCEDURE: Heart transplantation Assistance Publique - Hôpitaux de Paris ICAN Nutrition Education and Research

NCT06513091 US National TOP Registry https://clinicaltrials.gov/study/NCT06513091 RECRUITING Lung Transplant DEVICE: OCS Lung TransMedics

NCT06515262 Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM https://clinicaltrials.gov/study/NCT06515262 RECRUITING Relapsed/Refractory Multiple Myeloma BIOLOGICAL: Anti-BCMA-GPRC5D CAR-T cells infusion 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Guangzhou Bio-gene Technology Co., Ltd

NCT06010862 Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06010862 RECRUITING Gastric Cancer

NCT05525091 Neoneur Feeding System Functionality in the Clinic https://clinicaltrials.gov/study/NCT05525091 RECRUITING Feeding Patterns

NCT05060991 Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT05060991 RECRUITING COVID-19

NCT06258291 First in Human Trial to Assess the Safety of HemoSystem REBOOT in Patients With Sepsis-induced Immunosuppression https://clinicaltrials.gov/study/NCT06258291 NOT_YET_RECRUITING Septic Shock DEVICE: Hemosystem REBOOT hemotune AG

NCT06058091 RY_SW01 Cell Injection Therapy in Systemic Sclerosis https://clinicaltrials.gov/study/NCT06058091 RECRUITING Systemic Sclerosis DRUG: RY_SW01 cell injection

NCT05467891 Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT05467891 RECRUITING Locoregional Recurrence

NCT05954091 OH2 Administered by Intratumoral Injection https://clinicaltrials.gov/study/NCT05954091 NOT_YET_RECRUITING Solid Tumor DRUG: OH2 Injection Binhui Biopharmaceutical Co., Ltd.

NCT05968391 Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP) https://clinicaltrials.gov/study/NCT05968391 RECRUITING Kidney Failure, Chronic RADIATION: PET scan metabolic day Université de Sherbrooke Nestle Health Science

NCT06256991 Potassium Correction for RAAS Optimization in Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06256991 RECRUITING Chronic Kidney Diseases

NCT06336291 A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence https://clinicaltrials.gov/study/NCT06336291 NOT_YET_RECRUITING Glioblastoma DRUG: L19TNF

NCT05199662 Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT https://clinicaltrials.gov/study/NCT05199662 RECRUITING Ischemic Stroke, Acute DRUG: Intravenous tenecteplase

NCT06633562 A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults https://clinicaltrials.gov/study/NCT06633562 NOT_YET_RECRUITING Healthy

NCT05652062 Prizvalve® Transcatheter Valve-in-Valve Implantation Exploratory Study https://clinicaltrials.gov/study/NCT05652062 RECRUITING Failing Bioprosthetic Valve DEVICE: Prizvalve® system Shanghai NewMed Medical Co., Ltd. Shanghai Zhongshan Hospital

NCT05451862 Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. https://clinicaltrials.gov/study/NCT05451862 RECRUITING Hepatocellular Carcinoma DEVICE: Holmium-166 treatment

NCT05925491 Pembrolizumab in Locally Advanced Sinonasal Carcinoma https://clinicaltrials.gov/study/NCT05925491 NOT_YET_RECRUITING Sinonasal Undifferentiated Carcinoma DRUG: Pembrolizumab

NCT05285891 Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis https://clinicaltrials.gov/study/NCT05285891 RECRUITING Multiple Sclerosis DRUG: Ocrelizumab

NCT06721091 Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males https://clinicaltrials.gov/study/NCT06721091 RECRUITING Healthy Volunteer DRUG: VNA-318

NCT06669091 Food-effect Study of Ecopipam Pharmacokinetics https://clinicaltrials.gov/study/NCT06669091 NOT_YET_RECRUITING Food-effect DRUG: Ecopipam tablet Emalex Biosciences Inc.

NCT06045091 To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL https://clinicaltrials.gov/study/NCT06045091 RECRUITING Multiple Myeloma

NCT06497491 An Efficacy and Safety Study of GNR-086 (canakinumab Biosimilar) and Ilaris® in Patients with Adult-onset Still's Disease https://clinicaltrials.gov/study/NCT06497491 RECRUITING Still's Disease Adult Onset BIOLOGICAL: GNR-086

NCT05177562 Reproductive Endocrinology Oxford Study (RepOx) https://clinicaltrials.gov/study/NCT05177562 RECRUITING Polycystic Ovary Syndrome OTHER: No intervention University of Oxford Bayer

NCT06470191 A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. https://clinicaltrials.gov/study/NCT06470191 RECRUITING Primary Membranous Nephropathy DRUG: B007

NCT05695391 A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM https://clinicaltrials.gov/study/NCT05695391 RECRUITING Hemophilia BIOLOGICAL: Coagulation Factor VIIa (Recombinant) Laboratoire français de Fractionnement et de Biotechnologies

NCT06715891 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years. https://clinicaltrials.gov/study/NCT06715891 RECRUITING Acute Respiratory Viral Infection DRUG: Raphamin

NCT04635891 Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) https://clinicaltrials.gov/study/NCT04635891 RECRUITING FSHD University of Kansas Medical Center FSHD Society, Inc.

NCT05599191 A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough https://clinicaltrials.gov/study/NCT05599191 RECRUITING Refractory Chronic Cough DRUG: BLU-5937

NCT06559891 THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS‚Ñ¢) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension https://clinicaltrials.gov/study/NCT06559891 NOT_YET_RECRUITING Hypertension DEVICE: TIVUS‚Ñ¢ Renal Denervation System

NCT05904691 Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT05904691 RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: OCU-10-C-110 for Injection Ocugenix Corporation

NCT05398991 Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation https://clinicaltrials.gov/study/NCT05398991 RECRUITING Coronary Artery Perforation DEVICE: the Coronary Covered Stents System manufactured by Shanghai MicroPort Medical (Group) Co., Ltd. Shanghai MicroPort Rhythm MedTech Co., Ltd.

NCT06694662 PKU EASY Microtabs Plus - Acceptability and Tolerance https://clinicaltrials.gov/study/NCT06694662 NOT_YET_RECRUITING Phenylketonuria (PKU) DIETARY_SUPPLEMENT: PKU EASY Microtabs Plus Galen Limited Birmingham Women's and Children's NHS Foundation Trust

NCT05635162 Zanubrutinib Plus Rituximab for Patients with Indolent Mantle Cell Lymphoma https://clinicaltrials.gov/study/NCT05635162 RECRUITING Mantle Cell Lymphoma DRUG: Zanubrutinib

NCT03848962 Collection and Distribution of Biospecimens for Novel Research Uses https://clinicaltrials.gov/study/NCT03848962 RECRUITING Cancer

NCT06598462 A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults with Eosinophilic Esophagitis https://clinicaltrials.gov/study/NCT06598462 RECRUITING Eosinophilic Esophagitis (EoE) DRUG: Solrikitug Low Dose

NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies https://clinicaltrials.gov/study/NCT02651662 RECRUITING Relapsed/Refractory Aggressive B-Cell Lymphoma DRUG: cemiplimab

NCT06267391 Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes https://clinicaltrials.gov/study/NCT06267391 RECRUITING Type 2 Diabetes Mellitus

NCT05769491 Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05769491 NOT_YET_RECRUITING Triple Negative Breast Cancer

NCT06233591 Evaluating LP-10 in Subjects With OLP https://clinicaltrials.gov/study/NCT06233591 RECRUITING Oral Lichen Planus DRUG: LP-10 (Liposomal Tacrolimus) Lipella Pharmaceuticals, Inc.

NCT05725291 AMT-116 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05725291 RECRUITING Advanced Solid Tumor DRUG: AMT-116 Multitude Therapeutics Inc.

NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) https://clinicaltrials.gov/study/NCT05291091 RECRUITING Becker Muscular Dystrophy DRUG: Sevasemten 10 mg

NCT04648462 Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology https://clinicaltrials.gov/study/NCT04648462 RECRUITING Astrocytoma

NCT06585462 Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity https://clinicaltrials.gov/study/NCT06585462 RECRUITING Cardiometabolic Disease DRUG: AMG 513

NCT04984291 Zimmer Biomet Shoulder Arthroplasty PMCF https://clinicaltrials.gov/study/NCT04984291 RECRUITING Shoulder Fractures

NCT05487391 A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. https://clinicaltrials.gov/study/NCT05487391 RECRUITING Carcinoma, Non-Small-Cell Lung DRUG: QL1706 injection

NCT06315491 A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer https://clinicaltrials.gov/study/NCT06315491 RECRUITING Platinum-resistant Ovarian Cancer

NCT06203691 Nirvana Super Pro Supplementation in Orthopedic Surgery Patients https://clinicaltrials.gov/study/NCT06203691 RECRUITING Arthropathy of Knee

NCT06159491 Pacritinib in CMML https://clinicaltrials.gov/study/NCT06159491 RECRUITING Chronic Myelomonocytic Leukemia DRUG: Pacritinib

NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery https://clinicaltrials.gov/study/NCT03271762 RECRUITING Mitral Regurgitation DEVICE: percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW

NCT05208762 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05208762 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT05766462 Allometric-Pace Study https://clinicaltrials.gov/study/NCT05766462 RECRUITING Sinus Node Dysfunction OTHER: Pacemaker lower rate setting Medtronic Cardiac Rhythm and Heart Failure

NCT06646562 Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ‚â• 60 Years for 24 https://clinicaltrials.gov/study/NCT06646562 NOT_YET_RECRUITING HIV-1 Infected Adults with Controlled Viremia DRUG: Cabotegravir LA + Rilpivirine LA Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ViiV Healthcare

NCT05450562 Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05450562 RECRUITING Neoplasm BIOLOGICAL: SAR444200

NCT06300762 RCT Exudate Management Cutimed Sorbion Product Range https://clinicaltrials.gov/study/NCT06300762 RECRUITING Venous Leg Ulcer DEVICE: Superabsorbent dressing application BSN Medical GmbH

NCT04597476 A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck https://clinicaltrials.gov/study/NCT04597476 RECRUITING Squamous Cell Carcinomas of the Head and Neck DIETARY_SUPPLEMENT: Fucoidan

NCT06686576 A Study of Perioperative QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer https://clinicaltrials.gov/study/NCT06686576 NOT_YET_RECRUITING Colon Cancer BIOLOGICAL: QL1706

NCT06092476 Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients https://clinicaltrials.gov/study/NCT06092476 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 DEVICE: Revita® DMR Treatment

NCT03851627 Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism https://clinicaltrials.gov/study/NCT03851627 RECRUITING Fatty Liver

NCT04695327 TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy https://clinicaltrials.gov/study/NCT04695327 RECRUITING Solid Tumor BIOLOGICAL: TILT-123 TILT Biotherapeutics Ltd.

NCT05267327 A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast https://clinicaltrials.gov/study/NCT05267327 NOT_YET_RECRUITING The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks OTHER: Verzenios Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Eli Lilly and Company

NCT04406727 UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection https://clinicaltrials.gov/study/NCT04406727 NOT_YET_RECRUITING HIV-1 Infection BIOLOGICAL: UB-421

NCT05936827 Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitness https://clinicaltrials.gov/study/NCT05936827 RECRUITING Healthy DIAGNOSTIC_TEST: Ergometry

NCT05810727 Atrial Fibrillation Data Linkage Non-Interventional Study https://clinicaltrials.gov/study/NCT05810727 NOT_YET_RECRUITING Atrial Fibrillation Pfizer

NCT05945927 A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer https://clinicaltrials.gov/study/NCT05945927 RECRUITING Breast Cancer DRUG: Trastuzumab emtansine Hoffmann-La Roche

NCT06192927 Efficacy and Safety of TenoMiR in Lateral Epicondylitis https://clinicaltrials.gov/study/NCT06192927 RECRUITING Tennis Elbow DRUG: TenoMiR

NCT05701176 A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05701176 RECRUITING Advanced Stage Non-small Cell Lung Cancer DIAGNOSTIC_TEST: [18F]F-AraG PET scan Amsterdam UMC, location VUmc Boehringer Ingelheim

NCT04982276 A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT04982276 RECRUITING Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma BIOLOGICAL: AK109

NCT04457076 Evaluation of the Efficacy, Safety, and Tolerability of LevoCept https://clinicaltrials.gov/study/NCT04457076 NOT_YET_RECRUITING Contraception

NCT06429176 Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis https://clinicaltrials.gov/study/NCT06429176 RECRUITING Cystic Fibrosis DRUG: SPL84

NCT06291376 Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT06291376 RECRUITING Immunoglobulin A Nephropathy

NCT05793476 Therapeutic Efficacy of Erbium:YAG Laser in Postpartum Patients With Episiotomy Scars https://clinicaltrials.gov/study/NCT05793476 RECRUITING Episiotomy Wound

NCT05437276 A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT05437276 RECRUITING Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS) DEVICE: PoNS® Helius Medical Inc

NCT04519476 Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. https://clinicaltrials.gov/study/NCT04519476 RECRUITING Refractory Multiple Myeloma DRUG: Selinexor

NCT06434727 Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures. https://clinicaltrials.gov/study/NCT06434727 RECRUITING Thoracic

NCT06265727 A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors https://clinicaltrials.gov/study/NCT06265727 RECRUITING Solid Tumor, Adult DRUG: CRB-701 Corbus Pharmaceuticals Inc. CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

NCT05357027 HPV16 E6 TCR T Cells for Cervical Carcinoma https://clinicaltrials.gov/study/NCT05357027 RECRUITING Cervical Carcinoma BIOLOGICAL: TC-E202 cells

NCT06164327 Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT06164327 RECRUITING Relapsed/Refractory Diffuse Large B-Cell Lymphoma DRUG: BEBT-908 for Injection

NCT06514976 Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy https://clinicaltrials.gov/study/NCT06514976 RECRUITING Stroke, Acute

NCT06504927 Biomarker Discovery in Lung Cancer - Malaysia https://clinicaltrials.gov/study/NCT06504927 RECRUITING Lung Cancer University of Malaya MiRXES Pte Ltd

NCT06607627 PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT06607627 NOT_YET_RECRUITING Generalized Myasthenia Gravis

NCT06157827 A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma https://clinicaltrials.gov/study/NCT06157827 RECRUITING Advanced Neuroendocrine Carcinoma DRUG: LBL-024 for Injection

NCT05600127 Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer https://clinicaltrials.gov/study/NCT05600127 RECRUITING Urothelial Carcinoma DRUG: Avelumab Erasmus Medical Center Merck KGaA, Darmstadt, Germany

NCT05906576 Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients https://clinicaltrials.gov/study/NCT05906576 RECRUITING Crohn Disease DRUG: Infliximab Taizhou Mabtech Pharmaceutical Co.,Ltd

NCT06212076 Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients https://clinicaltrials.gov/study/NCT06212076 NOT_YET_RECRUITING Solid Tumor DRUG: IPG1094 Nanjing Immunophage Biotech Co., Ltd

NCT06537076 Safety and Efficacy of AR1005 in Patients with Lewy Body Disease https://clinicaltrials.gov/study/NCT06537076 RECRUITING Lewy Body Dementia DRUG: AR1005

NCT05359276 Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France https://clinicaltrials.gov/study/NCT05359276 RECRUITING Acid Sphingomyelinase Deficiency (ASMD) DRUG: Olipudase alfa Sanofi

NCT06091176 Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension https://clinicaltrials.gov/study/NCT06091176 NOT_YET_RECRUITING Essential Hypertension

NCT06672276 To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency https://clinicaltrials.gov/study/NCT06672276 NOT_YET_RECRUITING Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria DRUG: TQD3606 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT04927676 Hormones in Hypogonadotropic Hypogonadism https://clinicaltrials.gov/study/NCT04927676 RECRUITING AMH

NCT06318676 A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment https://clinicaltrials.gov/study/NCT06318676 RECRUITING Renal Impairment DRUG: Mezigdomide Celgene

NCT05285527 MiSight 1 Day Safety Post-Approval Study https://clinicaltrials.gov/study/NCT05285527 RECRUITING Myopia DEVICE: MiSight 1 Day Coopervision, Inc.

NCT03495427 PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores https://clinicaltrials.gov/study/NCT03495427 RECRUITING Prostate Cancer

NCT04523727 Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease https://clinicaltrials.gov/study/NCT04523727 RECRUITING Hyperphosphatemia Related to Chronic Kidney Disease DRUG: ferric citrate Keryx Biopharmaceuticals

NCT06317727 PULSed Field ablAtion of coloRectal Polyps https://clinicaltrials.gov/study/NCT06317727 NOT_YET_RECRUITING Colon Polyp DEVICE: Irreversible Electroporation using EndoVE(Endoscopic Vacuum Electrode) and electrical pulses generated using ePORE(electroporation device) King's College Hospital NHS Trust Mirai Medical

NCT06689176 Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion https://clinicaltrials.gov/study/NCT06689176 RECRUITING Bladder Cancer

NCT06461676 Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS) https://clinicaltrials.gov/study/NCT06461676 NOT_YET_RECRUITING Hypoplastic Left Heart Syndrome DRUG: Ventrix Bio Extracellular Matrix Emory University Ventrix, Inc.

NCT04665076 Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors https://clinicaltrials.gov/study/NCT04665076 RECRUITING Plasma Cell Tumors BIOLOGICAL: Auto CAR-T

NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future https://clinicaltrials.gov/study/NCT06039176 NOT_YET_RECRUITING LVAD

NCT05477576 Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy https://clinicaltrials.gov/study/NCT05477576 RECRUITING GEP-NET

NCT05840276 Cryoneurolysis Prior to Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT05840276 RECRUITING Post Operative Pain

NCT06397027 A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias https://clinicaltrials.gov/study/NCT06397027 NOT_YET_RECRUITING Refractory Acute Leukemia

NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling https://clinicaltrials.gov/study/NCT06356727 RECRUITING Heart Failure

NCT05766527 A Study of KM602 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05766527 NOT_YET_RECRUITING Advanced Solid Tumor BIOLOGICAL: KM602 Xuanzhu Biopharmaceutical Co., Ltd.

NCT06364527 Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma https://clinicaltrials.gov/study/NCT06364527 RECRUITING Asthma Chronic DEVICE: Aptar Digital Health respiratory disease management platform CoheroHealth Aptar Digital Health

NCT04329676 directSTIM Deep Brain Stimulation System Study https://clinicaltrials.gov/study/NCT04329676 RECRUITING Parkinson Disease PROCEDURE: Deep Brain Stimulation Aleva Neurotherapeutics SA

NCT06007976 LLLT to Reduce Low Back Pain https://clinicaltrials.gov/study/NCT06007976 RECRUITING Low Back Pain DEVICE: Erchonia® Trident Mayo Clinic Erchonia Corporation

NCT06436976 The Effect of Probiotics ATG-F4 in Cancer Patients https://clinicaltrials.gov/study/NCT06436976 RECRUITING Pancreatic Cancer

NCT06030076 A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06030076 RECRUITING Plaque Psoriasis DRUG: Tildrakizumab Almirall, S.A.

NCT06518876 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome https://clinicaltrials.gov/study/NCT06518876 NOT_YET_RECRUITING POEMS Syndrome BIOLOGICAL: KQ-2003 CAR T-cells Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

NCT05425576 OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition https://clinicaltrials.gov/study/NCT05425576 NOT_YET_RECRUITING Malignant Pleural Mesothelioma DRUG: OT-101 Oncotelic Inc.

NCT06249776 Gravity Stent-Retriever System for Reperfusion of Large Vessel Occlusion Stroke Trial https://clinicaltrials.gov/study/NCT06249776 RECRUITING Ischemic Stroke

NCT05556876 Effect of Oral Nutritional Supplements to Older Patients Discharged with a Rehabilitation Plan https://clinicaltrials.gov/study/NCT05556876 RECRUITING Nutritional Risk

NCT06441227 Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects https://clinicaltrials.gov/study/NCT06441227 RECRUITING Lipoprotein Disorder Disease DRUG: HRS-5346 tablets

NCT05957276 Global Patient Registry of Inherited Retinal Diseases https://clinicaltrials.gov/study/NCT05957276 RECRUITING Inherited Retinal Diseases OTHER: Standard of Care Janssen Research & Development, LLC

NCT01524276 Product Surveillance Registry https://clinicaltrials.gov/study/NCT01524276 RECRUITING Cardiac Rhythm Disorders

NCT05894876 A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature https://clinicaltrials.gov/study/NCT05894876 RECRUITING Idiopathic Short Stature OTHER: No treatment is given Novo Nordisk A/S

NCT04104776 A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas https://clinicaltrials.gov/study/NCT04104776 RECRUITING Advanced Solid Tumor

NCT04720976 JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04720976 RECRUITING Solid Tumor

NCT06539676 A Study to Compare Nighttime Aligners to Daytime Aligners https://clinicaltrials.gov/study/NCT06539676 RECRUITING Teeth Straightening

NCT06699576 ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. https://clinicaltrials.gov/study/NCT06699576 NOT_YET_RECRUITING Osteosarcoma

NCT05091476 OcuDyne System in the Treatment of AMD https://clinicaltrials.gov/study/NCT05091476 RECRUITING Age-Related Macular Degeneration DEVICE: OPTiC System OcuDyne, Inc.

NCT05310227 Nerivio Device for Treatment of New Daily Headache Persistence (NDHP) https://clinicaltrials.gov/study/NCT05310227 RECRUITING New Daily Persistent Headache (NDPH) DEVICE: Nerivio Children's National Research Institute Theranica

NCT05645276 A Study of AK129 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05645276 RECRUITING Advanced Malignant Tumors(Stage IA-IB) DRUG: AK129 IV infusion Akeso

NCT06550076 A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06550076 RECRUITING Plaque Psoriasis DRUG: TAK-279 Takeda

NCT05970276 Non-Invasive At-Home Sleep Therapy System https://clinicaltrials.gov/study/NCT05970276 RECRUITING Sleep

NCT06357676 Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma https://clinicaltrials.gov/study/NCT06357676 NOT_YET_RECRUITING Mantle Cell Lymphoma PROCEDURE: Biospecimen Collection

NCT03150576 Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer https://clinicaltrials.gov/study/NCT03150576 RECRUITING Breast Cancer DRUG: Olaparib

NCT06430827 Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma https://clinicaltrials.gov/study/NCT06430827 NOT_YET_RECRUITING Biliary Tract Carcinoma DRUG: irinotecan hydrochloride liposome injection

NCT04691427 Effectiveness of Virtual Reality Vision Therapy - VERVE https://clinicaltrials.gov/study/NCT04691427 RECRUITING Convergence Insufficiency DEVICE: Virtual Eye Rotation Vision Exercises (VERVE) OculoMotor Technologies New Jersey Institute of Technology

NCT06205576 ACOART AVF RENEW: A Post Market Clinical Study https://clinicaltrials.gov/study/NCT06205576 RECRUITING Stenosis of Native Hemodialysis Arteriovenous Fistulas DEVICE: DCB catheter Acotec Scientific Co., Ltd

NCT04609176 Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT04609176 RECRUITING Gastric Cancer DRUG: Camrelizumab plus Apatinib and SOX

NCT05682976 Ophthalmological Adverse Events of Tralokinumab in AD https://clinicaltrials.gov/study/NCT05682976 NOT_YET_RECRUITING Atopic Dermatitis Nantes University Hospital LEO Pharma

NCT03651076 Traxi Panniculus Retractor for Cesarean Delivery https://clinicaltrials.gov/study/NCT03651076 RECRUITING Obesity, Morbid

NCT05133076 Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications https://clinicaltrials.gov/study/NCT05133076 RECRUITING Opioid-Induced Constipation BIOLOGICAL: Lactobacillus gasseri BGP345A

NCT06100276 Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS) https://clinicaltrials.gov/study/NCT06100276 RECRUITING Amyotrophic Lateral Sclerosis DRUG: AMT-162 UniQure Biopharma B.V.

NCT05322876 Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention https://clinicaltrials.gov/study/NCT05322876 RECRUITING Cardiovascular Diseases

NCT06627127 A Study to Investigate the Feasibility and Respiratory Effects of Stimulating Two Functional Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea https://clinicaltrials.gov/study/NCT06627127 RECRUITING Sleep Apnea

NCT05518227 Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens https://clinicaltrials.gov/study/NCT05518227 RECRUITING Cataract DEVICE: The Clareon‚Ñ¢ PanOptix‚Ñ¢ Trifocal (toric and non-toric models) Vivid Laser Center Sengi

NCT06514027 Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations https://clinicaltrials.gov/study/NCT06514027 NOT_YET_RECRUITING Non Small Cell Lung Cancer DRUG: BEBT-109 Capsules

NCT05594927 Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) https://clinicaltrials.gov/study/NCT05594927 RECRUITING Hepatocellular Carcinoma DRUG: Icaritin

NCT05387031 Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease https://clinicaltrials.gov/study/NCT05387031 RECRUITING Crohn Disease

NCT05772182 Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias https://clinicaltrials.gov/study/NCT05772182 RECRUITING Cardiac Arrhythmia DEVICE: ACORYS MAPPING SYSTEM Corify Care S.L. Hospital General Universitario Gregorio Marañon

NCT05902182 Study to Demonstrate the Efficacy and Safety of Convatec ConvaFoam‚Ñ¢ Silicone, ConvaFoam‚Ñ¢ Border and ConvaFoam‚Ñ¢ Non-adhesive Dressings to Protect Against Skin Breakdown https://clinicaltrials.gov/study/NCT05902182 NOT_YET_RECRUITING Skin Breakdown DEVICE: ConvaFoam ConvaTec Inc.

NCT04713982 Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease https://clinicaltrials.gov/study/NCT04713982 RECRUITING Huntington Disease DRUG: Deutetrabenazine Vanderbilt University Medical Center Teva Branded Pharmaceutical Products R&D, Inc.

NCT04056520 Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System https://clinicaltrials.gov/study/NCT04056520 RECRUITING Degenerative Disc Disease DEVICE: Medtronic Infinity Occipitocervical-Upper Thoracic System using the O-arm Imaging System and StealthStation Navigation system Ohio State University Medtronic

NCT06150820 A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease https://clinicaltrials.gov/study/NCT06150820 RECRUITING Pompe Disease (Late-onset) OTHER: No Intervention Astellas Gene Therapies

NCT06369831 HER2 Targeted Molecular Imaging in MBC Using 68Ga-ABS011 https://clinicaltrials.gov/study/NCT06369831 RECRUITING Metastatic Breast Cancer DIAGNOSTIC_TEST: 68Ga-NOTA-ABSCINT-HER2 PET/CT ABSCINT NV/SA

NCT06295731 INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS‚â•20 HNSCC https://clinicaltrials.gov/study/NCT06295731 RECRUITING Head and Neck Squamous Cell Carcinoma (HNSCC) DRUG: INBRX-106

NCT06255782 An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency (OTC-HOPE) https://clinicaltrials.gov/study/NCT06255782 RECRUITING Ornithine Transcarbamylase Deficiency

NCT01733082 The Mycophenolate Pregnancy Registry https://clinicaltrials.gov/study/NCT01733082 RECRUITING Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Genentech, Inc. Accord Healthcare, Inc.

NCT05300282 Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients https://clinicaltrials.gov/study/NCT05300282 RECRUITING Relapsed or Refractory Hodgkin's Lymphoma DRUG: Atezolizumab

NCT05872282 Percutaneous Endovascular Arch Repair Trial (PEART) Study https://clinicaltrials.gov/study/NCT05872282 RECRUITING Aortic Diseases DEVICE: ZIPPER aortic arch stentgraft system Hangzhou Endonom Medtech Co., Ltd. Wayne W.Zhang , Seattle，Washington，USA

NCT06418282 Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema https://clinicaltrials.gov/study/NCT06418282 RECRUITING Phlebolymphedema

NCT06567782 A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer https://clinicaltrials.gov/study/NCT06567782 NOT_YET_RECRUITING Neoplasms, Colon BIOLOGICAL: Dostarlimab

NCT05147220 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) https://clinicaltrials.gov/study/NCT05147220 RECRUITING Relapsing Multiple Sclerosis DRUG: Remibrutinib

NCT06637631 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. https://clinicaltrials.gov/study/NCT06637631 NOT_YET_RECRUITING Crohn's Disease DRUG: SAR441566

NCT06441682 A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS) https://clinicaltrials.gov/study/NCT06441682 RECRUITING Amyotrophic Lateral Sclerosis BIOLOGICAL: ARGX-119

NCT05558982 BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT05558982 RECRUITING Metastatic Pancreatic Ductal Adenocarcinoma DRUG: BXCL701

NCT06543082 MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study https://clinicaltrials.gov/study/NCT06543082 RECRUITING Acute Coronary Syndrome DRUG: Colchicine 0.6 mg CHA University Biotronik SE & Co. KG

NCT04340882 Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade https://clinicaltrials.gov/study/NCT04340882 RECRUITING Metastatic Non-Small Lung Cell Cancer

NCT06701682 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab https://clinicaltrials.gov/study/NCT06701682 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome (ARDS)

NCT02819882 A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) https://clinicaltrials.gov/study/NCT02819882 RECRUITING Breast Neoplasms OTHER: No intervention Spanish Breast Cancer Research Group Hoffmann-La Roche

NCT02773082 DBS for Obsessive-Compulsive Disorder https://clinicaltrials.gov/study/NCT02773082 RECRUITING Obsessive-Compulsive Disorder (OCD) DEVICE: Reclaim‚Ñ¢ DBS Therapy Northwell Health Medtronic

NCT06465420 A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine https://clinicaltrials.gov/study/NCT06465420 RECRUITING Haemophilus Influenzae Meningitis

NCT05489120 Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD) https://clinicaltrials.gov/study/NCT05489120 RECRUITING Chronic Kidney Disease Stage 3B

NCT06016920 Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06016920 RECRUITING HPV Positive Oropharyngeal Squamous Cell Carcinoma

NCT05972720 A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05972720 RECRUITING Cancer

NCT06121882 Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis https://clinicaltrials.gov/study/NCT06121882 RECRUITING Knee Osteoarthritis

NCT03767582 Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. https://clinicaltrials.gov/study/NCT03767582 RECRUITING Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05007782 Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05007782 RECRUITING Advanced Solid Tumor DRUG: GS-1811

NCT06120582 Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) https://clinicaltrials.gov/study/NCT06120582 RECRUITING Hemophilia B GENETIC: ANB-002, dose 1

NCT05606120 H-35 CL TRAUMA Cemented Femoral Stem https://clinicaltrials.gov/study/NCT05606120 RECRUITING Arthroplasty

NCT06548620 A Study of RD06-04 in Patients With Active Autoimmune Diseases https://clinicaltrials.gov/study/NCT06548620 NOT_YET_RECRUITING SLE (Systemic Lupus)

NCT06572982 Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients https://clinicaltrials.gov/study/NCT06572982 NOT_YET_RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine Hikma Pharmaceuticals LLC

NCT05486182 Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05486182 RECRUITING Metastatic Breast Cancer DRUG: 18F Fluoroestradiol Radiopharmaceutical with PET/CT Zionexa GE Healthcare

NCT06384131 A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection https://clinicaltrials.gov/study/NCT06384131 RECRUITING Chronic Hepatitis B DRUG: ABI-4334

NCT03616782 Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL) https://clinicaltrials.gov/study/NCT03616782 RECRUITING Mantle Cell Lymphoma DRUG: Ixazomib Ho Sup Lee Takeda

NCT04686682 A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors https://clinicaltrials.gov/study/NCT04686682 RECRUITING NSCLC

NCT05596682 Prospective Multicenter Clinical Study on the Visual and Refractive Outcomes and Safety Outcomes Following Implantation of an AddOn Intraocular Lens in Previously Pseudophakic Eyes https://clinicaltrials.gov/study/NCT05596682 RECRUITING Presbyopia

NCT04919382 Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04919382 RECRUITING Extensive Stage Lung Small Cell Carcinoma

NCT04058782 Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction https://clinicaltrials.gov/study/NCT04058782 RECRUITING Myocardial Infarction

NCT06333782 Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation https://clinicaltrials.gov/study/NCT06333782 RECRUITING Vulvar Atrophy DEVICE: Experimental- Genefill Contour®

NCT06479382 Study of the ETX-4143 2.0 Device in Subjects With Eye Pain https://clinicaltrials.gov/study/NCT06479382 NOT_YET_RECRUITING Eye Pain DEVICE: ETX-4143 2.0 EyeCool Therapeutics, Inc.

NCT06146920 Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation https://clinicaltrials.gov/study/NCT06146920 RECRUITING Melanoma

NCT04881682 Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://clinicaltrials.gov/study/NCT04881682 RECRUITING CIDP DEVICE: Immunoadsorption

NCT05324982 Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants https://clinicaltrials.gov/study/NCT05324982 RECRUITING Behavioral Pharmacology of Cannabis DRUG: Oral Placebo

NCT06389682 Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients https://clinicaltrials.gov/study/NCT06389682 RECRUITING Clear Cell Renal Cell Carcinoma Metastatic DRUG: 68Ga-NYM005 injection Norroy Bioscience Co., LTD

NCT06439082 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) https://clinicaltrials.gov/study/NCT06439082 RECRUITING Sickle Cell Disease BIOLOGICAL: Crizanlizumab

NCT05692882 A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China https://clinicaltrials.gov/study/NCT05692882 RECRUITING Intracranial Arteriosclerosis

NCT05966220 Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices. https://clinicaltrials.gov/study/NCT05966220 NOT_YET_RECRUITING Hip Surgery DEVICE: Hip surgery with FH Ortho devices FH ORTHO

NCT06149520 A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis https://clinicaltrials.gov/study/NCT06149520 RECRUITING Thrombolysis

NCT05029882 Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab https://clinicaltrials.gov/study/NCT05029882 RECRUITING Non-Small Cell Lung Cancer

NCT06679582 Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age with Relapsed/Refractory CBFA2T3::GLIS2 AML https://clinicaltrials.gov/study/NCT06679582 RECRUITING Acute Myeloid Leukemia (AML) DRUG: Luveltamab tazevibulin Sutro Biopharma, Inc. Children's Oncology Group (COG)

NCT05687682 Safety of AM-928 Infusion in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05687682 RECRUITING Advanced Solid Tumor BIOLOGICAL: AM-928 AcadeMab Biomedical Inc.

NCT06550882 A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea https://clinicaltrials.gov/study/NCT06550882 NOT_YET_RECRUITING Acquired Hemophilia A DRUG: OBIZUR Takeda

NCT04604782 A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients https://clinicaltrials.gov/study/NCT04604782 RECRUITING Myocardial Ischemia

NCT04652882 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) https://clinicaltrials.gov/study/NCT04652882 RECRUITING Sleep Wake Disorders

NCT05967520 JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05967520 RECRUITING Lupus Erythematosus, Systemic DRUG: JMKX000189

NCT06558682 Neoadjuvant Therapy in Cervical Cancer https://clinicaltrials.gov/study/NCT06558682 NOT_YET_RECRUITING Uterine Cervical Neoplasms DRUG: Disitamab Vedotin and Cisplatin Qilu Hospital of Shandong University RemeGen Co., Ltd.

NCT05417282 MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases https://clinicaltrials.gov/study/NCT05417282 RECRUITING Cognitive Dysfunction, Cognitive Disorder DRUG: MW151 ImmunoChem Therapeutics, LLC National Cancer Institute (NCI)

NCT05661682 Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition https://clinicaltrials.gov/study/NCT05661682 NOT_YET_RECRUITING Manganese Safety in Adults DRUG: Tralement

NCT03631420 Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants https://clinicaltrials.gov/study/NCT03631420 RECRUITING Bronchopulmonary Dysplasia BIOLOGICAL: Human Umbilical Cord Derived-Mesenchymal Stem Cells Meridigen Biotech Co., Ltd.

NCT05669482 Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT05669482 RECRUITING KRAS Activating Mutation

NCT06007482 A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06007482 RECRUITING Advanced Solid Tumor DRUG: ES009 Elpiscience Biopharma Australia Pty. Ltd.

NCT05133882 A Phase ‚Ö†b/‚Ö° Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML https://clinicaltrials.gov/study/NCT05133882 NOT_YET_RECRUITING Acute Myeloid Leukemia, Adult DRUG: Clifutinib Besylate Sunshine Lake Pharma Co., Ltd.

NCT03537482 APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies https://clinicaltrials.gov/study/NCT03537482 RECRUITING Hematologic Malignancies DRUG: APG-2575 Ascentage Pharma Group Inc.

NCT06293482 Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population https://clinicaltrials.gov/study/NCT06293482 RECRUITING Hearing Loss, Sensorineural

NCT06539182 DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) https://clinicaltrials.gov/study/NCT06539182 RECRUITING Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma DRUG: DZD8586

NCT05955482 Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT05955482 RECRUITING COPD

NCT06413420 SUNOSI® (Solriamfetol) Pregnancy Registry https://clinicaltrials.gov/study/NCT06413420 RECRUITING Narcolepsy

NCT05898620 A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children with Rett Syndrome https://clinicaltrials.gov/study/NCT05898620 RECRUITING Rett Syndrome GENETIC: NGN-401 Neurogene Inc.

NCT04957329 Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells https://clinicaltrials.gov/study/NCT04957329 RECRUITING Glaucoma

NCT06199180 Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF https://clinicaltrials.gov/study/NCT06199180 NOT_YET_RECRUITING Atrial Fibrillation Recurrent DEVICE: pulmonary vein isolation with RFA

NCT05551780 Treatment of Calcific Total Occlusions in Peripheral Artery Disease https://clinicaltrials.gov/study/NCT05551780 RECRUITING Chronic Total Occlusion of Artery of the Extremities DEVICE: SoundBite Crossing System SoundBite Medical Solutions, Inc.

NCT06208280 F01 in the Treatment of Autoimmune Diseases https://clinicaltrials.gov/study/NCT06208280 RECRUITING Autoimmune Diseases DRUG: After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated. RenJi Hospital Shanghai Simnova Biotechnology Co.,Ltd.

NCT06236880 A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD https://clinicaltrials.gov/study/NCT06236880 RECRUITING Major Depressive Disorder DRUG: GM-2505 Gilgamesh Pharmaceuticals

NCT06347380 Usability Study of the FemPulse System https://clinicaltrials.gov/study/NCT06347380 RECRUITING Overactive Bladder DEVICE: FemPulse System FemPulse Corporation

NCT06229080 SEGWAY(Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization) https://clinicaltrials.gov/study/NCT06229080 RECRUITING Liver Cancer (Primary and Metastatic) DEVICE: NexGel Next Biomedical Co., Ltd.

NCT06413680 A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies https://clinicaltrials.gov/study/NCT06413680 RECRUITING Melanoma

NCT06363162 Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery https://clinicaltrials.gov/study/NCT06363162 RECRUITING Glioma DIAGNOSTIC_TEST: Immunohistochemistry or genetic test Beijing Tiantan Hospital West China Hospital

NCT04879329 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 https://clinicaltrials.gov/study/NCT04879329 RECRUITING Urothelial Carcinoma DRUG: disitamab vedotin

NCT04528680 Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT04528680 RECRUITING Glioblastoma

NCT04052880 Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM https://clinicaltrials.gov/study/NCT04052880 RECRUITING Newly Diagnosed Multiple Myeloma DRUG: Daratumumab

NCT06031480 Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors https://clinicaltrials.gov/study/NCT06031480 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: Anlotinib and TQB2450 Shanghai Zhongshan Hospital Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06648980 Effect of a Nutritional Supplement with Phytoglycogen on Gut-brain Axis with Focus to Perceived Stress, Mood and Sleep https://clinicaltrials.gov/study/NCT06648980 NOT_YET_RECRUITING Perceived Stress DIETARY_SUPPLEMENT: Placebo

NCT06440980 A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight https://clinicaltrials.gov/study/NCT06440980 RECRUITING Healthy

NCT06321562 Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma https://clinicaltrials.gov/study/NCT06321562 RECRUITING Primary Open-angle Glaucoma DRUG: TimoD implant

NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 https://clinicaltrials.gov/study/NCT06346392 RECRUITING Gastric Cancer

NCT05433792 To Evaluate the Effectiveness of New Specially Designed Fitlens Soft Lens. https://clinicaltrials.gov/study/NCT05433792 RECRUITING Myopia DEVICE: Myolens CN (Central-Near) soft contact lens

NCT06216392 Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis https://clinicaltrials.gov/study/NCT06216392 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: GR1802 injection

NCT05086692 A Beta-only IL-2 ImmunoTherapY Study https://clinicaltrials.gov/study/NCT05086692 RECRUITING Advanced Solid Tumor

NCT05890092 Vulvar Disease in Nigeria Observational Study https://clinicaltrials.gov/study/NCT05890092 RECRUITING Vulvar Diseases

NCT04882592 Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy https://clinicaltrials.gov/study/NCT04882592 RECRUITING Cerebral Palsy DEVICE: SCiP SpineX Inc.

NCT05846789 Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers https://clinicaltrials.gov/study/NCT05846789 RECRUITING Metastatic Breast Cancer

NCT05796089 Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy https://clinicaltrials.gov/study/NCT05796089 RECRUITING Extensive-Stage Small-Cell Lung Cancer RADIATION: Thoracic Radiotherapy

NCT05515289 Study of SHR6390 in Renal Insufficiency and Healthy Subjects https://clinicaltrials.gov/study/NCT05515289 RECRUITING Breast Cancer DRUG: SHR6390 Jiangsu HengRui Medicine Co., Ltd.

NCT04562129 IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients https://clinicaltrials.gov/study/NCT04562129 RECRUITING Melanoma Stage III

NCT04695080 ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis https://clinicaltrials.gov/study/NCT04695080 RECRUITING Advanced Multiple Sclerosis

NCT06323980 INHANCE Stemless Reverse Shoulder IDE https://clinicaltrials.gov/study/NCT06323980 NOT_YET_RECRUITING Arthroplasty

NCT05978180 Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2) https://clinicaltrials.gov/study/NCT05978180 RECRUITING Knee Osteoarthritis DEVICE: Medical Device : HO-1

NCT05517980 Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis https://clinicaltrials.gov/study/NCT05517980 NOT_YET_RECRUITING Glomerulonephritis DRUG: KP104 Kira Pharmacenticals (US), LLC.

NCT06209580 AMT-253 in Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06209580 RECRUITING Malignant Melanoma

NCT04398680 A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function https://clinicaltrials.gov/study/NCT04398680 RECRUITING Multiple Myeloma DRUG: Belantamab mafodotin GlaxoSmithKline

NCT03945162 Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients https://clinicaltrials.gov/study/NCT03945162 RECRUITING Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG COMBINATION_PRODUCT: Ruvidar® (TLD-1433) Bladder infusion and PDT Theralase® Technologies Inc.

NCT06497062 Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06497062 NOT_YET_RECRUITING Acute Myeloid Leukemia DRUG: sonrotoclax

NCT05819580 Studying the Clinical Trial Experiences of Patients With Mesothelioma https://clinicaltrials.gov/study/NCT05819580 NOT_YET_RECRUITING Mesothelioma Power Life Sciences Inc.

NCT06253780 Multidisciplinary Study to Verify Blood Pressure Documentation and Response to Titration of Intravenous Medications https://clinicaltrials.gov/study/NCT06253780 RECRUITING Blood Pressure University of Texas Southwestern Medical Center Chiesi USA, Inc.

NCT03727880 Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT03727880 RECRUITING Resectable Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04679662 EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation https://clinicaltrials.gov/study/NCT04679662 NOT_YET_RECRUITING Degenerative Mitral Valve Disease DEVICE: Transcatheter mitral valve repair (PLAR Implant and Delivery System) Polares Medical SA Polares Medical, Inc.

NCT04163562 Oral Immunotherapy for Peanut Allergic Patients https://clinicaltrials.gov/study/NCT04163562 RECRUITING Peanut Allergy DRUG: INP20

NCT06087289 A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer https://clinicaltrials.gov/study/NCT06087289 RECRUITING Epithelial Ovarian Cancer

NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT06193889 RECRUITING Myasthenia Gravis

NCT05538689 Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) https://clinicaltrials.gov/study/NCT05538689 RECRUITING Metrorrhagia

NCT06719089 Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent https://clinicaltrials.gov/study/NCT06719089 NOT_YET_RECRUITING Urinary Lithiasis DEVICE: Biodegradable double loop ureteral stent

NCT05400980 Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross(TM) Expander System & Retrieval Sheath https://clinicaltrials.gov/study/NCT05400980 RECRUITING Benign Prostatic Hyperplasia DEVICE: Urocross implant

NCT05568680 SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma https://clinicaltrials.gov/study/NCT05568680 RECRUITING Ovarian Cancer

NCT04789980 Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY https://clinicaltrials.gov/study/NCT04789980 RECRUITING Locally Advanced Pancreatic Cancer

NCT06014762 P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies https://clinicaltrials.gov/study/NCT06014762 RECRUITING Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

NCT06442462 Study of SPG302 in Adults With Schizophrenia https://clinicaltrials.gov/study/NCT06442462 RECRUITING Schizophrenia DRUG: SPG302

NCT05625529 ExoLuminate Study for Early Detection of Pancreatic Cancer https://clinicaltrials.gov/study/NCT05625529 RECRUITING Pancreas Cancer

NCT05960929 InfasurfAero‚Ñ¢ Versus Sham Treatment in Preterm Newborns With RDS https://clinicaltrials.gov/study/NCT05960929 NOT_YET_RECRUITING Respiratory Distress Syndrome (Neonatal)

NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial https://clinicaltrials.gov/study/NCT04419480 RECRUITING Cardiogenic Shock

NCT05576480 SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05576480 NOT_YET_RECRUITING Rectal Cancer

NCT05926180 Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients With EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) https://clinicaltrials.gov/study/NCT05926180 RECRUITING Non-small Cell Lung Cancer DRUG: DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin) Dizal Pharmaceuticals

NCT06049680 Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD And/or PNAC in Pediatric and Adult Patients https://clinicaltrials.gov/study/NCT06049680 RECRUITING Malnutrition, Child

NCT03776162 A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction https://clinicaltrials.gov/study/NCT03776162 RECRUITING Anterior Cruciate Ligament Tear PROCEDURE: ACL Reconstruction (Bone Patellar Tendon Bone Graft)

NCT06257680 A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06257680 RECRUITING Advanced Solid Tumor BIOLOGICAL: ReT01 ACT Aeonvital Biomedicine

NCT05393180 CONVERGE Post-Approval Study (PAS) https://clinicaltrials.gov/study/NCT05393180 RECRUITING Chronic Atrial Fibrillation DEVICE: Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF AtriCure, Inc.

NCT03423680 A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression https://clinicaltrials.gov/study/NCT03423680 RECRUITING Depression, Bipolar DRUG: Abilify 2, 5, 10, 15mg (Tablet)

NCT04801680 Mpact 3D Metal Cup PMS https://clinicaltrials.gov/study/NCT04801680 RECRUITING Total Hip Arthroplasty DEVICE: Mpact 3D metal cup Medacta International SA

NCT04566380 ONO-4538 Phase II Rollover Study (ONO-4538-98) https://clinicaltrials.gov/study/NCT04566380 RECRUITING Pan-tumor DRUG: ONO-4538

NCT06097780 Efficacy and Safety of NestaCell® in Huntington's Disease https://clinicaltrials.gov/study/NCT06097780 NOT_YET_RECRUITING Huntington Disease GENETIC: NestaCell® Azidus Brasil Cellavita Pesquisa Científica Ltda

NCT03892980 Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy https://clinicaltrials.gov/study/NCT03892980 RECRUITING Nipple Sparing Mastectomy DEVICE: Nipple-Sparing Mastectomy Intuitive Surgical

NCT06581380 JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06581380 NOT_YET_RECRUITING Small Cell Lung Cancer DRUG: JK-1201I

NCT05807880 Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma https://clinicaltrials.gov/study/NCT05807880 NOT_YET_RECRUITING Nasopharyngeal Neoplasms DRUG: The combination treatment of anlotinib, penpulimab and capecitabine. Sun Yat-sen University Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06251180 Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06251180 RECRUITING B-cell Non-Hodgkin Lymphoma DRUG: Rocbrutinib

NCT05692180 A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) https://clinicaltrials.gov/study/NCT05692180 RECRUITING Asthma DRUG: Benralizumab

NCT04404062 Serological and PCR Testing for COVID-19 https://clinicaltrials.gov/study/NCT04404062 RECRUITING COVID-19 DIAGNOSTIC_TEST: Membrane-based immunoassay kit

NCT06073873 A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea https://clinicaltrials.gov/study/NCT06073873 RECRUITING Ulcerative Colitis DRUG: Ozanimod Bristol-Myers Squibb

NCT05882773 Asian Myeloproliferative Neoplasm (MPN) Registry https://clinicaltrials.gov/study/NCT05882773 RECRUITING Myeloproliferative Neoplasm

NCT06319573 The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization https://clinicaltrials.gov/study/NCT06319573 RECRUITING Infertility OTHER: Counseling Supported by Univfy® Report

NCT06177431 An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease https://clinicaltrials.gov/study/NCT06177431 RECRUITING Motor Neuron Disease DRUG: Monepantel Neurizon Therapeutics Limited Calvary Health Care Bethlehem

NCT04023331 67Cu-SARTATE‚Ñ¢ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma https://clinicaltrials.gov/study/NCT04023331 RECRUITING Neuroblastoma

NCT06473831 MagDI Australia Study https://clinicaltrials.gov/study/NCT06473831 RECRUITING Obesity

NCT05883631 RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. https://clinicaltrials.gov/study/NCT05883631 RECRUITING Atrial Fibrillation

NCT06021431 Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT https://clinicaltrials.gov/study/NCT06021431 RECRUITING Opioid Use Disorder DEVICE: MORE-VR

NCT05133531 A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment https://clinicaltrials.gov/study/NCT05133531 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: Ravulizumab

NCT00567073 Pompe Pregnancy Sub-Registry https://clinicaltrials.gov/study/NCT00567073 RECRUITING Glycogen Storage Disease Type II (GSD-II)

NCT03654573 The MOCA I Study - Microvascular Obstruction With CoFI‚Ñ¢ System Assessment https://clinicaltrials.gov/study/NCT03654573 RECRUITING STEMI - ST Elevation Myocardial Infarction

NCT05750173 The EASE-IT CT Registry https://clinicaltrials.gov/study/NCT05750173 RECRUITING Transcatheter Aortic Valve Implantation (TAVI) OTHER: Streamlining of the pre-procedural patient pathway Institut für Pharmakologie und Präventive Medizin Edwards Lifesciences

NCT06456073 E-CEL UVEC Treatment for Anal Fissures https://clinicaltrials.gov/study/NCT06456073 RECRUITING Chronic Anal Fissure BIOLOGICAL: E-CEL UVEC cells (AB-207) Weill Medical College of Cornell University Angiocrine Bioscience

NCT06502873 Setting up a Cohort of Patients With Crohn's Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease https://clinicaltrials.gov/study/NCT06502873 RECRUITING Crohn Disease PROCEDURE: biological samples collection Artialis

NCT06690931 Neurofeedback Rehabilitation with FES and VR for PD https://clinicaltrials.gov/study/NCT06690931 RECRUITING Parkinson Disease DEVICE: Brain-Computer Interface with FES and VR

NCT06122831 A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) https://clinicaltrials.gov/study/NCT06122831 RECRUITING Myelofibrosis DRUG: TQ05105 Tablets

NCT06072131 To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL https://clinicaltrials.gov/study/NCT06072131 RECRUITING Peripheral T Cell Lymphoma DRUG: Belinostat Injection

NCT06688331 Treatment of Pre-diabetic State in Pediatric Population with Treg Cell Preparations and Rituximab https://clinicaltrials.gov/study/NCT06688331 NOT_YET_RECRUITING Presymptomatic Diabetes Type 1 (stage 1)

NCT06104631 A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms https://clinicaltrials.gov/study/NCT06104631 NOT_YET_RECRUITING Irritable Bowel Syndrome-like Symptoms

NCT05294731 Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader https://clinicaltrials.gov/study/NCT05294731 RECRUITING B-cell Malignancy

NCT06318273 A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06318273 RECRUITING Metastatic Castration-Resistant Prostate Cancer DRUG: ABBV-969 AbbVie

NCT06311773 Pivotal Trial of the Boomerang Catheter for pDVA https://clinicaltrials.gov/study/NCT06311773 NOT_YET_RECRUITING Chronic Limb-Threatening Ischemia DEVICE: Boomerang Catheter Aveera Medical, Inc.

NCT05172973 ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves https://clinicaltrials.gov/study/NCT05172973 RECRUITING Aortic Valve Insufficiency

NCT05845073 The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms https://clinicaltrials.gov/study/NCT05845073 RECRUITING Antibiotic-associated Diarrhea DIETARY_SUPPLEMENT: Probiotic

NCT06662773 Drug-Drug Interaction (DDI) Study for TQB3616 https://clinicaltrials.gov/study/NCT06662773 NOT_YET_RECRUITING Healthy DRUG: TQB3616 capsule + itraconazole

NCT04581473 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection https://clinicaltrials.gov/study/NCT04581473 RECRUITING Gastric Adenocarcinoma

NCT05319873 Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer https://clinicaltrials.gov/study/NCT05319873 RECRUITING Anatomic Stage II Breast Cancer AJCC v8

NCT06556173 Phase 2a Study of VTX3232 in Parkinson's Disease https://clinicaltrials.gov/study/NCT06556173 RECRUITING Idiopathic Parkinson Disease DRUG: VTX3232 Zomagen Biosciences Ltd.

NCT04353973 Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients https://clinicaltrials.gov/study/NCT04353973 RECRUITING Cancer OTHER: Pre-Test Intervention

NCT05597631 G-IVF and Sperm Parameters https://clinicaltrials.gov/study/NCT05597631 NOT_YET_RECRUITING Infertility, Male DEVICE: G-IVF PLUS Vitrolife

NCT05762731 Screening for Lung Cancer in Subjects With Family History of Lung Cancer https://clinicaltrials.gov/study/NCT05762731 RECRUITING Lung Cancer DIAGNOSTIC_TEST: Low dose CT thorax

NCT06246331 Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection https://clinicaltrials.gov/study/NCT06246331 RECRUITING Reversal of Neuromuscular Blockade Hanlim Pharm. Co., Ltd.

NCT05676931 Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05676931 RECRUITING Advanced Non-Small Cell Lung Cancer DRUG: Domvanalimab

NCT04347473 ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. https://clinicaltrials.gov/study/NCT04347473 RECRUITING Psoriasis DRUG: Ilumya Injectable Product Psoriasis Treatment Center of Central New Jersey Sun Pharmaceutical Industries Limited

NCT06435273 A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma https://clinicaltrials.gov/study/NCT06435273 RECRUITING Asthma DRUG: AZD4604

NCT05301673 ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence https://clinicaltrials.gov/study/NCT05301673 RECRUITING Attention Deficit Hyperactivity Disorder

NCT05272631 Depuy Synthes Lower Extremity Shaft Nail Registry https://clinicaltrials.gov/study/NCT05272631 RECRUITING Femoral Fractures

NCT06519331 Development of a New Method for Liver Stiffness Measurement Using FibroScan https://clinicaltrials.gov/study/NCT06519331 NOT_YET_RECRUITING Liver Diseases DEVICE: Research FibroScan (FS) Echosens

NCT06321731 Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain. https://clinicaltrials.gov/study/NCT06321731 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) AstraZeneca

NCT05011331 The Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome https://clinicaltrials.gov/study/NCT05011331 RECRUITING Rotator Cuff Injuries DEVICE: MedCline Shoulder Relief System Rhode Island Hospital Amenity Health, Inc.

NCT05731973 Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum https://clinicaltrials.gov/study/NCT05731973 RECRUITING Pectus Excavatum

NCT04116073 INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer https://clinicaltrials.gov/study/NCT04116073 RECRUITING Pancreatic Cancer Non-resectable

NCT06661473 Interventional Study Exploring the Occurrence of Surgical Site Infections. https://clinicaltrials.gov/study/NCT06661473 RECRUITING Total Knee Arthroplasty

NCT05800873 Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 https://clinicaltrials.gov/study/NCT05800873 RECRUITING Primary Membranous Nephropathy DRUG: EVER001 Everest Medicines (China) Co.,Ltd.

NCT05601973 Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI https://clinicaltrials.gov/study/NCT05601973 RECRUITING Non Small Cell Lung Cancer DRUG: Amivantamab

NCT06393673 A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women https://clinicaltrials.gov/study/NCT06393673 NOT_YET_RECRUITING Vasomotor Symptoms DRUG: HS-10384 tablet Dose 1

NCT04433273 Electrical Vestibular Stimulation (VeNS): Assessment of AMPK & SIRT1 Following Repeated Usage https://clinicaltrials.gov/study/NCT04433273 NOT_YET_RECRUITING Overweight and Obesity DEVICE: Electrical vestibular nerve stimulation Neurovalens Ltd. Compliance Solutions Ltd.

NCT03549273 Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions https://clinicaltrials.gov/study/NCT03549273 RECRUITING Carcinoma

NCT02880631 BAROSTIM THERAPY‚Ñ¢ In Resistant Hypertension https://clinicaltrials.gov/study/NCT02880631 RECRUITING Hypertension DEVICE: BAROSTIM NEO‚Ñ¢ System CVRx, Inc.

NCT05338931 Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05338931 RECRUITING B-cell Non Hodgkin Lymphoma DRUG: AT101(Anti-CD19 Chimeric Antigen Receptor T cell) AbClon

NCT06494631 Xeltis Hemodialysis Access Graft (aXess) US Study https://clinicaltrials.gov/study/NCT06494631 NOT_YET_RECRUITING End Stage Renal Disease DEVICE: Xeltis Hemodialysis Access (aXess) graft Xeltis

NCT05327127 Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis https://clinicaltrials.gov/study/NCT05327127 RECRUITING NASH DRUG: K-877-ER

NCT06239727 Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response https://clinicaltrials.gov/study/NCT06239727 RECRUITING Nasopharyngeal Carcinoma DRUG: PD-1 blocking antibody

NCT04471727 A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) https://clinicaltrials.gov/study/NCT04471727 RECRUITING Small-Cell Lung Cancer

NCT06605573 Lay User Evaluation of the Panbio‚Ñ¢ HCV Self-Test https://clinicaltrials.gov/study/NCT06605573 NOT_YET_RECRUITING HEPATITIS C (HCV) DIAGNOSTIC_TEST: Panbio‚Ñ¢ HCV Self Test Abbott Rapid Dx Aga Khan University

NCT05456373 Intraoperative Use of ClearEdge Device in Breast Conserving Surgery https://clinicaltrials.gov/study/NCT05456373 RECRUITING Breast Cancer DEVICE: ClearEdge device LS BioPath

NCT06671873 Study on Mass Balance of [14C]HMPL-306（Isocitrate Dehydrogenase Inhibitor） in Healthy Chinese Adult Male Subjects https://clinicaltrials.gov/study/NCT06671873 RECRUITING Mass Balance Study DRUG: 100 µCi [14C] HMPL-306 Hutchmed

NCT05250973 A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis https://clinicaltrials.gov/study/NCT05250973 RECRUITING Amyloidosis DRUG: Daratumumab

NCT06649773 The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients https://clinicaltrials.gov/study/NCT06649773 RECRUITING Type 2 Diabetes DRUG: Noiiglutide Injection

NCT05786573 A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) https://clinicaltrials.gov/study/NCT05786573 RECRUITING Warm Autoimmune Hemolytic Anemia DRUG: Obexelimab

NCT06423573 A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez https://clinicaltrials.gov/study/NCT06423573 NOT_YET_RECRUITING Epidermolysis Bullosa, Dystrophic

NCT05988073 A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy https://clinicaltrials.gov/study/NCT05988073 RECRUITING Multifocal Motor Neuropathy argenx

NCT05941273 A Study of the SING IMT in an Israeli Cohort https://clinicaltrials.gov/study/NCT05941273 NOT_YET_RECRUITING Age-Related Macular Degeneration

NCT06506773 Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) https://clinicaltrials.gov/study/NCT06506773 RECRUITING Cystic Fibrosis Vertex Pharmaceuticals Incorporated

NCT05309473 Acoustic Stimulation During Restricted Sleep After Sleep Deprivation https://clinicaltrials.gov/study/NCT05309473 RECRUITING Sleep Deprivation

NCT03672773 Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT03672773 RECRUITING Recurrent Extensive Stage Small Cell Lung Carcinoma

NCT06415773 Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin https://clinicaltrials.gov/study/NCT06415773 RECRUITING T2DM (Type 2 Diabetes Mellitus) DRUG: HTD1801

NCT03486873 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) https://clinicaltrials.gov/study/NCT03486873 RECRUITING Solid Tumors

NCT05515367 A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) https://clinicaltrials.gov/study/NCT05515367 RECRUITING Chronic Kidney Diseases

NCT06431373 A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis https://clinicaltrials.gov/study/NCT06431373 RECRUITING Uveitis, Posterior

NCT05606367 Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis(CREST) https://clinicaltrials.gov/study/NCT05606367 RECRUITING Coronary Artery Stenosis DEVICE: Non-slip Balloon Catheter of Shanghai MicroPort Rhythm

NCT04977167 Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma https://clinicaltrials.gov/study/NCT04977167 RECRUITING Solid Tumor

NCT05660967 Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05660967 RECRUITING Diffuse Large B-Cell Lymphoma BIOLOGICAL: Epcoritamab

NCT01623167 Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia https://clinicaltrials.gov/study/NCT01623167 RECRUITING Severe Aplastic Anemia DRUG: Cohort 1: hATG, CsA, EPAG Day 14 to Month 6

NCT06548867 Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib https://clinicaltrials.gov/study/NCT06548867 RECRUITING Metastatic Renal Cell Carcinoma DRUG: Cabozantinib Gruppo Oncologico Italiano di Ricerca Clinica Yghea

NCT04501367 Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. https://clinicaltrials.gov/study/NCT04501367 RECRUITING Vitrectomy

NCT06673667 First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06673667 RECRUITING Healthy Participants Study DRUG: KT-621

NCT06521567 A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer https://clinicaltrials.gov/study/NCT06521567 NOT_YET_RECRUITING Melanoma DRUG: Cobolimab

NCT03947567 Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients. https://clinicaltrials.gov/study/NCT03947567 RECRUITING Hemophilia A DRUG: Recombinant Human Coagulation FVIII Sinocelltech Ltd.

NCT06063967 A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. https://clinicaltrials.gov/study/NCT06063967 RECRUITING Crohn's Disease DRUG: Risankizumab SC

NCT04918667 Effect of Gamma-cyclodextrin on the Bioavailability of Berberine https://clinicaltrials.gov/study/NCT04918667 NOT_YET_RECRUITING Drug Absorption COMBINATION_PRODUCT: Berberine incorporated in gamma cyclodextrin

NCT06346067 A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) https://clinicaltrials.gov/study/NCT06346067 RECRUITING Advanced or Metastatic NRAS-mutant Melanoma DRUG: Naporafenib

NCT06444867 A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 https://clinicaltrials.gov/study/NCT06444867 RECRUITING Joint Pain

NCT06305767 A Clinical Study of V940 Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) https://clinicaltrials.gov/study/NCT06305767 RECRUITING Bladder Cancer BIOLOGICAL: Pembrolizumab

NCT06310967 A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06310967 NOT_YET_RECRUITING Hyperuricemia

NCT06422767 Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers https://clinicaltrials.gov/study/NCT06422767 NOT_YET_RECRUITING Hepatitis B DRUG: Bepirovirsen

NCT05337540 A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee https://clinicaltrials.gov/study/NCT05337540 RECRUITING Osteoarthritis

NCT05701540 A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn https://clinicaltrials.gov/study/NCT05701540 RECRUITING Gastroesophageal Reflux Disease DRUG: Tegoprazan

NCT06333067 Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators https://clinicaltrials.gov/study/NCT06333067 RECRUITING Lax Skin DEVICE: Sofwave Sofwave Medical LTD

NCT04982367 Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis https://clinicaltrials.gov/study/NCT04982367 RECRUITING Peripheral Artery Disease DEVICE: Sirolimus-eluting balloon catheter

NCT03127267 Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients https://clinicaltrials.gov/study/NCT03127267 RECRUITING Amyotrophic Lateral Sclerosis DRUG: Masitinib (6.0)

NCT06018467 Senolytics to Improve Osteoporosis Therapy https://clinicaltrials.gov/study/NCT06018467 RECRUITING Osteopenia, Osteoporosis DRUG: Dasatinib 100 Mg Oral Tablet

NCT06383767 A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT06383767 RECRUITING Metastatic Breast Cancer DRUG: ESG401

NCT06394167 A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults https://clinicaltrials.gov/study/NCT06394167 RECRUITING Pain DRUG: VX-993

NCT04579367 Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia https://clinicaltrials.gov/study/NCT04579367 RECRUITING Hypercholesterolemia

NCT06109467 Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer https://clinicaltrials.gov/study/NCT06109467 RECRUITING GastroEsophageal Cancer

NCT05234567 A Prospective Sub-Study of the Global Hypophosphatasia Registry https://clinicaltrials.gov/study/NCT05234567 RECRUITING Hypophosphatasia BIOLOGICAL: Asfotase Alfa Alexion Pharmaceuticals, Inc.

NCT06528067 Mindful Motivation for Reducing Binge Eating https://clinicaltrials.gov/study/NCT06528067 NOT_YET_RECRUITING Binge Eating

NCT06262867 Early Allergen System Experience https://clinicaltrials.gov/study/NCT06262867 NOT_YET_RECRUITING Food Allergy in Infants DIETARY_SUPPLEMENT: Ready. Set. Food! Stage 1 Mix ins Prollergy dba Ready Set Food ObvioHealth

NCT05287867 Trial for Treating Painful Degenerative Disc Disease https://clinicaltrials.gov/study/NCT05287867 RECRUITING Degenerative Disc Disease BIOLOGICAL: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP)

NCT05330767 DermaClose DUKE Fasciotomy and Wound Study https://clinicaltrials.gov/study/NCT05330767 RECRUITING Wound of Skin DEVICE: DermaClose Continuous External Tissue Expander Device

NCT04942067 APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04942067 RECRUITING Multiple Myeloma

NCT05460767 Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma https://clinicaltrials.gov/study/NCT05460767 RECRUITING Solid Tumors or Lymphoma BIOLOGICAL: IBI363 Innovent Biologics (Suzhou) Co. Ltd.

NCT06071767 Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 https://clinicaltrials.gov/study/NCT06071767 RECRUITING HIV-1-infection BIOLOGICAL: ChAdOx1.tHIVconsv1

NCT05105867 CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies https://clinicaltrials.gov/study/NCT05105867 RECRUITING Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

NCT05090267 The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study https://clinicaltrials.gov/study/NCT05090267 RECRUITING Cognition

NCT06368167 A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma https://clinicaltrials.gov/study/NCT06368167 NOT_YET_RECRUITING Follicular Lymphoma DRUG: SHR2554 Jiangsu HengRui Medicine Co., Ltd.

NCT06035367 SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes https://clinicaltrials.gov/study/NCT06035367 RECRUITING Diabetes DEVICE: Non-invasive continuous monitoring device to record photoacoustic signal Eclypia

NCT04405167 Tasquinimod for the Treatment of Relapsed or Refractory Myeloma https://clinicaltrials.gov/study/NCT04405167 RECRUITING Multiple Myeloma DRUG: Tasquinimod

NCT06716801 Real-world Clinical Response to Cenobamate Early Add-on in France, Germany and Spain https://clinicaltrials.gov/study/NCT06716801 NOT_YET_RECRUITING Focal Epilepsy with and Without Secondary Generalization DRUG: Cenobamate Aziende Chimiche Riunite Angelini Francesco S.p.A Iqvia Pty Ltd

NCT06643767 Evaluation of the Bexa Breast Examination https://clinicaltrials.gov/study/NCT06643767 RECRUITING Breast Cancer DEVICE: Bexa and focus ultrasound Sure, Inc. Hendrick Medical Center

NCT06153667 Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) https://clinicaltrials.gov/study/NCT06153667 RECRUITING Uterine Fibroid DEVICE: Bearing nsPVA Merit Medical Systems, Inc.

NCT06326567 Comprehensive Connected Cancer Care (C4): Intervention Evaluation https://clinicaltrials.gov/study/NCT06326567 RECRUITING Cancer

NCT06717867 Long-Term PEA Safety Study https://clinicaltrials.gov/study/NCT06717867 NOT_YET_RECRUITING Healthy

NCT06052267 A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations https://clinicaltrials.gov/study/NCT06052267 RECRUITING Asthma DRUG: TEV-56248

NCT06385067 Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter https://clinicaltrials.gov/study/NCT06385067 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: Biolimus Coated Coronary Artery Balloon Dilation Catheter JW Medical Systems Ltd

NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia https://clinicaltrials.gov/study/NCT06651567 RECRUITING Agitation Associated With Alzheimer's Dementia DRUG: ITI-1284

NCT05872867 Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) https://clinicaltrials.gov/study/NCT05872867 RECRUITING Advanced Solid Tumor

NCT05797740 Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA) https://clinicaltrials.gov/study/NCT05797740 RECRUITING Multiple Sclerosis DRUG: Mavenclad Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

NCT05988840 Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study. https://clinicaltrials.gov/study/NCT05988840 NOT_YET_RECRUITING Anxiety Disorders

NCT05507827 Safety of Myeloablative Conditioning, Orca-T, and Allogeneic, Donor-Derived CD19/CD22-CAR (Chimeric Antigen Receptor) T Cells in Adults With B-cell Acute Lymphoblastic Leukemia (ALL) https://clinicaltrials.gov/study/NCT05507827 RECRUITING Lymphoid Leukemia DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)

NCT06079827 Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients https://clinicaltrials.gov/study/NCT06079827 RECRUITING Alzheimer Disease MaxWell Clinic, PLC

NCT06554873 Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders https://clinicaltrials.gov/study/NCT06554873 RECRUITING Smoking Cessation

NCT05311527 UroLift System With SAbR for Prostate Cancer and BPH https://clinicaltrials.gov/study/NCT05311527 RECRUITING Prostate Cancer DEVICE: Urolift

NCT06593327 NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study https://clinicaltrials.gov/study/NCT06593327 NOT_YET_RECRUITING Type 2 Diabetes

NCT05812027 A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05812027 RECRUITING Head and Neck Cancer

NCT06690827 Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN https://clinicaltrials.gov/study/NCT06690827 RECRUITING AML (Acute Myeloid Leukemia)

NCT06224673 ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06224673 NOT_YET_RECRUITING HER2 Low Breast Carcinoma

NCT03072927 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study https://clinicaltrials.gov/study/NCT03072927 RECRUITING Lumbar Spinal Stenosis DEVICE: MILD

NCT05393427 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors https://clinicaltrials.gov/study/NCT05393427 RECRUITING Locally Advanced or Metastatic Urinary Tumors

NCT05983627 Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome https://clinicaltrials.gov/study/NCT05983627 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome BIOLOGICAL: Human Umbilical Cord Mesenchymal Stem Cells Asia Cell Therapeutics (Shanghai) Co., Ltd.

NCT06202027 Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients https://clinicaltrials.gov/study/NCT06202027 RECRUITING FGF23-related Hypophosphataemic Rickets and Osteomalacia DRUG: FGF23-related hypophosphataemic rickets and osteomalacia Kyowa Kirin Korea Co., Ltd.

NCT06048627 Anti-gingivitis Mouthrinse https://clinicaltrials.gov/study/NCT06048627 RECRUITING Gingivitis DRUG: Amine/zinc lactate/fluoride system

NCT05525273 Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma https://clinicaltrials.gov/study/NCT05525273 RECRUITING Craniopharyngioma DRUG: Oral dabrafenib and trametinib Eva Marie Erfurth, MD, PhD Novartis

NCT05678673 Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT05678673 RECRUITING Non-Clear Cell Renal Cell Carcinoma DRUG: XL092

NCT06352073 Dupilumab for Eosinophilic Esophagitis With Severe Strictures https://clinicaltrials.gov/study/NCT06352073 RECRUITING Eosinophilic Esophagitis

NCT06501573 A Study of SGB-9768 in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06501573 NOT_YET_RECRUITING Healthy Volunteer DRUG: SGB-9768

NCT06145373 A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab https://clinicaltrials.gov/study/NCT06145373 RECRUITING Hemophilia A DRUG: Fitusiran (SAR439774)

NCT05564273 Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions https://clinicaltrials.gov/study/NCT05564273 RECRUITING Metabolic Health COMBINATION_PRODUCT: VIOME Precision Nutrition Program

NCT05879627 To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05879627 RECRUITING Advanced Solid Tumors DRUG: BAT8007 for injection Bio-Thera Solutions Zhejiang Tumor Hospital

NCT05917327 Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease https://clinicaltrials.gov/study/NCT05917327 RECRUITING Hepatolenticular Degeneration; Wilson DEVICE: Low-volume continuous veno-venous haemodialysis Mexbrain Integrated Scientific Services (ISS) AG

NCT05822427 A Long-term Follow-up Study of Participants Who Received an Allogeneic CAR T-Cell Product https://clinicaltrials.gov/study/NCT05822427 RECRUITING Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study Precision BioSciences, Inc.

NCT04175327 Prospective and Non-randomized Registry of CardioCel 3D https://clinicaltrials.gov/study/NCT04175327 RECRUITING Intracardiac and Septal Defects

NCT03897127 Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics https://clinicaltrials.gov/study/NCT03897127 RECRUITING Acute Myeloid Leukemia DRUG: Cytarabine

NCT06445127 Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) https://clinicaltrials.gov/study/NCT06445127 RECRUITING Lupus Nephritis

NCT05735327 A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY https://clinicaltrials.gov/study/NCT05735327 RECRUITING Non-small Cell Lung Cancer (NSCLC) DRUG: No intervention Takeda

NCT06031727 CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) https://clinicaltrials.gov/study/NCT06031727 RECRUITING Neovascular Age-related Macular Degeneration(nAMD) GENETIC: HG202 HuidaGene Therapeutics Co., Ltd. Tianjin Medical University Eye Hospital

NCT05479773 Safety and Usability of the LUMENA Non-invasive Ventilation Mask https://clinicaltrials.gov/study/NCT05479773 RECRUITING Respiratory Failure DEVICE: Standard NIV mask

NCT06141473 Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis https://clinicaltrials.gov/study/NCT06141473 RECRUITING Multiple Sclerosis DRUG: Frexalimab

NCT05869773 A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy https://clinicaltrials.gov/study/NCT05869773 RECRUITING Narcolepsy DRUG: JZP258 Jazz Pharmaceuticals

NCT05656573 CART-PSMA Cells for Advanced Prostate Cancer https://clinicaltrials.gov/study/NCT05656573 RECRUITING Prostate Cancer DRUG: CART-PSMA cells Nova Therapeutics LLC Chinese PLA General Hospital

NCT06634927 Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects. https://clinicaltrials.gov/study/NCT06634927 RECRUITING Type 2 Diabetes DRUG: Ozempic®

NCT06483373 A Clinical Study of SPH7854 Granules in Healthy Subjects. https://clinicaltrials.gov/study/NCT06483373 RECRUITING Inflammatory Bowel Disease DRUG: SPH7854

NCT06651073 ATTR-CM: A Multi-country, Non-interventional Disease Registry https://clinicaltrials.gov/study/NCT06651073 NOT_YET_RECRUITING Transthyretin Amyloid Cardiopathy OTHER: Observational Pfizer

NCT05430373 GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors https://clinicaltrials.gov/study/NCT05430373 RECRUITING Solid Tumors, Adult BIOLOGICAL: GT101 Grit Biotechnology

NCT05711927 Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants https://clinicaltrials.gov/study/NCT05711927 RECRUITING Prematurity

NCT06581627 A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants https://clinicaltrials.gov/study/NCT06581627 RECRUITING Healthy Volunteers

NCT06351527 Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 in Mature B-cell Malignancies https://clinicaltrials.gov/study/NCT06351527 NOT_YET_RECRUITING Mature B-cell Malignancies DRUG: ICP-248 InnoCare Pharma Inc.

NCT06212427 Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) https://clinicaltrials.gov/study/NCT06212427 RECRUITING Premature Infant

NCT05866627 A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants https://clinicaltrials.gov/study/NCT05866627 RECRUITING Healthy Volunteers DRUG: Famotidine

NCT06314373 A Study for HSK39775 in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT06314373 RECRUITING Advanced Solid Tumors DRUG: HSK39775 Monotherapy Xizang Haisco Pharmaceutical Co., Ltd

NCT05973773 REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) https://clinicaltrials.gov/study/NCT05973773 RECRUITING Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation DRUG: TAS6417 Taiho Oncology, Inc.

NCT05193227 Sustained Release Lidocaine for the Treatment of Postoperative Pain https://clinicaltrials.gov/study/NCT05193227 RECRUITING Postoperative Pain

NCT05431127 High Dose Inspiratory Muscle Training in LOPD https://clinicaltrials.gov/study/NCT05431127 RECRUITING Late-Onset Pompe Disease

NCT06487273 Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis https://clinicaltrials.gov/study/NCT06487273 NOT_YET_RECRUITING Non-cystic Fibrosis Bronchiectasis DEVICE: SIMEOX

NCT04647227 SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors https://clinicaltrials.gov/study/NCT04647227 RECRUITING Hemophilia A With Inhibitor

NCT03985527 Janus Feasibility Study https://clinicaltrials.gov/study/NCT03985527 RECRUITING Sleep Apnea Syndromes DEVICE: Transvenous nerve stimulation Respicardia, Inc.

NCT04714827 Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04714827 RECRUITING Multiple Myeloma BIOLOGICAL: KQ-2003 CAR-T cells Shanxi Province Cancer Hospital Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

NCT05162573 EBRT + Lu-PSMA for N1M0 Prostate Cancer https://clinicaltrials.gov/study/NCT05162573 RECRUITING Prostatic Neoplasm DRUG: 177Lu-PSMA-617

NCT05542173 Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations https://clinicaltrials.gov/study/NCT05542173 NOT_YET_RECRUITING Aphthous Stomatitis DRUG: BALI association

NCT05007873 ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase https://clinicaltrials.gov/study/NCT05007873 RECRUITING Chronic Phase Chronic Myelogenous Leukemia

NCT04792073 Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma https://clinicaltrials.gov/study/NCT04792073 RECRUITING Merkel Cell Carcinoma DRUG: Avelumab

NCT06282289 Elicitation of Steady-state Audiovisual Responses in 6- and 10-month-old Infants https://clinicaltrials.gov/study/NCT06282289 NOT_YET_RECRUITING Speech BEHAVIORAL: Magnetoencephalography (MEG)

NCT05629689 A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies https://clinicaltrials.gov/study/NCT05629689 RECRUITING Malignant Solid Tumor

NCT06080789 A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants with Acute Pancreatitis https://clinicaltrials.gov/study/NCT06080789 RECRUITING Acute Pancreatitis DRUG: RABI-767 Panafina, Inc.

NCT06629389 Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms https://clinicaltrials.gov/study/NCT06629389 RECRUITING Parkinson Disease DRUG: Cannabidiol 100 mg/ml

NCT05264389 Post-market Clinical Follow-up (PMCF) Study of the Poly-Tape Device for Medial Patellofemoral Ligament (MPFL) Reconstruction https://clinicaltrials.gov/study/NCT05264389 RECRUITING Medial Patellofemoral Dislocation DEVICE: Poly-Tape Xiros Ltd

NCT06646289 A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) https://clinicaltrials.gov/study/NCT06646289 NOT_YET_RECRUITING X-Linked Retinitis Pigmentosa BIOLOGICAL: AAV5-hRKp.RPGR

NCT06058689 A Pilot Bioequivalence Study of Pomalidomide https://clinicaltrials.gov/study/NCT06058689 NOT_YET_RECRUITING Bioequivalence Study DRUG: Pomalidomide 4 MG Oral Capsule Megalabs

NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. https://clinicaltrials.gov/study/NCT00404989 RECRUITING HIV Infections

NCT05646589 A Person-centred Care Transition Support for People With Stroke/TIA https://clinicaltrials.gov/study/NCT05646589 RECRUITING Stroke

NCT05924789 Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America https://clinicaltrials.gov/study/NCT05924789 RECRUITING Gastric Cancer

NCT06171789 PRO1107 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06171789 RECRUITING Endometrial Cancer

NCT05142189 Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients with Advanced Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05142189 RECRUITING Non-Small Cell Lung Cancer BIOLOGICAL: BNT116

NCT06654089 A Study Evaluating Quality of Life Parameters Following Use of Emergen-C https://clinicaltrials.gov/study/NCT06654089 RECRUITING Dietary Supplements DIETARY_SUPPLEMENT: Emergen-C Core Super Orange Powder

NCT05417789 Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) https://clinicaltrials.gov/study/NCT05417789 RECRUITING TGCT DRUG: Emactuzumab

NCT06535789 Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes https://clinicaltrials.gov/study/NCT06535789 NOT_YET_RECRUITING Diabetes, Gestational

NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the MitraClip G4 https://clinicaltrials.gov/study/NCT05455489 RECRUITING Mitral Valve Regurgitation Fondazione GISE Onlus University of Padova

NCT05498389 EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer https://clinicaltrials.gov/study/NCT05498389 NOT_YET_RECRUITING Metastatic Lung Non-Small Cell Carcinoma

NCT05850689 Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder https://clinicaltrials.gov/study/NCT05850689 RECRUITING Major Depressive Disorder DRUG: Lumateperone

NCT04801589 Goal-Directed Sedation in Mechanically Ventilated Infants and Children https://clinicaltrials.gov/study/NCT04801589 RECRUITING Delirium

NCT06547489 GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder https://clinicaltrials.gov/study/NCT06547489 NOT_YET_RECRUITING Major Depressive Disorder DRUG: zelquistinel Gate Neurosciences, Inc

NCT05095389 Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT05095389 NOT_YET_RECRUITING Diabetic Foot Ulcer DEVICE: ADRCs

NCT00571389 A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. https://clinicaltrials.gov/study/NCT00571389 RECRUITING Solid Tumor, Adult

NCT06440889 A Clinical Study to Determine the Safety and Efficacy of Bio-Ray Knee Guard in Panelists With Varicose Vein and Knee Pain. https://clinicaltrials.gov/study/NCT06440889 NOT_YET_RECRUITING Varicose Veins With Self-declared Knee Pain DEVICE: Bio-Ray Knee Guard NovoBliss Research Pvt Ltd Winnox Cosmeceutics Sdn. Bhd

NCT05669989 International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab https://clinicaltrials.gov/study/NCT05669989 RECRUITING Plasma Cell Myeloma DRUG: Isatuximab intravenous (IV)

NCT06483789 Efficacy and Safety of HB-1 for Panic Disorder https://clinicaltrials.gov/study/NCT06483789 NOT_YET_RECRUITING Panic Disorder

NCT06552689 Sutra Hemi-valve First-in-Human Study https://clinicaltrials.gov/study/NCT06552689 NOT_YET_RECRUITING Mitral Regurgitation DEVICE: Sutra Hemi-valve Transcatheter Mitral Valve Replacement (TMVR) System Sutra Medical, Inc.

NCT06183489 Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma https://clinicaltrials.gov/study/NCT06183489 RECRUITING Smoldering Multiple Myeloma DRUG: Elranatamab Stichting European Myeloma Network Pfizer

NCT03736889 Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors https://clinicaltrials.gov/study/NCT03736889 RECRUITING MSI-H/dMMR Solid Tumors DRUG: Tislelizumab (BGB-A317) BeiGene

NCT06448689 Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis https://clinicaltrials.gov/study/NCT06448689 RECRUITING Atopic Dermatitis

NCT04850989 Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia https://clinicaltrials.gov/study/NCT04850989 RECRUITING Social Anxiety Disorder DEVICE: Pico Goblin VR headset Penn State University Limbix Health, Inc.

NCT06695689 An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06695689 RECRUITING Solid Tumor DRUG: LM303 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT06420089 CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) https://clinicaltrials.gov/study/NCT06420089 RECRUITING T Cell Non-Hodgkin Lymphoma DRUG: Senza5 CART5 Vittoria Biotherapeutics University of Pennsylvania

NCT06539689 A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries https://clinicaltrials.gov/study/NCT06539689 RECRUITING Peripheral Arterial Disease

NCT06278389 Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06278389 RECRUITING Healthy Adult Participants DRUG: ACC017 tablets

NCT06633289 Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy https://clinicaltrials.gov/study/NCT06633289 NOT_YET_RECRUITING Cow's Milk Protein Allergy OTHER: Experimental formula

NCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V https://clinicaltrials.gov/study/NCT05268289 RECRUITING Lupus Nephritis DRUG: Iptacopan (part 1)

NCT05727189 A Study of Idazoxan in Healthy Participants https://clinicaltrials.gov/study/NCT05727189 RECRUITING Healthy DRUG: TR-01-XRR (1)

NCT06694389 Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ‚â•50 Years of Age https://clinicaltrials.gov/study/NCT06694389 RECRUITING COVID-19

NCT05701189 Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome https://clinicaltrials.gov/study/NCT05701189 RECRUITING Guillain-Barre Syndrome DRUG: Efgartigimod Alfa-Fcab

NCT05395689 Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM https://clinicaltrials.gov/study/NCT05395689 RECRUITING House Dust Mite Allergy BIOLOGICAL: House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae

NCT02630589 Implantation of an Auditory Brainstem Implant for the Treatment of Incapacitating Unilateral Tinnitus https://clinicaltrials.gov/study/NCT02630589 RECRUITING Tinnitus DEVICE: Auditory brainstem implant University Medical Center Groningen MED-EL Elektromedizinische Geräte GesmbH

NCT06637189 Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. https://clinicaltrials.gov/study/NCT06637189 NOT_YET_RECRUITING Stimulation in the Ovary

NCT03567889 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients https://clinicaltrials.gov/study/NCT03567889 RECRUITING Melanoma Stage IIIB/C DRUG: Daromun

NCT06222489 Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT https://clinicaltrials.gov/study/NCT06222489 NOT_YET_RECRUITING Non-Small Cell Lung Carcinoma

NCT05409989 MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED‚Ñ¢ X‚Ñ¢) Post-Approval Study https://clinicaltrials.gov/study/NCT05409989 RECRUITING Intracranial Aneurysm DEVICE: FRED‚Ñ¢ X‚Ñ¢ Microvention-Terumo, Inc.

NCT05489289 A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection https://clinicaltrials.gov/study/NCT05489289 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: AK104

NCT06378489 The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study https://clinicaltrials.gov/study/NCT06378489 NOT_YET_RECRUITING Endometrial Hyperplasia Without Atypia DRUG: Etonogestrel implant University of the Philippines Organon

NCT06486467 Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI https://clinicaltrials.gov/study/NCT06486467 NOT_YET_RECRUITING Velocity-time Integral Measurement

NCT05966467 Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies https://clinicaltrials.gov/study/NCT05966467 RECRUITING Neuromyelitis Optica Spectrum Disorder

NCT05087667 Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) ) https://clinicaltrials.gov/study/NCT05087667 RECRUITING Femoral Fracture DEVICE: Implantation of Ortholoop cerclage

NCT04347967 Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS) https://clinicaltrials.gov/study/NCT04347967 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome BIOLOGICAL: UMC119-06 Meridigen Biotech Co., Ltd.

NCT05452889 PET Image in PAH Patients https://clinicaltrials.gov/study/NCT05452889 RECRUITING Pulmonary Arterial Hypertension DIAGNOSTIC_TEST: 18F-FGLN PET Imaging

NCT03865589 Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome https://clinicaltrials.gov/study/NCT03865589 RECRUITING Bone Marrow Transplant Complications

NCT06202989 Multiprofen-CC‚Ñ¢ to Reduce Pain After Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT06202989 RECRUITING Postsurgical Pain DRUG: Multiprofen-CC‚Ñ¢ plus standard treatment

NCT05828589 A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies https://clinicaltrials.gov/study/NCT05828589 RECRUITING Relapsed Non-Hodgkin Lymphoma

NCT06452589 The Field PULSE Study https://clinicaltrials.gov/study/NCT06452589 RECRUITING Atrial Arrhythmias DEVICE: FieldForce Ablation System Field Medical

NCT06279689 Echography Study_Anthropometric Measurements https://clinicaltrials.gov/study/NCT06279689 RECRUITING Healthy Subjects OTHER: Ultrasound scans Crossject

NCT05894889 Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC https://clinicaltrials.gov/study/NCT05894889 RECRUITING Stage IIIB(N2) Non-small Cell Lung Cancer

NCT03805789 The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant https://clinicaltrials.gov/study/NCT03805789 RECRUITING Acute-graft-versus-host Disease BIOLOGICAL: Alpha-1 antitrypsin (AAT)

NCT06651489 Efficacy of Guselkumab in Treating Hailey Hailey Disease https://clinicaltrials.gov/study/NCT06651489 NOT_YET_RECRUITING Hailey Hailey Disease DRUG: Guselkumab Yale University Janssen Scientific Affairs, LLC

NCT05296889 Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical https://clinicaltrials.gov/study/NCT05296889 RECRUITING Spine Fracture

NCT05972967 Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab https://clinicaltrials.gov/study/NCT05972967 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: OMS906 Study Drug - 3 mg/kg

NCT06436092 Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry) https://clinicaltrials.gov/study/NCT06436092 RECRUITING Stable Angina

NCT05692492 A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) https://clinicaltrials.gov/study/NCT05692492 RECRUITING Nonalcoholic Steatohepatitis (NASH) DRUG: ZSP1601

NCT06072989 Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors https://clinicaltrials.gov/study/NCT06072989 RECRUITING Advanced Solid Tumor BIOLOGICAL: B4T2-001 autologous CAR-T Shanghai East Hospital Bio4T2 LLC

NCT04644289 WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC https://clinicaltrials.gov/study/NCT04644289 RECRUITING Epithelial Ovarian Cancer DRUG: olaparib

NCT06399289 Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy https://clinicaltrials.gov/study/NCT06399289 RECRUITING Hemophilia B BIOLOGICAL: Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) CSL Behring

NCT06717789 Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain https://clinicaltrials.gov/study/NCT06717789 NOT_YET_RECRUITING Musculoskeletal Conditions

NCT06180889 Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT06180889 RECRUITING Knee Arthroplasty, Total DRUG: Enoxaparin

NCT06201689 Radicle Energy 24: a Study of Health and Wellness Products on Fatigue and Related Health Outcomes https://clinicaltrials.gov/study/NCT06201689 RECRUITING Fatigue

NCT05740189 CBAS180 De-escalation Study https://clinicaltrials.gov/study/NCT05740189 RECRUITING Barrett's Esophagus

NCT03913689 StimRouter Registry Clinical Protocol https://clinicaltrials.gov/study/NCT03913689 RECRUITING Chronic Pain

NCT06369389 Real-life Management of Patients Eligible for CAR-T Cell Therapy https://clinicaltrials.gov/study/NCT06369389 NOT_YET_RECRUITING Hemopathy OTHER: Patients eligible for CAR-T treatment University Hospital, Toulouse Ligue contre le cancer, France

NCT06045689 A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants https://clinicaltrials.gov/study/NCT06045689 RECRUITING Myelodysplastic Syndromes DRUG: Luspatercept Bristol-Myers Squibb

NCT06084689 Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures https://clinicaltrials.gov/study/NCT06084689 NOT_YET_RECRUITING Adult Soft Tissue Sarcoma

NCT06542289 Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy https://clinicaltrials.gov/study/NCT06542289 NOT_YET_RECRUITING Bell's Palsy

NCT06362889 Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy https://clinicaltrials.gov/study/NCT06362889 NOT_YET_RECRUITING Acne Vulgaris (Disorder) COMBINATION_PRODUCT: Microneedling with CBD Rejuva Medical Aesthetics HealMD, LLC

NCT06035289 Register Schweres Asthma - German Asthma Net e.V. https://clinicaltrials.gov/study/NCT06035289 RECRUITING Severe Asthma German Asthma Net e.V. AstraZeneca

NCT06100289 A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease https://clinicaltrials.gov/study/NCT06100289 NOT_YET_RECRUITING Ulcerative Colitis

NCT06625489 A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib https://clinicaltrials.gov/study/NCT06625489 NOT_YET_RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Part A: Placebo

NCT06292689 A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer https://clinicaltrials.gov/study/NCT06292689 RECRUITING Vulvar and Vaginal Cancer DRUG: Cardunolizumab Zhejiang Cancer Hospital Akeso

NCT06044389 Observational Study on the Safety and Efficacy of the Medical Product Fructosin. https://clinicaltrials.gov/study/NCT06044389 NOT_YET_RECRUITING Fructose Intolerance DEVICE: Fructosin Sciotec Diagnostic Technologies GmbH

NCT04657289 A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) https://clinicaltrials.gov/study/NCT04657289 RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: Ranibizumab

NCT05773092 A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC https://clinicaltrials.gov/study/NCT05773092 RECRUITING NSCLC DRUG: Oral S-1 + Oral Osimertinib National Cancer Centre, Singapore Taiho Pharmaceutical Co., Ltd.

NCT06501092 To Assess the Utility of the Point Mini in a Clinical Take-home Study https://clinicaltrials.gov/study/NCT06501092 NOT_YET_RECRUITING Amputation; Traumatic, Hand

NCT06114992 Servo-n HFOV Study: Safety and Performance in Neonates and Infants https://clinicaltrials.gov/study/NCT06114992 RECRUITING Elective HFOV for Respiratory Failure in Neonates/Infants

NCT05971589 A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05971589 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT05634889 The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases. https://clinicaltrials.gov/study/NCT05634889 RECRUITING Breast Cancer RADIATION: De-escalation Region Skane Exact Sciences Corporation

NCT03592472 A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) https://clinicaltrials.gov/study/NCT03592472 RECRUITING Renal Cell Carcinoma DRUG: Pazopanib

NCT05641272 Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract https://clinicaltrials.gov/study/NCT05641272 NOT_YET_RECRUITING Allergic Rhinitis

NCT05383872 Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors https://clinicaltrials.gov/study/NCT05383872 RECRUITING Glioblastoma

NCT04794972 A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04794972 RECRUITING Recurrent Glioma

NCT06101472 Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens. https://clinicaltrials.gov/study/NCT06101472 RECRUITING Cataract DEVICE: ASQELIO Toric Biaspheric Monofocal Lens AST Products, Inc.

NCT04189172 MiDura-Study (Neuro-Patch in Duraplasty) https://clinicaltrials.gov/study/NCT04189172 RECRUITING Meningioma

NCT05386472 A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19 https://clinicaltrials.gov/study/NCT05386472 RECRUITING COVID-19 DRUG: nirmatrelvir

NCT05924672 Efficacy of Ra-223 in PSMA PET Optimally Selected Patients https://clinicaltrials.gov/study/NCT05924672 RECRUITING Castration-Resistant Prostate Carcinoma

NCT06324604 Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients https://clinicaltrials.gov/study/NCT06324604 NOT_YET_RECRUITING Healthy Volunteers

NCT05880472 Percutaneous Holmium Injection in Pancreatic Cancer https://clinicaltrials.gov/study/NCT05880472 RECRUITING Pancreas Cancer DEVICE: Intratumoral Radboud University Medical Center Quirem Medical B.V.

NCT06637072 A Study to Assess Adults with CIDP Transitioning from IVIg to Efgartigimod PH20 SC https://clinicaltrials.gov/study/NCT06637072 NOT_YET_RECRUITING Chronic Inflammatory Demyelinating Polyneuropathy BIOLOGICAL: Efgartigimod PH20 SC argenx

NCT06221072 A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid https://clinicaltrials.gov/study/NCT06221072 NOT_YET_RECRUITING Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors DRUG: JMT103

NCT06548672 A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT06548672 RECRUITING Advanced Cancer

NCT04606472 A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04606472 RECRUITING Solid Tumor DRUG: SI-B003 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT06049472 Patient Perspectives in Mantle Cell Lymphoma Clinical Research https://clinicaltrials.gov/study/NCT06049472 NOT_YET_RECRUITING Mantle Cell Lymphoma Power Life Sciences Inc.

NCT06289504 A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight https://clinicaltrials.gov/study/NCT06289504 RECRUITING Obesity DRUG: Cagrilintide

NCT06344572 Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia https://clinicaltrials.gov/study/NCT06344572 RECRUITING Myopia DEVICE: SAT-001

NCT05630872 Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis https://clinicaltrials.gov/study/NCT05630872 RECRUITING HIV-associated Tuberculosis DRUG: Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC

NCT02392572 ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT02392572 RECRUITING Recurrent Acute Lymphoblastic Leukemia

NCT06598072 Comparative Study to Evaluate the Efficacy of an Alcohol-free Mouthwash Regimen with CPC+Zn, Flossing and Brushing, and an Alcohol-based Mouthwash Regimen with Essential Oils in Reducing Plaque and Gingivitis. https://clinicaltrials.gov/study/NCT06598072 NOT_YET_RECRUITING Gingival Bleeding

NCT06399172 OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy https://clinicaltrials.gov/study/NCT06399172 NOT_YET_RECRUITING Locally Advanced Pancreatic Adenocarcinoma DEVICE: OncoSil OncoSil Medical Limited

NCT06527872 Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN https://clinicaltrials.gov/study/NCT06527872 RECRUITING Lupus Nephritis OTHER: None (Observational study) GlaxoSmithKline

NCT06165172 Early Feasibility Study of the MyoRegulator® for Treatment of ALS https://clinicaltrials.gov/study/NCT06165172 RECRUITING Amyotrophic Lateral Sclerosis DEVICE: MyoRegulator® PathMaker Neurosystems Inc. Spaulding Rehabilitation Hospital

NCT05012072 Reducing Pregnancy Risks: The Mastery Lifestyle Intervention https://clinicaltrials.gov/study/NCT05012072 RECRUITING Mental Health Wellness 1

NCT04958772 Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers https://clinicaltrials.gov/study/NCT04958772 NOT_YET_RECRUITING Healthy BIOLOGICAL: Filgrastim Megalabs

NCT05575804 GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05575804 RECRUITING Advanced/ Metastatic Her-2 Positive Breast Cancer DRUG: GQ1001+pyrotinib

NCT04971772 SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries https://clinicaltrials.gov/study/NCT04971772 RECRUITING Peripheral Arterial Disease

NCT06687980 A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2) https://clinicaltrials.gov/study/NCT06687980 NOT_YET_RECRUITING Lichen Simplex Chronicus DRUG: Dupilumab

NCT06385262 TOP 2301: Neoadjuvant Chemo for NSCLC https://clinicaltrials.gov/study/NCT06385262 RECRUITING Non Small Cell Lung Cancer DRUG: Alirocumab

NCT06628362 A Study of CT-388 in Participants Who Are Overweight or Obese with Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06628362 RECRUITING Overweight or Obese

NCT06386289 Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT06386289 NOT_YET_RECRUITING Acute Ischemic Stroke DEVICE: Cereglide 92 Cerenovus, Part of DePuy Synthes Products, Inc.

NCT04440189 Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis https://clinicaltrials.gov/study/NCT04440189 RECRUITING Osteoarthritis, Knee DEVICE: GID SVF-2 Device System GID BIO, Inc.

NCT04672889 Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis https://clinicaltrials.gov/study/NCT04672889 RECRUITING Intestinal Bacteria Flora Disturbance DIETARY_SUPPLEMENT: Placebo

NCT05248789 OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer https://clinicaltrials.gov/study/NCT05248789 RECRUITING Advanced Bladder Carcinoma BIOLOGICAL: OH2 injection Binhui Biopharmaceutical Co., Ltd.

NCT05421689 Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia https://clinicaltrials.gov/study/NCT05421689 RECRUITING Oropharyngeal Dysphagia BIOLOGICAL: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)

NCT06525389 Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST) https://clinicaltrials.gov/study/NCT06525389 NOT_YET_RECRUITING Talaromycosis DRUG: Liposomal Amphotericin B (LAmB)

NCT05469789 A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) https://clinicaltrials.gov/study/NCT05469789 RECRUITING Hereditary Angioedema (HAE) OTHER: No Intervention Takeda

NCT06050980 Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation https://clinicaltrials.gov/study/NCT06050980 RECRUITING NSCLC DRUG: HSK40118 Haisco Pharmaceutical Group Co., Ltd.

NCT05684380 Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) https://clinicaltrials.gov/study/NCT05684380 NOT_YET_RECRUITING Allergic Rhinitis DRUG: MAZ-101association

NCT02977780 INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) https://clinicaltrials.gov/study/NCT02977780 RECRUITING Glioblastoma DRUG: Temozolomide

NCT06491862 RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil https://clinicaltrials.gov/study/NCT06491862 RECRUITING Non-squamous Non-Small Cell Lung Cancer AstraZeneca

NCT05088889 Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer https://clinicaltrials.gov/study/NCT05088889 RECRUITING Stage IV Pancreatic Cancer DRUG: Nivolumab

NCT05728840 Virtual-reality Exercises for Alleviating Attention Deficits in Patients with Acquired Brain Injury https://clinicaltrials.gov/study/NCT05728840 RECRUITING Stroke

NCT06709040 A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters https://clinicaltrials.gov/study/NCT06709040 NOT_YET_RECRUITING Growth Hormone Deficiency

NCT06641362 Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED) https://clinicaltrials.gov/study/NCT06641362 NOT_YET_RECRUITING Bradycardia

NCT06074562 A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain https://clinicaltrials.gov/study/NCT06074562 RECRUITING Diabetic Peripheral Neuropathy DRUG: LY3556050

NCT06203262 Ventricular Catheter Ablation Study (VCAS) https://clinicaltrials.gov/study/NCT06203262 RECRUITING Ventricular Tachyarrhythmia

NCT04954989 Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers https://clinicaltrials.gov/study/NCT04954989 NOT_YET_RECRUITING Healthy BIOLOGICAL: Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU

NCT05169489 A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL) https://clinicaltrials.gov/study/NCT05169489 RECRUITING Diffuse Large B Cell Lymphoma (DLBCL) BIOLOGICAL: bbT369 2seventy bio

NCT01429389 Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy https://clinicaltrials.gov/study/NCT01429389 RECRUITING Down Syndrome

NCT05733962 Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05733962 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 DEVICE: Use of the device DBL-4pen Diabeloop Icadom

NCT05665062 Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies https://clinicaltrials.gov/study/NCT05665062 RECRUITING CLL/SLL

NCT05996562 Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated with Chronic Heart Failure（PADN-CpcPH-PILOT） https://clinicaltrials.gov/study/NCT05996562 RECRUITING Pulmonary Hypertension

NCT06081062 Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease https://clinicaltrials.gov/study/NCT06081062 RECRUITING Fabry Disease BIOLOGICAL: Fabagal® (Agalsidase beta)

NCT06682962 Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma https://clinicaltrials.gov/study/NCT06682962 NOT_YET_RECRUITING Glaucoma

NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) https://clinicaltrials.gov/study/NCT05537662 RECRUITING Chronic Pain DEVICE: Standard of care neuromodulation therapy (SCS or DRG) Abbott Medical Devices

NCT02836262 Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty https://clinicaltrials.gov/study/NCT02836262 RECRUITING Osteoarthritis of Hip DEVICE: HIT Hip Replacement System Hip Innovation Technology

NCT05063162 A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) https://clinicaltrials.gov/study/NCT05063162 RECRUITING Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) DRUG: Rozanolixizumab

NCT05778162 RISC Panel Remnant Sample Collection https://clinicaltrials.gov/study/NCT05778162 RECRUITING Arthritis, Inflammatory DIAGNOSTIC_TEST: Synovasure® RISC™ Panel Zimmer Biomet

NCT05883462 Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH) https://clinicaltrials.gov/study/NCT05883462 RECRUITING Chronic Rhinosinusitis COMBINATION_PRODUCT: Airiver Nasal Drug Coated Balloon (DCB) Catheter. Airiver Medical, Inc.

NCT06714162 A Dietary Supplement Examined for Anti-ageing Effects https://clinicaltrials.gov/study/NCT06714162 NOT_YET_RECRUITING Ageing Signs DIETARY_SUPPLEMENT: Longevity pill Prenetics Global San Francisco Research Institute

NCT06434662 Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML https://clinicaltrials.gov/study/NCT06434662 RECRUITING Relapsed/Refractory Acute Myeloid Leukaemia

NCT05668962 Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC https://clinicaltrials.gov/study/NCT05668962 RECRUITING Thyroid Cancer

NCT04786262 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes https://clinicaltrials.gov/study/NCT04786262 RECRUITING Diabetes Mellitus, Type 1

NCT04307862 Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis https://clinicaltrials.gov/study/NCT04307862 RECRUITING Atopic Dermatitis DRUG: ZEP-3Na 0.1%

NCT06333262 Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT06333262 RECRUITING Chronic Lymphocytic Leukemia

NCT06632262 A Phase 2 Clinical Study of ABSK061 and ABSK043 https://clinicaltrials.gov/study/NCT06632262 RECRUITING HER2-Gastric/Gastroesophageal Junction Cancer

NCT06455462 Patient Characteristics, Treatment Patterns and Outcomes of Patients Enrolled in the Tezepelumab Patient Access Programme; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres https://clinicaltrials.gov/study/NCT06455462 RECRUITING Severe Asthma DRUG: Tezepelumab AstraZeneca

NCT02469662 Clinical Outcomes Study of the Nexel Total Elbow https://clinicaltrials.gov/study/NCT02469662 RECRUITING Elbow Joint Destruction

NCT06715462 Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy https://clinicaltrials.gov/study/NCT06715462 NOT_YET_RECRUITING Painful Diabetic Peripheral Neuropathy (PDPN) DRUG: N0750

NCT06042062 Clinical Evaluation of Infection Control to Knee Periprosthetic Joint Infection (PJI) -United Cellbrick Knee Spacer https://clinicaltrials.gov/study/NCT06042062 RECRUITING Knee; Infection, Joint DEVICE: Novel spacer

NCT06590740 Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients. https://clinicaltrials.gov/study/NCT06590740 NOT_YET_RECRUITING Cough-Variant Asthma DRUG: Budesonide-Formoterol treatment AstraZeneca

NCT06360640 A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults https://clinicaltrials.gov/study/NCT06360640 RECRUITING Healthy Subjects DRUG: APC148 and Placebo AdjuTec Pharma AS CTC Clinical Trial Consultants AB

NCT06104644 A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN) https://clinicaltrials.gov/study/NCT06104644 RECRUITING Plaque Psoriasis DRUG: Deucravacitinib Bristol-Myers Squibb

NCT02833792 Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease https://clinicaltrials.gov/study/NCT02833792 RECRUITING Alzheimer Dementia DRUG: Human Mesenchymal Stem Cells and Lactated Riunger's Solution

NCT06261892 Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine https://clinicaltrials.gov/study/NCT06261892 RECRUITING Cervical Cancer DIAGNOSTIC_TEST: Collect HPV DNA from urine WomenX Biotech Limited Hong Kong Science and Technology Parks Corporation

NCT05665192 A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib https://clinicaltrials.gov/study/NCT05665192 RECRUITING Myelofibrosis Bristol-Myers Squibb

NCT06434792 Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06434792 RECRUITING Chronic Obstructive Pulmonary Disease DRUG: Bronpass Tab.

NCT06705192 Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 https://clinicaltrials.gov/study/NCT06705192 NOT_YET_RECRUITING Dementia

NCT03621592 VLU Dressing Study https://clinicaltrials.gov/study/NCT03621592 RECRUITING Venous Leg Ulcer DEVICE: Cutimed® Sorbact®

NCT05913089 A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05913089 RECRUITING Non Small Cell Lung Cancer DRUG: TQB2450 injection + Chemotherapy

NCT05027776 Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years https://clinicaltrials.gov/study/NCT05027776 RECRUITING HPV Infections

NCT05334576 Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA https://clinicaltrials.gov/study/NCT05334576 RECRUITING Sickle Cell Disease OTHER: Crizanlizumab Andria Ford Novartis Pharmaceuticals

NCT06431776 Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). https://clinicaltrials.gov/study/NCT06431776 NOT_YET_RECRUITING Autoimmune Pulmonary Alveolar Proteinosis DRUG: Molgramostim Savara Inc.

NCT03827876 Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis https://clinicaltrials.gov/study/NCT03827876 RECRUITING Psoriasis DRUG: Enstilar 0.005%-0.064% Topical Foam Psoriasis Treatment Center of Central New Jersey LEO Pharma

NCT02777476 Clinical Performance of B-Lite® Light Weight Breast Implant https://clinicaltrials.gov/study/NCT02777476 RECRUITING Breast Implants DEVICE: B-Lite- Light Weight Breast Implants G&G Biotechnology Ltd.

NCT04146376 Von Willebrand Factor in Pregnancy (VIP) Study https://clinicaltrials.gov/study/NCT04146376 RECRUITING Von Willebrand Diseases OTHER: Use of a postpartum diary and additional blood draws

NCT05831176 A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis https://clinicaltrials.gov/study/NCT05831176 RECRUITING Eosinophilic Gastritis

NCT06721676 Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis https://clinicaltrials.gov/study/NCT06721676 NOT_YET_RECRUITING Aortic Stenosis Symptomatic DEVICE: transcatheter aortic valve replacement in severe aortic stenosis Peijia Medical Technology (Suzhou) Co., Ltd. Shanghai Zhongshan Hospital

NCT06633627 Neurological Responses in Patients with Dentine Hypersensitivity https://clinicaltrials.gov/study/NCT06633627 RECRUITING Dentine Hypersensitivity OTHER: Recording of brain activity using electroencephalography (EEG) Sheffield Teaching Hospitals NHS Foundation Trust University of Sheffield

NCT06415227 The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris https://clinicaltrials.gov/study/NCT06415227 NOT_YET_RECRUITING Vasospastic Angina DRUG: Vericiguat Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Bayer

NCT05804227 Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adults https://clinicaltrials.gov/study/NCT05804227 RECRUITING Gliomas DRUG: Ulixertinib M.D. Anderson Cancer Center BioMed Valley Discoveries, Inc

NCT04813627 Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy https://clinicaltrials.gov/study/NCT04813627 RECRUITING Colorectal Cancer Stage II

NCT03040973 Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone https://clinicaltrials.gov/study/NCT03040973 RECRUITING Advanced Solid Tumors Which Are cMET-dependent DRUG: Capmatinib

NCT05354973 ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy https://clinicaltrials.gov/study/NCT05354973 RECRUITING Patient Reported Outcome Measures

NCT04941573 Hyperpolarized MRI of Lung Transplants https://clinicaltrials.gov/study/NCT04941573 RECRUITING Lung Transplant Rejection COMBINATION_PRODUCT: Hyperpolarized 129-Xenon (MagniXene) MRI of the lung Xemed LLC University of Pennsylvania

NCT04201873 Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT04201873 RECRUITING Recurrent Glioblastoma BIOLOGICAL: Dendritic Cell Tumor Cell Lysate Vaccine

NCT06638073 Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC https://clinicaltrials.gov/study/NCT06638073 NOT_YET_RECRUITING Surgical Procedure, Unspecified

NCT06335173 A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants with Early Alzheimer's Disease (ALTITUDE-AD) https://clinicaltrials.gov/study/NCT06335173 RECRUITING Alzheimer Disease DRUG: sabirnetug

NCT05971576 A Clinical Study on TILs for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05971576 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT05813327 Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT05813327 RECRUITING Soft Tissue Sarcoma

NCT06391827 A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants https://clinicaltrials.gov/study/NCT06391827 NOT_YET_RECRUITING Healthy DRUG: DA-7503 Single dose

NCT05705427 The COMBAT HBV Feasibility Trial https://clinicaltrials.gov/study/NCT05705427 RECRUITING Hepatitis B

NCT05776927 A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. https://clinicaltrials.gov/study/NCT05776927 NOT_YET_RECRUITING Asthma DRUG: QVM149

NCT04064827 A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) https://clinicaltrials.gov/study/NCT04064827 RECRUITING Chronic Kidney Disease (CKD)

NCT05171673 Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury https://clinicaltrials.gov/study/NCT05171673 RECRUITING Soft Tissue Injuries DRUG: Licart‚Ñ¢ (diclofenac epolamine) topical system IBSA Institut Biochimique SA

NCT05923073 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease https://clinicaltrials.gov/study/NCT05923073 RECRUITING Crohn's Disease DRUG: Guselkumab

NCT06210373 Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome https://clinicaltrials.gov/study/NCT06210373 RECRUITING Dry Eye Disease DEVICE: Myrialen Gel

NCT06717373 Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis https://clinicaltrials.gov/study/NCT06717373 NOT_YET_RECRUITING Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease DEVICE: AutoAS Caption Health, Inc.

NCT05040373 Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program https://clinicaltrials.gov/study/NCT05040373 RECRUITING Hereditary Transthyretin-mediated (hATTR) Amyloidosis

NCT05685173 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT05685173 RECRUITING B-cell Non-Hodgkins Lymphoma (B-NHL) DRUG: Odronextamab

NCT04709276 A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT04709276 RECRUITING Metastatic Prostate Neuroendocrine Carcinoma

NCT06326476 A Study to Demonstrate the Safety and Efficacy of Siplizumab in the Treatment of Hidradenitis Suppurativa https://clinicaltrials.gov/study/NCT06326476 NOT_YET_RECRUITING Hidradenitis Suppurativa DRUG: Siplizumab University of Alabama at Birmingham ITB-Med LLC

NCT05233527 Novosyn® Quick in Patients Undergoing Episiotomy Closure https://clinicaltrials.gov/study/NCT05233527 RECRUITING Episiotomy Wound PROCEDURE: Episiotomy Closure Aesculap AG B.Braun Surgical SA

NCT05048927 Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis https://clinicaltrials.gov/study/NCT05048927 RECRUITING Severe Sepsis Bluejay Diagnostics, Inc.

NCT06368427 Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD https://clinicaltrials.gov/study/NCT06368427 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) DRUG: budesonide / glycopyrronium / formoterol AstraZeneca

NCT05910827 Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers https://clinicaltrials.gov/study/NCT05910827 RECRUITING Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT05483673 Analyzing Orthopedic Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05483673 NOT_YET_RECRUITING Orthopedic Disorder Power Life Sciences Inc.

NCT05535673 Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma https://clinicaltrials.gov/study/NCT05535673 NOT_YET_RECRUITING Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL DRUG: ThisCART19A Zhengzhou University Fundamenta Therapeutics, Ltd.

NCT04649073 Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04649073 RECRUITING Multiple Myeloma (MM) BIOLOGICAL: OPC-415 Otsuka Pharmaceutical Co., Ltd.

NCT06573073 Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation https://clinicaltrials.gov/study/NCT06573073 RECRUITING Non Small Cell Lung Cancer

NCT05705973 Ultimaster Nagomi‚Ñ¢ Sirolimus Eluting Coronary Stent System in Complex PCI Patients https://clinicaltrials.gov/study/NCT05705973 RECRUITING Cardiovascular Disease

NCT04034173 Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation https://clinicaltrials.gov/study/NCT04034173 NOT_YET_RECRUITING Treatment Related Cancer DRUG: Panitumumab

NCT05772273 PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT https://clinicaltrials.gov/study/NCT05772273 RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine

NCT05196373 Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars https://clinicaltrials.gov/study/NCT05196373 NOT_YET_RECRUITING Hypertrophic Scar DRUG: STP705 Sirnaomics

NCT05914376 Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors https://clinicaltrials.gov/study/NCT05914376 RECRUITING Advanced Solid Tumors BIOLOGICAL: Recombinant human IL-21-expressing oncolytic vaccinia virus injection Hangzhou Converd Co., Ltd.

NCT06715527 Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison https://clinicaltrials.gov/study/NCT06715527 RECRUITING Polycystic Ovarian Syndrome (PCOS) DIETARY_SUPPLEMENT: Myo-Inositol and D-Chiro-Inositol (40:1)

NCT06043427 Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma https://clinicaltrials.gov/study/NCT06043427 RECRUITING Gastroesophageal Adenocarcinoma DRUG: Paclitaxel

NCT06361927 A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients https://clinicaltrials.gov/study/NCT06361927 RECRUITING NSCLC DRUG: SSGJ-707 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

NCT05515627 Atezolizumab for Idiopathic Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT05515627 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Atezolizumab Cedars-Sinai Medical Center Genentech, Inc.

NCT05975073 A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors https://clinicaltrials.gov/study/NCT05975073 RECRUITING MTAP-null Non-Small-Cell Lung Cancer

NCT05265273 A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT05265273 RECRUITING Myasthenia Gravis DRUG: Nipocalimab Janssen Research & Development, LLC

NCT05832073 Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1 https://clinicaltrials.gov/study/NCT05832073 NOT_YET_RECRUITING Rabies Virus Infection DRUG: Natural full human monoclonal antibody CBB 1 injection

NCT06448273 A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06448273 RECRUITING Systemic Lupus Erythematosus DRUG: TQB3702 tablets

NCT05507073 A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement https://clinicaltrials.gov/study/NCT05507073 RECRUITING Hip Osteoarthritis

NCT06719427 QEEG Brain Signature of Depression & Neuromodulation-induced Recovery https://clinicaltrials.gov/study/NCT06719427 NOT_YET_RECRUITING Major Depressive Diorder DEVICE: Transcranial Magnetic Stimulation Sunnybrook Health Sciences Centre Mitacs

NCT05422027 Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma https://clinicaltrials.gov/study/NCT05422027 RECRUITING Multiple Myeloma DRUG: Selinexor

NCT06718127 Description of the Immune Response to Yellow Fever Vaccination https://clinicaltrials.gov/study/NCT06718127 RECRUITING Immunization

NCT06385327 A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes https://clinicaltrials.gov/study/NCT06385327 RECRUITING Recurrent Genital Herpes Simplex Type 2 DRUG: ABI-5366

NCT06620627 Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection https://clinicaltrials.gov/study/NCT06620627 RECRUITING Colorectal Cancer Screening Natera, Inc.

NCT05900973 A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer https://clinicaltrials.gov/study/NCT05900973 RECRUITING Prostate Cancer DRUG: Darolutamide Oral Tablet [Nubeqa] D'Or Institute for Research and Education Bayer

NCT03958773 Cardiovalve Transfemoral System - FIM Study https://clinicaltrials.gov/study/NCT03958773 RECRUITING Mitral Regurgitation DEVICE: Cardiovalve transfemoral Mitral valve system Cardiovalve Ltd. Meditrial Europe Ltd.

NCT06099873 Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents with Influenza https://clinicaltrials.gov/study/NCT06099873 RECRUITING Respiratory Viral Infection DRUG: ZX-7101A

NCT06402773 A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy https://clinicaltrials.gov/study/NCT06402773 RECRUITING Vasectomy DEVICE: The Signati Separo‚Ñ¢ Vessel Sealing System Signati Medical Inc

NCT06383273 A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) https://clinicaltrials.gov/study/NCT06383273 RECRUITING Cataract DRUG: MELT-300 sublingual tablet

NCT06040827 A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension https://clinicaltrials.gov/study/NCT06040827 RECRUITING Knee Osteoarthritis DEVICE: Total Knee Arthroplasty Canary Medical

NCT05060627 Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide https://clinicaltrials.gov/study/NCT05060627 RECRUITING Relapsed Multiple Myeloma DRUG: Belantamab mafodotin

NCT06224127 Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) https://clinicaltrials.gov/study/NCT06224127 NOT_YET_RECRUITING Anxiety Disorders

NCT06545227 Early Versus Late Monitoring Among Pregnant Women With a History of Gestational Diabetes https://clinicaltrials.gov/study/NCT06545227 RECRUITING Pregnancy Complications

NCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications https://clinicaltrials.gov/study/NCT06553027 RECRUITING Parkinson Disease DRUG: CVN424 75 mg

NCT06542627 Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study https://clinicaltrials.gov/study/NCT06542627 RECRUITING PreDiabetes

NCT02942927 Team Approach to Polypharmacy Evaluation and Reduction https://clinicaltrials.gov/study/NCT02942927 RECRUITING Multi-morbidity

NCT05702073 To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin. https://clinicaltrials.gov/study/NCT05702073 RECRUITING Type 2 Diabetes Mellitus DRUG: INS068 injection

NCT06232473 Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder https://clinicaltrials.gov/study/NCT06232473 RECRUITING Functional Disorder BEHAVIORAL: Patient Education

NCT05338073 KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models https://clinicaltrials.gov/study/NCT05338073 RECRUITING Cancer

NCT05349227 Comprehensive Outcomes for After Cancer Health https://clinicaltrials.gov/study/NCT05349227 RECRUITING Ovarian Cancer

NCT04216927 NO During CPB in Neonates to Reduce Risk of AKI https://clinicaltrials.gov/study/NCT04216927 RECRUITING AKI

NCT06277427 Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells https://clinicaltrials.gov/study/NCT06277427 RECRUITING Lupus Nephritis

NCT04534127 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia https://clinicaltrials.gov/study/NCT04534127 RECRUITING Skin Cancer

NCT05095727 A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) https://clinicaltrials.gov/study/NCT05095727 RECRUITING Glycogen Storage Disease DRUG: mRNA-3745 ModernaTX, Inc.

NCT05579327 Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) https://clinicaltrials.gov/study/NCT05579327 RECRUITING Monocarboxylate Transporter 8 Deficiency

NCT05583227 Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis https://clinicaltrials.gov/study/NCT05583227 RECRUITING Eosinophilic Esophagitis BIOLOGICAL: Tezepelumab

NCT05106127 Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem https://clinicaltrials.gov/study/NCT05106127 NOT_YET_RECRUITING Advanced Endometrial Cancer DRUG: EG-007

NCT05002127 A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06) https://clinicaltrials.gov/study/NCT05002127 RECRUITING Gastric Cancer

NCT05051527 Study to Evaluate the Effectiveness of Legalon® https://clinicaltrials.gov/study/NCT05051527 RECRUITING Non-alcoholic Fatty Liver Disease (NAFLD) DRUG: Legalon® 140 mg Mylan Inc. Meda Pharma S.p.A.

NCT06470373 A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration https://clinicaltrials.gov/study/NCT06470373 NOT_YET_RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: RBS-001 Solution for intravitreal injection

NCT04069273 Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma https://clinicaltrials.gov/study/NCT04069273 RECRUITING Gastric Cancer

NCT04173273 A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease https://clinicaltrials.gov/study/NCT04173273 RECRUITING Crohn's Disease DRUG: Etrasimod

NCT06492876 Gene Therapy for DME https://clinicaltrials.gov/study/NCT06492876 RECRUITING Diabetic Macular Edema GENETIC: FT-003 Frontera Therapeutics

NCT05417776 Collagen-targeted PET Imaging for Early Interstitial Lung Disease https://clinicaltrials.gov/study/NCT05417776 RECRUITING Interstitial Lung Disease DRUG: [68Ga]CBP8

NCT05850676 Disentangling the Role of Depression in Hypersomnia https://clinicaltrials.gov/study/NCT05850676 RECRUITING Hypersomnia DIAGNOSTIC_TEST: Sleep study University of Pennsylvania Jazz Pharmaceuticals

NCT05672576 A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05672576 RECRUITING Lupus Erythematosus, Systemic DRUG: Cenerimod

NCT06234527 Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins https://clinicaltrials.gov/study/NCT06234527 NOT_YET_RECRUITING Hyperpigmentation OTHER: tested product Cosmetique Active International

NCT06560827 CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection https://clinicaltrials.gov/study/NCT06560827 RECRUITING HCC BIOLOGICAL: CT011 CAR-GPC3 T Cells Injection CARsgen Therapeutics Co., Ltd. Shanghai Zhongshan Hospital

NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain https://clinicaltrials.gov/study/NCT05103527 RECRUITING Knee Osteoarthritis

NCT05188573 EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients https://clinicaltrials.gov/study/NCT05188573 NOT_YET_RECRUITING Pancreatic Cancer DEVICE: Early detection pancreatic cancer test

NCT05471973 CIED Infection Quality Initiative Demonstration Project https://clinicaltrials.gov/study/NCT05471973 RECRUITING Infections OTHER: Multidisciplinary Team

NCT02438631 Placental Passage and Disposition of Drugs: A Physiology-based Approach https://clinicaltrials.gov/study/NCT02438631 RECRUITING Pregnancy Radboud University Medical Center Janssen Pharmaceuticals

NCT05797831 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer https://clinicaltrials.gov/study/NCT05797831 RECRUITING Endometrial Cancer DRUG: Navtemadlin

NCT03665831 Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults https://clinicaltrials.gov/study/NCT03665831 RECRUITING Major Depressive Disorder

NCT05052931 Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer https://clinicaltrials.gov/study/NCT05052931 RECRUITING Gastric Cancer DRUG: Nab-paclitaxel combined with oxaliplatin and S-1 Jianjun Yang CSPC Ouyi Pharmaceutical Co., Ltd.

NCT04113382 Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy https://clinicaltrials.gov/study/NCT04113382 RECRUITING Bowel Preparation DRUG: CLENPIQ

NCT05330182 LMN-201 for Prevention of C. Difficile Infection Recurrence https://clinicaltrials.gov/study/NCT05330182 RECRUITING Clostridioides Difficile Infection DRUG: LMN-201

NCT05045482 Hepatic Impairment with Cirrhosis Due to Cholestatic Liver Disease https://clinicaltrials.gov/study/NCT05045482 RECRUITING Hepatic Impairment

NCT06676982 Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06676982 NOT_YET_RECRUITING Advanced Hepatocellular Carcinoma BIOLOGICAL: anti-CD19 CAR-T Zhejiang University Juventas Cell Therapy Ltd.

NCT05271682 A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma https://clinicaltrials.gov/study/NCT05271682 RECRUITING Multiple Myeloma DRUG: FHND6091 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

NCT06357182 Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06357182 RECRUITING Acute Myeloid Leukemia

NCT05834582 Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer https://clinicaltrials.gov/study/NCT05834582 RECRUITING TNBC - Triple-Negative Breast Cancer DRUG: Fluzoparib+Paclitaxel

NCT04637282 Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3 https://clinicaltrials.gov/study/NCT04637282 NOT_YET_RECRUITING Juvenile Neuronal Ceroid Lipofuscinosis DRUG: PLX-200

NCT05410782 Power Prenatal Supplements for Sperm Quality https://clinicaltrials.gov/study/NCT05410782 RECRUITING Spermatogenesis and Semen Disorders

NCT06142682 Dexamethasone Eluting Cochlear Implant: a Pivotal Study https://clinicaltrials.gov/study/NCT06142682 RECRUITING Cochlear Implant DEVICE: Cochlear Implant MED-EL Elektromedizinische Geräte GesmbH

NCT04755920 SGM-101 in Colorectal Brain Metastases. https://clinicaltrials.gov/study/NCT04755920 RECRUITING Rectal Neoplasms

NCT05901831 A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes https://clinicaltrials.gov/study/NCT05901831 RECRUITING Chronic Kidney Disease

NCT04521231 A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients https://clinicaltrials.gov/study/NCT04521231 RECRUITING B Cell Precursor Acute Lymphoblastic Leukemia DRUG: Blinatumomab Amgen

NCT06351631 A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) https://clinicaltrials.gov/study/NCT06351631 RECRUITING Thrombocythemia, Essential

NCT05735431 Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil https://clinicaltrials.gov/study/NCT05735431 NOT_YET_RECRUITING Moderate Asthma DRUG: Administration of investigation drug

NCT06391931 A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery https://clinicaltrials.gov/study/NCT06391931 RECRUITING Anesthesia DRUG: Cipepofol

NCT03161431 SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab https://clinicaltrials.gov/study/NCT03161431 RECRUITING Melanoma Stage III

NCT06113731 A Phase‚Ö° Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine https://clinicaltrials.gov/study/NCT06113731 RECRUITING SARS-CoV-2 Infection BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)

NCT04402931 Randomized Trial of Transcatheter Valve-in-Valve vs Redo Surgery for Bioprosthetic Mitral Dysfunction https://clinicaltrials.gov/study/NCT04402931 RECRUITING Mitral Prosthetic Valve Stenosis and Regurgitation PROCEDURE: Transcatheter Valve-in-Valve Intervention

NCT06003231 A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 https://clinicaltrials.gov/study/NCT06003231 RECRUITING Carcinoma, Squamous Cell of Head and Neck

NCT05933031 Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients https://clinicaltrials.gov/study/NCT05933031 RECRUITING Helicobacter Pylori Infection DRUG: Tegoprazan 50 mg Triple Therapy

NCT06213831 A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream https://clinicaltrials.gov/study/NCT06213831 RECRUITING Prurigo Nodularis DRUG: Ruxolitinib Cream 1.5% Incyte Corporation

NCT05731882 First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder https://clinicaltrials.gov/study/NCT05731882 RECRUITING Nonvalvular Atrial Fibrillation DEVICE: E-SeaLA, CardioPulse PFA system Hangzhou Dinova EP Technology Co., Ltd

NCT06687382 Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis https://clinicaltrials.gov/study/NCT06687382 NOT_YET_RECRUITING Diverticulitis

NCT05623982 Phase Ib/II Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05623982 RECRUITING Non-hodgkin's Lymphoma DRUG: GNC-038 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT05656482 Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients https://clinicaltrials.gov/study/NCT05656482 RECRUITING Rhinitis, Allergic OTHER: Cats fed with PRO PLAN® LIVECLEAT® MASK-air SAS

NCT02451982 Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas https://clinicaltrials.gov/study/NCT02451982 RECRUITING Pancreatic Cancer DRUG: Cyclophosphamide

NCT05525182 Efficacy and Safety of ES16001 in Patients With COVID-19 https://clinicaltrials.gov/study/NCT05525182 RECRUITING COVID-19 DRUG: ES16001 40 mg

NCT05825131 Natural History Study of Participants With Sanfilippo Syndrome Type IIIC https://clinicaltrials.gov/study/NCT05825131 RECRUITING Sanfilippo Syndrome Type C Phoenix Nest Vaincres Les Maladies Lysosomales

NCT06545331 Study of XB010 in Subjects With Solid Tumors https://clinicaltrials.gov/study/NCT06545331 RECRUITING Locally Advanced or Metastatic Solid Tumors DRUG: XB010

NCT06441331 Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors https://clinicaltrials.gov/study/NCT06441331 NOT_YET_RECRUITING NET

NCT04965831 Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT) https://clinicaltrials.gov/study/NCT04965831 NOT_YET_RECRUITING Lung Adenocarcinoma DRUG: Furmonertinib Tianjin Medical University Cancer Institute and Hospital Allist Pharmaceuticals, Inc.

NCT06072482 A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis https://clinicaltrials.gov/study/NCT06072482 RECRUITING Antineutrophil Cytoplasmic Antibody-associated Vasculitis DRUG: Avacopan

NCT06636682 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer https://clinicaltrials.gov/study/NCT06636682 RECRUITING Prostate Cancer (Adenocarcinoma)

NCT05700682 Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee https://clinicaltrials.gov/study/NCT05700682 RECRUITING Osteoarthritis, Knee

NCT05409482 A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05409482 RECRUITING Hepatocellular Carcinoma Meng Chao Hepatobiliary Hospital of Fujian Medical University Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06587282 PREEMIE: Study for Treatment of PDA in Premature Infants https://clinicaltrials.gov/study/NCT06587282 NOT_YET_RECRUITING Patent Ductus Arteriosus (PDA) DEVICE: Bloom Micro Occluder System Merit Medical Systems, Inc.

NCT06068582 Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis https://clinicaltrials.gov/study/NCT06068582 RECRUITING Multiple Sclerosis BEHAVIORAL: Strenghtening the brain

NCT06419582 BHV-7000 Acute Treatment of Bipolar Mania https://clinicaltrials.gov/study/NCT06419582 RECRUITING Bipolar Disorder DRUG: BHV-7000

NCT05313282 A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification https://clinicaltrials.gov/study/NCT05313282 RECRUITING C-staged Hepatocellular Carcinoma in BCLC Classification COMBINATION_PRODUCT: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab

NCT04651673 Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA) https://clinicaltrials.gov/study/NCT04651673 RECRUITING Knee Osteoarthritis OTHER: This is a non interventional registry Össur Iceland ehf Region Skane

NCT05572073 Otoferlin Gene-mediated Hearing Loss Natural History Study https://clinicaltrials.gov/study/NCT05572073 RECRUITING Sensorineural Hearing Loss, Bilateral OTHER: Natural History Study Akouos, Inc. Eli Lilly and Company

NCT06495931 Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human https://clinicaltrials.gov/study/NCT06495931 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: HRS-1780 tablets

NCT06310031 Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure https://clinicaltrials.gov/study/NCT06310031 RECRUITING Cardiovascular Diseases

NCT03767231 ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing https://clinicaltrials.gov/study/NCT03767231 NOT_YET_RECRUITING Hepatitis C DIAGNOSTIC_TEST: Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) Johns Hopkins University Cepheid

NCT03784131 Tissue Engineered Veins in Patients With Chronic Venous Insufficiency https://clinicaltrials.gov/study/NCT03784131 RECRUITING Chronic Venous Insufficiency DRUG: P-TEV Verigraft AB

NCT06583031 Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years https://clinicaltrials.gov/study/NCT06583031 RECRUITING RSV Infection

NCT06299982 An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO https://clinicaltrials.gov/study/NCT06299982 NOT_YET_RECRUITING Plaque Psoriasis Patients DRUG: 608 Q2W

NCT06367582 Spine Bone Cements Outcomes - Post Market Follow-up https://clinicaltrials.gov/study/NCT06367582 RECRUITING Vertebral Fracture

NCT03270982 Comprehensive Segmental Revision System https://clinicaltrials.gov/study/NCT03270982 RECRUITING Degenerative Disease

NCT06244082 Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping https://clinicaltrials.gov/study/NCT06244082 RECRUITING DMD

NCT03455582 Cognition Evolution and MRI Markers in PPMS Patients on 2 Years https://clinicaltrials.gov/study/NCT03455582 RECRUITING Multiple Sclerosis, Primary Progressive OTHER: Clinical assessment

NCT05079282 Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma https://clinicaltrials.gov/study/NCT05079282 RECRUITING Relapsed or Refractory T Cell Lymphoma DRUG: ONO-4685 Ono Pharmaceutical Co. Ltd

NCT05214482 A Study of AK112 in Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05214482 RECRUITING Advanced Malignant Tumors DRUG: AK112

NCT05897320 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine https://clinicaltrials.gov/study/NCT05897320 RECRUITING Episodic Migraine DRUG: Eptinezumab

NCT06072820 Analytical Evaluation of the Endotest® Diagnostic https://clinicaltrials.gov/study/NCT06072820 NOT_YET_RECRUITING Endometriosis

NCT04880473 Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment https://clinicaltrials.gov/study/NCT04880473 RECRUITING Gastrointestinal Complication DEVICE: PrevisEA device Entac Medical Inc.

NCT06619873 A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects https://clinicaltrials.gov/study/NCT06619873 NOT_YET_RECRUITING Breast Cancer DRUG: HRS-8080 Shandong Suncadia Medicine Co., Ltd.

NCT05994131 IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC https://clinicaltrials.gov/study/NCT05994131 RECRUITING NSCLC DRUG: IN10018

NCT04747431 A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN) https://clinicaltrials.gov/study/NCT04747431 RECRUITING Frontotemporal Dementia

NCT06598631 Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06598631 RECRUITING Chronic Kidney Disease DRUG: Volenrelaxin

NCT05478382 Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects https://clinicaltrials.gov/study/NCT05478382 NOT_YET_RECRUITING Postoperative Pain

NCT03957382 Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment https://clinicaltrials.gov/study/NCT03957382 RECRUITING Intracranial Aneurysm DEVICE: Accero® (heal) Stent Acandis GmbH

NCT04260282 Microbiome and Exacerbations in Neutrophilic Asthma https://clinicaltrials.gov/study/NCT04260282 RECRUITING Asthma

NCT06537882 Evaluate the Effect of Synbiotics on MAFLD https://clinicaltrials.gov/study/NCT06537882 RECRUITING Metabolic Dysfunction-Associated Fatty Liver Disease DIETARY_SUPPLEMENT: G-NiiB synbiotics formula (SLP07)

NCT06625931 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition https://clinicaltrials.gov/study/NCT06625931 NOT_YET_RECRUITING Parenteral Nutrition DRUG: NTCB01-1

NCT05117931 A Study of Amivantamab in People with Esophagogastric Cancer https://clinicaltrials.gov/study/NCT05117931 RECRUITING Esophagogastric Cancer DRUG: Amivantamab Memorial Sloan Kettering Cancer Center Janssen Pharmaceuticals

NCT06373731 ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) https://clinicaltrials.gov/study/NCT06373731 RECRUITING Age Related Macular Degeneration (ARMD) DRUG: Elamipretide

NCT05808231 Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 ) https://clinicaltrials.gov/study/NCT05808231 RECRUITING COVID-19 DRUG: Standard of Care + Quinine Sulfate

NCT06710431 A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder https://clinicaltrials.gov/study/NCT06710431 NOT_YET_RECRUITING Alcohol Abuse

NCT05223231 Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05223231 RECRUITING Advanced Malignant Tumors DRUG: LBL-019 Injection

NCT05083182 A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis https://clinicaltrials.gov/study/NCT05083182 RECRUITING Arthritis, Juvenile DRUG: Ustekinumab

NCT05738382 Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures https://clinicaltrials.gov/study/NCT05738382 NOT_YET_RECRUITING Assisted Reproductive Technology

NCT06421831 Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients https://clinicaltrials.gov/study/NCT06421831 RECRUITING Spinal Muscular Atrophy Type 3 GENETIC: GC101 GeneCradle Inc

NCT04675931 To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria https://clinicaltrials.gov/study/NCT04675931 RECRUITING Severe Malaria DRUG: KAE609

NCT05870631 Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) https://clinicaltrials.gov/study/NCT05870631 NOT_YET_RECRUITING Vaccine Reaction BIOLOGICAL: vaccinate with DTaP

NCT06701331 Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06701331 NOT_YET_RECRUITING Atopic Dermatitis DRUG: Placebo

NCT06311682 A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06311682 RECRUITING Atopic Dermatitis DRUG: Tralokinumab + TCS

NCT06111482 Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments. https://clinicaltrials.gov/study/NCT06111482 RECRUITING Dermatologic Conditions DEVICE: Intense pulsed light.

NCT06359782 Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) https://clinicaltrials.gov/study/NCT06359782 NOT_YET_RECRUITING Subarachnoid Hemorrhage, Aneurysmal DRUG: C1 Esterase Inhibitor Injection [Cinryze]

NCT06171282 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors https://clinicaltrials.gov/study/NCT06171282 RECRUITING Osteosarcoma

NCT05210582 A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face https://clinicaltrials.gov/study/NCT05210582 RECRUITING Vitiligo DRUG: Afamelanotide Clinuvel, Inc.

NCT05023382 A Study of Teduglutide in Japanese People With Short Bowel Syndrome https://clinicaltrials.gov/study/NCT05023382 RECRUITING Short Bowel Syndrome DRUG: Teduglutide Takeda

NCT06585982 Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis https://clinicaltrials.gov/study/NCT06585982 RECRUITING Fatty Liver Disease DIETARY_SUPPLEMENT: Treatment

NCT06049082 A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency https://clinicaltrials.gov/study/NCT06049082 RECRUITING Alpha 1-Antitrypsin Deficiency DRUG: KB408 (Nebulization) Krystal Biotech, Inc.

NCT06048120 A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) https://clinicaltrials.gov/study/NCT06048120 RECRUITING Pulmonary Hypertension Due to Left Heart Disease DRUG: BAY2701250 IV

NCT06269120 SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary https://clinicaltrials.gov/study/NCT06269120 NOT_YET_RECRUITING Type 2 Diabetes DRUG: Oral Semaglutide Novo Nordisk A/S

NCT06665620 Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents https://clinicaltrials.gov/study/NCT06665620 NOT_YET_RECRUITING Suicide

NCT05324631 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis https://clinicaltrials.gov/study/NCT05324631 RECRUITING Non-radiographic Axial Spondyloarthritis DRUG: SHR0302

NCT06541431 Analytical Validation of Stream‚Ñ¢ Platform https://clinicaltrials.gov/study/NCT06541431 NOT_YET_RECRUITING Gastrointestinal Diseases OTHER: Abdominal Drainage Fluid Collection FluidAI Medical Hamilton Health Sciences Corporation

NCT06470282 Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT06470282 NOT_YET_RECRUITING Bladder Cancer

NCT03655782 Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury https://clinicaltrials.gov/study/NCT03655782 RECRUITING MTBI - Mild Traumatic Brain Injury BEHAVIORAL: PATH neurotraining

NCT06098482 An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App https://clinicaltrials.gov/study/NCT06098482 RECRUITING Hearing Loss DEVICE: Mobile Research App (MRA)

NCT05676320 Investigating Bone Cement With or Without Inossia‚Ñ¢ Cement Softener for Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT05676320 RECRUITING Vertebral Compression Fracture DEVICE: V-Flex

NCT06075420 Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients https://clinicaltrials.gov/study/NCT06075420 RECRUITING Acute Coronary Syndrome

NCT06660173 A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) https://clinicaltrials.gov/study/NCT06660173 RECRUITING Type 2 Diabetes Mellitus (T2DM) DRUG: Maridebart Cafraglutide

NCT03513731 Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint https://clinicaltrials.gov/study/NCT03513731 RECRUITING Osteoarthritis of Facet Joint of Lumbar Spine DEVICE: Adipose-derived stem cell injection

NCT05319431 A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC https://clinicaltrials.gov/study/NCT05319431 RECRUITING Unresectable, Non-metastatic Hepatocellular Carcinoma BIOLOGICAL: AK104

NCT05732831 Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors https://clinicaltrials.gov/study/NCT05732831 RECRUITING Locally Advanced Solid Tumor DRUG: TNG462 Tango Therapeutics, Inc.

NCT05610631 Pulmonary Hypertension Registry Switzerland https://clinicaltrials.gov/study/NCT05610631 RECRUITING Pulmonary Hypertension University of Zurich Actelion

NCT06428331 A Study of SKB518 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06428331 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: SKB518 for injection Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

NCT06492031 Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients https://clinicaltrials.gov/study/NCT06492031 RECRUITING Chronic Renal Failure DRUG: Icodextrin Peritoneal Dialysis Solution

NCT05821231 Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma https://clinicaltrials.gov/study/NCT05821231 RECRUITING Soft Tissue Sarcoma COMBINATION_PRODUCT: SBRT + MEDI5752 Institut Claudius Regaud National Cancer Institute, France

NCT05770882 Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT05770882 RECRUITING Hepatocellular Carcinoma (HCC) DRUG: Chidamide

NCT06526182 A Study of of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06526182 RECRUITING Dermatitis, Atopic

NCT05769582 Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT05769582 RECRUITING BK Viremia; BKV DNAemia BIOLOGICAL: Anti-BK polyomavirus (AntiBKV) Memo Therapeutics AG

NCT06610682 Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib https://clinicaltrials.gov/study/NCT06610682 NOT_YET_RECRUITING BRAF V600E Mutation DRUG: Plixorafenib Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Fore Biotherapeutics

NCT06114082 TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX) https://clinicaltrials.gov/study/NCT06114082 RECRUITING Hepatocellular Carcinoma

NCT06670482 The Effect of Mask Design on Transcutaneous Carbon Dioxide in Healthy Volunteers: a Pilot Clinical Investigation https://clinicaltrials.gov/study/NCT06670482 NOT_YET_RECRUITING Healthy Volunteers

NCT06314282 INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use https://clinicaltrials.gov/study/NCT06314282 NOT_YET_RECRUITING Systemic Lupus Erythematosus (SLE) AstraZeneca

NCT05727176 Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement https://clinicaltrials.gov/study/NCT05727176 RECRUITING Advanced Cholangiocarcinoma

NCT06041776 Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations https://clinicaltrials.gov/study/NCT06041776 RECRUITING Non-Small Cell Lung Cancer

NCT06500676 A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations https://clinicaltrials.gov/study/NCT06500676 RECRUITING KRAS G12D Mutations

NCT05961176 Exploratory Study on Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Acute and Critical Care Setting https://clinicaltrials.gov/study/NCT05961176 RECRUITING Heart Failure DEVICE: Skiin pediatric band and Skiin biometric pod The Hospital for Sick Children Myant Medical Corp.

NCT06125327 SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) https://clinicaltrials.gov/study/NCT06125327 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: SC1011

NCT06233227 Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule https://clinicaltrials.gov/study/NCT06233227 NOT_YET_RECRUITING Healthy Subjects DRUG: Dutasteride-Test product

NCT05990127 A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05990127 NOT_YET_RECRUITING Locally Advanced or Metastatic NSCLC DRUG: AK104

NCT05145127 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors https://clinicaltrials.gov/study/NCT05145127 RECRUITING Hemophilia A

NCT06285227 Study of CM313 in Healthy Subjects https://clinicaltrials.gov/study/NCT06285227 RECRUITING Healthy BIOLOGICAL: CM313 injection Keymed Biosciences Co.Ltd

NCT06680427 Siegel‚Ñ¢ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study https://clinicaltrials.gov/study/NCT06680427 NOT_YET_RECRUITING Aortic Stenosis Symptomatic DEVICE: Siegel Transcatheter Aortic Valve (TAVR) MiRus

NCT05864573 Study of ZGGS15 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05864573 RECRUITING Advanced Solid Tumors BIOLOGICAL: ZGGS15 Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT06454773 To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial https://clinicaltrials.gov/study/NCT06454773 RECRUITING Intervention DIETARY_SUPPLEMENT: NCT/NFT Diabetes Foundation, India Brightseed

NCT06087276 Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) https://clinicaltrials.gov/study/NCT06087276 RECRUITING Essential Tremor DRUG: 60 mg ulixacaltamide

NCT04701476 TATE and Pembrolizumab (MK3475) in mCRC and NSCLC https://clinicaltrials.gov/study/NCT04701476 RECRUITING Colorectal Cancer; Lung Cancer DRUG: TATE and pembrolizumab

NCT05773976 An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients. https://clinicaltrials.gov/study/NCT05773976 RECRUITING Opthalomology/Dry Eye DEVICE: Afomill Refreshing Soothing, Afomill Anti-redness Eye Drops, Iridil Montefarmaco OTC SpA

NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab https://clinicaltrials.gov/study/NCT06169527 RECRUITING Atopic Dermatitis DRUG: Dupilumab Sanofi Regeneron Pharmaceuticals

NCT06449027 Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects. https://clinicaltrials.gov/study/NCT06449027 NOT_YET_RECRUITING Breast Cancer Subjects DRUG: T Leuprolide Injectable Emulsion

NCT03363373 Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow https://clinicaltrials.gov/study/NCT03363373 RECRUITING Neuroblastoma BIOLOGICAL: GM-CSF + Naxitamab Y-mAbs Therapeutics

NCT05318573 A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05318573 RECRUITING Advanced Urothelial Carcinoma

NCT06384573 DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease https://clinicaltrials.gov/study/NCT06384573 RECRUITING Alzheimer's Disease

NCT06014073 TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL https://clinicaltrials.gov/study/NCT06014073 RECRUITING Non Hodgkin's Lymphoma BIOLOGICAL: TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)

NCT06596473 A Study of BG-C477 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06596473 RECRUITING Advanced Solid Tumors DRUG: BG-C477

NCT06080776 SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations https://clinicaltrials.gov/study/NCT06080776 RECRUITING Non-small Cell Lung Cancer DRUG: SH-1028 tablets

NCT06316076 Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases https://clinicaltrials.gov/study/NCT06316076 RECRUITING Systemic Lupus Erythematosus

NCT06251076 Plan Development for Giving Teclistamab in the Outpatient Setting https://clinicaltrials.gov/study/NCT06251076 NOT_YET_RECRUITING Multiple Myeloma

NCT06174376 Clinical Outcomes of the Gore Synthetic Cornea Device https://clinicaltrials.gov/study/NCT06174376 RECRUITING Corneal Opacity DEVICE: GORE Synthetic Cornea Device W.L.Gore & Associates

NCT06312176 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) https://clinicaltrials.gov/study/NCT06312176 RECRUITING Breast Neoplasms DRUG: Sacituzumab tirumotecan

NCT05442827 A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids https://clinicaltrials.gov/study/NCT05442827 RECRUITING Uterine Fibroids With Menorrhagia DRUG: SHR7280 tablets

NCT05844527 Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients https://clinicaltrials.gov/study/NCT05844527 RECRUITING Wound of Skin

NCT06419127 Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing https://clinicaltrials.gov/study/NCT06419127 RECRUITING Infertility, Female

NCT05636527 Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO‚Ñ¢ Aortic Arch Stent Graft System https://clinicaltrials.gov/study/NCT05636527 RECRUITING AAT9 Endospan Ltd.

NCT06010173 Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children https://clinicaltrials.gov/study/NCT06010173 RECRUITING Lesion in Body Region

NCT04903873 A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04903873 RECRUITING Solid Tumor

NCT06500273 Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL https://clinicaltrials.gov/study/NCT06500273 RECRUITING Large B-cell Lymphoma GENETIC: cemacabtagene ansegedleucel

NCT03059173 Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome https://clinicaltrials.gov/study/NCT03059173 RECRUITING Polycystic Ovary Syndrome

NCT06613373 An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT06613373 NOT_YET_RECRUITING Breast Cancer DRUG: Dalpiciclib Jiangsu Famous Medical Technology Co., Ltd.

NCT06407973 A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes https://clinicaltrials.gov/study/NCT06407973 RECRUITING Primary Open Angle Glaucoma DEVICE: OMNI Surgical System

NCT06347731 Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan) https://clinicaltrials.gov/study/NCT06347731 RECRUITING Tumor, Solid DEVICE: Proton Radiation Therapy Varian, a Siemens Healthineers Company

NCT06243731 A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation https://clinicaltrials.gov/study/NCT06243731 NOT_YET_RECRUITING Cytomegalovirus (CMV)

NCT06267482 Using ROSA for Challenging The TKA Standard of Care https://clinicaltrials.gov/study/NCT06267482 RECRUITING Knee Osteoarthritis PROCEDURE: ROSA PSA Parapatellar Approach

NCT05881382 Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction https://clinicaltrials.gov/study/NCT05881382 NOT_YET_RECRUITING ST Elevation Myocardial Infarction DRUG: Dutogliptin + Filgrastim

NCT03547973 Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread https://clinicaltrials.gov/study/NCT03547973 RECRUITING Metastatic Urothelial Cancer DRUG: Sacituzumab Govitecan-hziy

NCT04533373 Sensory Restoration After DIEP Flap Neurotization https://clinicaltrials.gov/study/NCT04533373 RECRUITING Breast Cancer

NCT05741073 Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC https://clinicaltrials.gov/study/NCT05741073 RECRUITING Basal Cell Carcinoma

NCT06159231 FAME II-10-year Follow-Up https://clinicaltrials.gov/study/NCT06159231 RECRUITING Coronary Artery Disease CoreAalst BV Abbott Medical Devices

NCT06427031 Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients https://clinicaltrials.gov/study/NCT06427031 RECRUITING Dry Eye

NCT05349682 Bayer OA Knee Pain Pilot https://clinicaltrials.gov/study/NCT05349682 RECRUITING Osteoarthritis, Knee DIAGNOSTIC_TEST: dynamic contrast enhanced MRI

NCT04737382 Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. https://clinicaltrials.gov/study/NCT04737382 RECRUITING Non-small-cell Lung Carcinoma DIAGNOSTIC_TEST: biopsy

NCT05141682 Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT05141682 RECRUITING T-Cell Large Granular Lymphocyte Leukemia DRUG: Oral Azacitidine Jonathan Brammer Bristol-Myers Squibb

NCT05660382 Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis https://clinicaltrials.gov/study/NCT05660382 RECRUITING Otomycosis DRUG: Miconazole (2%) oil and mineral oil

NCT05642182 Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques https://clinicaltrials.gov/study/NCT05642182 RECRUITING Psoriasis DRUG: Drug (SFA002) Vitamin D, Magnesium

NCT05889182 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy https://clinicaltrials.gov/study/NCT05889182 RECRUITING Hidradenitis Suppurativa DRUG: Upadacitinib

NCT04092673 Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT04092673 RECRUITING Solid Tumor, Adult DRUG: eFT226

NCT06111131 Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures https://clinicaltrials.gov/study/NCT06111131 RECRUITING Small Bowel Disease DEVICE: Enteroscopy Aspero Medical, Inc. National Institutes of Health (NIH)

NCT05143931 Avoid and Resist Strategies for Weight Management https://clinicaltrials.gov/study/NCT05143931 RECRUITING Obesity

NCT06077331 A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06077331 RECRUITING Psoriasis DRUG: HS-10374 tablets 1mg

NCT05777031 Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease https://clinicaltrials.gov/study/NCT05777031 RECRUITING Peyronie Disease

NCT04897282 Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients. https://clinicaltrials.gov/study/NCT04897282 RECRUITING Ulcerative Colitis DIAGNOSTIC_TEST: UCRI Glycominds, LLC University of California, Davis

NCT06387082 A Clinical Study of HMPL-506 in Patients With Hematological Malignancies https://clinicaltrials.gov/study/NCT06387082 RECRUITING Hematological Malignancies DRUG: HMPL-506 Hutchmed

NCT03546582 SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma https://clinicaltrials.gov/study/NCT03546582 RECRUITING Head and Neck Squamous Cell Carcinoma (HNSCC) DRUG: Pembrolizumab

NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide https://clinicaltrials.gov/study/NCT04335682 RECRUITING Metastatic Prostate Cancer

NCT04541082 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms https://clinicaltrials.gov/study/NCT04541082 RECRUITING Central Nervous System Neoplasms

NCT06529731 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation https://clinicaltrials.gov/study/NCT06529731 RECRUITING Acute Myeloid Leukemia

NCT06531031 Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples https://clinicaltrials.gov/study/NCT06531031 NOT_YET_RECRUITING Bloodstream Infection

NCT06475131 A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06475131 RECRUITING Solid Tumor DRUG: BL-B16D1 Sichuan Baili Pharmaceutical Co., Ltd. Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

NCT06455982 Reduced Carbohydrates + Ketogenic Supplement on Energy Metabolism https://clinicaltrials.gov/study/NCT06455982 NOT_YET_RECRUITING Healthy Aging DIETARY_SUPPLEMENT: reduced carbohydrate menu combined with ketogenic supplement Université de Sherbrooke Nestlé Health Science

NCT05194982 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor https://clinicaltrials.gov/study/NCT05194982 RECRUITING Locally Advanced or Metastatic Solid Tumor DRUG: BL-B01D1 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT05492682 START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer https://clinicaltrials.gov/study/NCT05492682 RECRUITING Melanoma (Skin)

NCT06319482 The Adherence of Proactive Sleep Apnea Therapy https://clinicaltrials.gov/study/NCT06319482 RECRUITING Obstructive Sleep Apnea DEVICE: Proactive CPAP Therapy

NCT05789082 A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation https://clinicaltrials.gov/study/NCT05789082 RECRUITING Non-Small Cell Lung Cancer DRUG: Divarasib

NCT05354882 Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology https://clinicaltrials.gov/study/NCT05354882 RECRUITING Breast Cancer

NCT05774431 Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients With Acute Coronary Syndrome in a Real-world Registry https://clinicaltrials.gov/study/NCT05774431 RECRUITING Acute Myocardial Infarction OTHER: There was no intervention necessary. University Hospital Heidelberg AstraZeneca

NCT06146231 Motiva Flora® Aesthetic Breast Recon® Clinical Study https://clinicaltrials.gov/study/NCT06146231 RECRUITING Mammaplasty

NCT06186531 PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health https://clinicaltrials.gov/study/NCT06186531 RECRUITING Menopause

NCT06256731 ETNA-MS Device Validation Study https://clinicaltrials.gov/study/NCT06256731 RECRUITING Multiple Sclerosis DEVICE: Eye-Tracking Innodem Neurosciences Syneos Health

NCT05862831 Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05862831 RECRUITING Advanced Solid Tumors BIOLOGICAL: PM1003 Injection Biotheus Inc.

NCT06095531 A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive https://clinicaltrials.gov/study/NCT06095531 RECRUITING Craniotomy DEVICE: Tetranite for Cranial Flap Fixation (TN-CFF) RevBio

NCT06642831 Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study https://clinicaltrials.gov/study/NCT06642831 RECRUITING Polycystic Ovarian Syndrome (PCOS) University Hospital Erlangen Roche Diagnostics International AG

NCT05661331 VIATORR Device Registry https://clinicaltrials.gov/study/NCT05661331 RECRUITING Chronic Liver Disease DEVICE: Transjugular intrahepatic portosystemic shunt W.L.Gore & Associates

NCT06270082 Study of IK-595 in RAS- or RAF-altered Advanced Tumors https://clinicaltrials.gov/study/NCT06270082 RECRUITING Solid Tumor, Adult

NCT05907382 Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects https://clinicaltrials.gov/study/NCT05907382 RECRUITING Safety and Tolerability DRUG: JMKX003002 will be administered orally

NCT06345482 A Study of MHB039A for Advanced Solid Tumor https://clinicaltrials.gov/study/NCT06345482 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: MHB039A Minghui Pharmaceutical (Hangzhou) Ltd

NCT05812482 Treatment of Urethral Stricture With Urethral Drug Ball https://clinicaltrials.gov/study/NCT05812482 RECRUITING Urethral Stricture Less Than 2 cm PROCEDURE: Drug balloon dilatation

NCT06263231 A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) https://clinicaltrials.gov/study/NCT06263231 RECRUITING Sarcoma,Soft Tissue DRUG: INT230-6

NCT04631731 Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity https://clinicaltrials.gov/study/NCT04631731 RECRUITING Lung Cancer, Nonsmall Cell

NCT06307431 A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) https://clinicaltrials.gov/study/NCT06307431 RECRUITING Renal Cell Carcinoma BIOLOGICAL: V940

NCT06419231 Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms https://clinicaltrials.gov/study/NCT06419231 RECRUITING Gut Health DIETARY_SUPPLEMENT: Butyrate Formulation

NCT05908682 Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes https://clinicaltrials.gov/study/NCT05908682 RECRUITING Vulvovaginal Candidiasis

NCT06384482 SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma https://clinicaltrials.gov/study/NCT06384482 RECRUITING Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma DRUG: SNC115 injection Shanghai Simnova Biotechnology Co.,Ltd. Shanghai Chest Hospital

NCT05653882 A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05653882 RECRUITING Solid Tumor

NCT03887273 Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis https://clinicaltrials.gov/study/NCT03887273 RECRUITING Transverse Myelitis BIOLOGICAL: Q-Cells Q Therapeutics, Inc.

NCT04450173 Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma https://clinicaltrials.gov/study/NCT04450173 RECRUITING Ann Arbor Stage II Follicular Lymphoma

NCT06028373 A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT06028373 RECRUITING Advanced Solid Tumors

NCT04696731 Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT04696731 RECRUITING Advanced/Metastatic Clear Cell Renal Cell Carcinoma GENETIC: ALLO-316

NCT04123431 ACE Acetabular Cup UK Multi-centre PMCF Study https://clinicaltrials.gov/study/NCT04123431 NOT_YET_RECRUITING Hip Disease DEVICE: Total Hip Replacement JRI Orthopaedics

NCT05384431 Can we Achieve 'High-quality' Weight Loss Through Supplementation and Exercise? The TRIM MUSCLE Study https://clinicaltrials.gov/study/NCT05384431 RECRUITING Overweight

NCT05643131 Hyivy Device as Non-hormonal Therapy in Endometriosis https://clinicaltrials.gov/study/NCT05643131 NOT_YET_RECRUITING Endometriosis

NCT06199531 Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency https://clinicaltrials.gov/study/NCT06199531 RECRUITING NGLY1 Deficiency GENETIC: GS-100 Grace Science, LLC

NCT06048731 Enlighten Study: The EV-ICD Post Approval Registry https://clinicaltrials.gov/study/NCT06048731 RECRUITING Ventricular Arrhythmia

NCT05481931 Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines https://clinicaltrials.gov/study/NCT05481931 RECRUITING Glabellar Frown Lines DRUG: prabotulinumtoxinA Evolus, Inc. Avania

NCT06703931 Performance Study of the Thermodiag Solution for Body Temperature Measurement https://clinicaltrials.gov/study/NCT06703931 NOT_YET_RECRUITING Temperature Change, Body

NCT06511882 Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD https://clinicaltrials.gov/study/NCT06511882 RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine

NCT05816382 A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions https://clinicaltrials.gov/study/NCT05816382 RECRUITING Narcolepsy Type 1 DRUG: TAK-861 Takeda

NCT06639282 Repurposing Siponimod for Alzheimer's Disease https://clinicaltrials.gov/study/NCT06639282 NOT_YET_RECRUITING Alzheimer Disease

NCT05849727 A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05849727 RECRUITING Rheumatoid Arthritis DRUG: TQH3821 tablets 200 mg

NCT04396327 SM-1 vs. an Active Comparator in A Model of Transient Insomnia https://clinicaltrials.gov/study/NCT04396327 NOT_YET_RECRUITING Transient Insomnia DRUG: SM-1

NCT05579873 Double Plating Versus Single Plating Techniques in Midshaft Clavicle Fractures https://clinicaltrials.gov/study/NCT05579873 NOT_YET_RECRUITING Clavicle Fracture PROCEDURE: Clavicle plating Luzerner Kantonsspital Kantonsspital Obwalden

NCT06108973 Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients https://clinicaltrials.gov/study/NCT06108973 NOT_YET_RECRUITING Chronic Obstructive Pulmonary Disease DEVICE: Capnography Employee's State Insurance Corporation, New Delhi Medtronic Spine LLC

NCT06644573 Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy‚Ñ¢ in Patients With Sleep Deprivation and Chronic Insomnia https://clinicaltrials.gov/study/NCT06644573 NOT_YET_RECRUITING Chronic Insomnia

NCT06270173 Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT06270173 RECRUITING Osteoporotic Vertebral Compression Fractures DEVICE: Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix) Wiltrom Co., Ltd. Maxis Medical GmbH

NCT06159673 ACP-204 in Adults With Alzheimer's Disease Psychosis https://clinicaltrials.gov/study/NCT06159673 RECRUITING Alzheimer's Disease Psychosis DRUG: ACP-204

NCT05206773 A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ‚â•16 Years of Age With Fabry Disease https://clinicaltrials.gov/study/NCT05206773 RECRUITING Fabry Disease DRUG: Venglustat (GZ402671)

NCT03810573 Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis https://clinicaltrials.gov/study/NCT03810573 RECRUITING Degenerative Disc Disease

NCT06199973 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan https://clinicaltrials.gov/study/NCT06199973 RECRUITING Advanced Colorectal Cancer DRUG: SHR-A1811

NCT06580873 Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT) https://clinicaltrials.gov/study/NCT06580873 NOT_YET_RECRUITING HIV-1-infection

NCT02861573 Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) https://clinicaltrials.gov/study/NCT02861573 RECRUITING Metastatic Castration-Resistant Prostate Cancer BIOLOGICAL: Pembrolizumab 200 mg

NCT05985473 Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement https://clinicaltrials.gov/study/NCT05985473 RECRUITING Deafness Neurosensory OTHER: audiological measurements

NCT06077773 Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria https://clinicaltrials.gov/study/NCT06077773 RECRUITING Chronic Spontaneous Urticaria DRUG: Oral EP262

NCT05712473 An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer https://clinicaltrials.gov/study/NCT05712473 NOT_YET_RECRUITING Prostate Cancer DIAGNOSTIC_TEST: PYLARIFY Specialty Networks Research. Lantheus Medical Imaging

NCT04965220 HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04965220 RECRUITING Solid Tumor DRUG: HLX 208 Shanghai Henlius Biotech

NCT05896020 A Study of SHR-A1811 in Subjects With Gynaecologic Oncology https://clinicaltrials.gov/study/NCT05896020 RECRUITING Gynaecological Malignancies DRUG: SHR- A1811 Jiangsu HengRui Medicine Co., Ltd.

NCT05534620 Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics https://clinicaltrials.gov/study/NCT05534620 RECRUITING Acute Myeloid Leukaemia (AML)

NCT05984420 Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis https://clinicaltrials.gov/study/NCT05984420 RECRUITING Atopic Dermatitis DEVICE: LimpiAD 2,5% plus cream

NCT04073420 Medtronic Cardiac Surgery PMCF Registry https://clinicaltrials.gov/study/NCT04073420 RECRUITING Valve Disease, Heart DEVICE: Surgical Heart Valve Repair Products

NCT04510220 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis https://clinicaltrials.gov/study/NCT04510220 RECRUITING Relapsing Multiple Sclerosis DRUG: Ofatumumab

NCT06265220 AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06265220 RECRUITING Lupus Nephritis - WHO Class III

NCT06708520 Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants https://clinicaltrials.gov/study/NCT06708520 RECRUITING Renal Impairment DRUG: Rupatadine Noucor Health S.A.

NCT06239220 PD-L1 T-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC https://clinicaltrials.gov/study/NCT06239220 RECRUITING Head and Neck Cancer

NCT06552520 To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06552520 NOT_YET_RECRUITING Atopic Dermatitis DRUG: TQH2722 injection

NCT04490720 The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors https://clinicaltrials.gov/study/NCT04490720 RECRUITING Cardiovascular Diseases DIETARY_SUPPLEMENT: Placebo

NCT05326620 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) https://clinicaltrials.gov/study/NCT05326620 RECRUITING Renal Cancer

NCT06035120 An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema https://clinicaltrials.gov/study/NCT06035120 RECRUITING Emphysema, Pulmonary

NCT06210620 Pro APP Prosthetic Outcome Registry https://clinicaltrials.gov/study/NCT06210620 RECRUITING Amputation Össur Iceland ehf

NCT06282120 Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer https://clinicaltrials.gov/study/NCT06282120 RECRUITING Metastatic Biliary Tract Cancer DRUG: Irinotecan Hydrochloride Liposome Injection ；Fluorouracil ；Leucovorin；immunotherapy Tianjin Medical University Cancer Institute and Hospital CSPC Ouyi Pharmaceutical Co., Ltd.

NCT06657820 Optical Brain Pulse Monitor: Validation of Cerebral Oximetry Monitoring (OBPM:VOCOM) Study. https://clinicaltrials.gov/study/NCT06657820 NOT_YET_RECRUITING Hypoxia PROCEDURE: Hypoxia in healthy individuals

NCT05821920 A Safety Study on Posterior Pedicle Screw System https://clinicaltrials.gov/study/NCT05821920 RECRUITING Degenerative Disc Disease

NCT05799820 QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC https://clinicaltrials.gov/study/NCT05799820 RECRUITING Colorectal Carcinoma DRUG: QL1706

NCT05847920 Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy https://clinicaltrials.gov/study/NCT05847920 RECRUITING Primary IgA Nephropathy DRUG: SHR-2010 Injection

NCT06042920 A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis https://clinicaltrials.gov/study/NCT06042920 RECRUITING Palmoplantar Psoriasis

NCT05077774 Harmony TPV Post-Approval Study https://clinicaltrials.gov/study/NCT05077774 RECRUITING Congenital Heart Disease

NCT06627673 MultiCenter IDE Study of the PEEK-OPTIMA‚Ñ¢ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design https://clinicaltrials.gov/study/NCT06627673 NOT_YET_RECRUITING Knee Osteoarthritis DEVICE: Total Knee Arthroplasty Maxx Orthopedics Inc

NCT06103773 A Study of Single and Multiple Oral Doses of TollB-001 https://clinicaltrials.gov/study/NCT06103773 RECRUITING Rheumatoid Arthritis DRUG: TollB-001 tablets

NCT06106373 iotaSOFT Pediatric Study https://clinicaltrials.gov/study/NCT06106373 RECRUITING Hearing Loss, Sensorineural

NCT06328673 A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06328673 RECRUITING Advanced Solid Tumor DRUG: DM919

NCT06268873 A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. https://clinicaltrials.gov/study/NCT06268873 RECRUITING Chronic Kidney Disease and Hypertension DRUG: Baxdrostat/dapagliflozin

NCT06072573 Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy https://clinicaltrials.gov/study/NCT06072573 RECRUITING Pain

NCT04012073 Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome https://clinicaltrials.gov/study/NCT04012073 RECRUITING Respiratory Distress Syndrome, Adult DEVICE: Invasive Mechanical ventilation

NCT06471673 A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer https://clinicaltrials.gov/study/NCT06471673 RECRUITING Breast Cancer

NCT06645873 Exploration of Continuous Glucose Monitoring on the Intensive Care Unit https://clinicaltrials.gov/study/NCT06645873 NOT_YET_RECRUITING Hypoglycemia, Hyperglycemia DEVICE: Continuous glucose monitoring (CGM) device Kim Kamphorst DexCom, Inc.

NCT05776173 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia https://clinicaltrials.gov/study/NCT05776173 RECRUITING β-thalassemia Major GENETIC: BD211 Shanghai BDgene Co., Ltd. Ruijin Hospital

NCT04909073 Observational Study of Afatinib 30 mg Daily https://clinicaltrials.gov/study/NCT04909073 RECRUITING Non-Small Cell Lung Cancer

NCT05972473 A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD https://clinicaltrials.gov/study/NCT05972473 RECRUITING Neovascular Age-related Macular Degeneration DRUG: Aflibercept Ophthalmic

NCT06494020 Task Practice and Spinal Cord Stimulation https://clinicaltrials.gov/study/NCT06494020 RECRUITING Spinal Cord Injury Cervical

NCT04546620 Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT04546620 RECRUITING Diffuse Large B Cell Lymphoma DRUG: R-CHOP

NCT05867420 A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. https://clinicaltrials.gov/study/NCT05867420 RECRUITING Advanced Solid Tumors BIOLOGICAL: ASKG915 AskGene Pharma, Inc. Jiangsu Aosaikang Pharmaceutical Co., Ltd.

NCT06046820 The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency https://clinicaltrials.gov/study/NCT06046820 RECRUITING Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency

NCT05455320 A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment https://clinicaltrials.gov/study/NCT05455320 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Talquetamab

NCT05316220 A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis https://clinicaltrials.gov/study/NCT05316220 NOT_YET_RECRUITING Ulcerative Colitis (UC) DRUG: Mesalamine

NCT06274320 Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment https://clinicaltrials.gov/study/NCT06274320 RECRUITING Actinic Keratoses OTHER: Group A: holistic approach

NCT05097820 Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants https://clinicaltrials.gov/study/NCT05097820 RECRUITING Testicular Cancer

NCT05322720 HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy https://clinicaltrials.gov/study/NCT05322720 NOT_YET_RECRUITING Solid Tumor, Adult BIOLOGICAL: EOC202

NCT05893420 A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning https://clinicaltrials.gov/study/NCT05893420 RECRUITING Sepsis

NCT05283720 A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05283720 RECRUITING Non-Hodgkin Lymphoma DRUG: Epcoritamab

NCT06062420 A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 https://clinicaltrials.gov/study/NCT06062420 RECRUITING Neoplasms, Head and Neck DRUG: Dostarlimab

NCT06634420 HAELO: a Phase 3 Study to Evaluate NTLA-2002 in Participants with Hereditary Angioedema (HAE) https://clinicaltrials.gov/study/NCT06634420 RECRUITING Hereditary Angioedema BIOLOGICAL: NTLA-2002

NCT04396574 A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine https://clinicaltrials.gov/study/NCT04396574 RECRUITING Migraine DRUG: Lasmiditan Eli Lilly and Company

NCT06419374 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants with Compensated Cirrhosis Due to MASH https://clinicaltrials.gov/study/NCT06419374 RECRUITING Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) with Compensated Cirrhosis BIOLOGICAL: Pegozafermin

NCT05040074 SQ-Kyrin TMVr FIM Study https://clinicaltrials.gov/study/NCT05040074 RECRUITING Mitral Regurgitation DEVICE: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System Shanghai Shenqi Medical Technology Co., Ltd

NCT04449874 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation https://clinicaltrials.gov/study/NCT04449874 RECRUITING Non-Small Cell Lung Cancer

NCT03897374 Strategic Targeting for Optimal Prevention of Cancer https://clinicaltrials.gov/study/NCT03897374 RECRUITING Early Detection of Cancer DIAGNOSTIC_TEST: Genetic Testing ClinLogic LLC MDGlobal

NCT06670274 A Dose Escalating Study of HC002 in Healthy Adult Volunteers https://clinicaltrials.gov/study/NCT06670274 NOT_YET_RECRUITING Inflammatory Disease

NCT06255665 A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors https://clinicaltrials.gov/study/NCT06255665 RECRUITING Advanced Stage Solid Tumors DRUG: JNJ-79032421

NCT05865665 Registry Of Best Up-titration STrategies in Acute Heart Failure https://clinicaltrials.gov/study/NCT05865665 NOT_YET_RECRUITING Acute Heart Failure Heart Initiative INSERM UMR-942, Paris, France

NCT05948865 A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05948865 RECRUITING Cancer

NCT05159765 Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial https://clinicaltrials.gov/study/NCT05159765 RECRUITING Myopia DEVICE: Single vision contact lenses

NCT05307965 RETRIEVE-AMI Study https://clinicaltrials.gov/study/NCT05307965 RECRUITING Myocardial Infarction

NCT06001320 De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT06001320 RECRUITING Kidney Transplant; Complications

NCT06373120 Interventional Ventricular Assist System for PCI in CHIP Patients https://clinicaltrials.gov/study/NCT06373120 RECRUITING High-Risk Percutaneous Coronary Intervention (High-risk PCI)

NCT03546374 Medtronic Terminate AF Study https://clinicaltrials.gov/study/NCT03546374 RECRUITING Persistent Atrial Fibrillation

NCT06107374 Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG https://clinicaltrials.gov/study/NCT06107374 RECRUITING Advanced Non Small Cell Lung Cancer DRUG: [18F]F-AraG CellSight Technologies, Inc.

NCT05631574 Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer https://clinicaltrials.gov/study/NCT05631574 RECRUITING Non Small Cell Lung Cancer

NCT06225674 Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects https://clinicaltrials.gov/study/NCT06225674 RECRUITING Osteochondral Defect DEVICE: Episealer Talus implant Episurf Medical Inc.

NCT06111274 A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer https://clinicaltrials.gov/study/NCT06111274 RECRUITING Advanced Pancreatic Cancer DRUG: Pimicotinib (ABSK021) Abbisko Therapeutics Co, Ltd

NCT05844774 Post Anaesthesia Care Hypotension Prevention https://clinicaltrials.gov/study/NCT05844774 NOT_YET_RECRUITING Hypotension During Surgery DEVICE: HPI (using HemoSphere) - guided algorithm

NCT03143374 PET Tau - Neurodegenerative Disease Imaging https://clinicaltrials.gov/study/NCT03143374 RECRUITING Neurodegenerative Disease DRUG: 18F-AV-1451 University of Pennsylvania Avid Radiopharmaceuticals

NCT06633965 Safety and Feasibility Testing of a Smaller Network Version of AIDANET https://clinicaltrials.gov/study/NCT06633965 RECRUITING Type 1 Diabetes DEVICE: AIDANET

NCT06568965 Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults. https://clinicaltrials.gov/study/NCT06568965 NOT_YET_RECRUITING Stress

NCT05272865 Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC https://clinicaltrials.gov/study/NCT05272865 NOT_YET_RECRUITING Nausea Post Chemotherapy

NCT06686420 Investigation of the Effects of a Bifidobacterial Strain on Bowel Movement in Healthy Adults https://clinicaltrials.gov/study/NCT06686420 RECRUITING Infrequent Bowel Movements DIETARY_SUPPLEMENT: B. longum

NCT05565820 A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation https://clinicaltrials.gov/study/NCT05565820 RECRUITING Pediculosis Capitis

NCT05798520 A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT05798520 RECRUITING Relapsing Forms of Multiple Sclerosis DRUG: BIIB091

NCT06041620 Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells https://clinicaltrials.gov/study/NCT06041620 RECRUITING Thalassemia, Beta

NCT06312020 A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome https://clinicaltrials.gov/study/NCT06312020 RECRUITING Sjogren's Syndrome DRUG: HZN-1116

NCT05772520 The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT05772520 RECRUITING Plaque Psoriasis DRUG: TLL018 tablets Hangzhou Highlightll Pharmaceutical Co., Ltd

NCT06678074 Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI https://clinicaltrials.gov/study/NCT06678074 NOT_YET_RECRUITING STEMI

NCT05779774 WayToServePlus: Improving Responsible Alcohol Service Ph II https://clinicaltrials.gov/study/NCT05779774 RECRUITING Alcohol Drinking

NCT06687174 Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT06687174 NOT_YET_RECRUITING IgA Nephropathy (IgAN) DRUG: MY008211A tablets

NCT05588674 The Effect of Probiotics on Exercise Performance and Recovery https://clinicaltrials.gov/study/NCT05588674 RECRUITING Probiotics

NCT06632574 A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06632574 RECRUITING Advanced Solid Tumor DRUG: paclitaxel cationic liposomes CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

NCT05121974 Tebipenem Trial in Children With Shigellosis https://clinicaltrials.gov/study/NCT05121974 RECRUITING Shigellosis DRUG: Tebipenem Pivoxil

NCT05744674 Phase ‚Ö° Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management https://clinicaltrials.gov/study/NCT05744674 RECRUITING Thoracoscopic Lobectomy DRUG: HR18034

NCT04014374 Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab https://clinicaltrials.gov/study/NCT04014374 RECRUITING Leukemia/Lymphoma

NCT04154774 A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic Function https://clinicaltrials.gov/study/NCT04154774 RECRUITING Hepatic Impairment DRUG: Apalutamide Janssen Research & Development, LLC

NCT05198674 SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN https://clinicaltrials.gov/study/NCT05198674 RECRUITING Hypertension

NCT06461065 Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM) https://clinicaltrials.gov/study/NCT06461065 NOT_YET_RECRUITING Diabetes DEVICE: AIDS

NCT05848765 Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy https://clinicaltrials.gov/study/NCT05848765 RECRUITING Relapsed Follicular Lymphoma

NCT03870620 Metastatic Breast Cancer in Austria https://clinicaltrials.gov/study/NCT03870620 RECRUITING Breast Cancer

NCT06055920 The PEERLESS II Study https://clinicaltrials.gov/study/NCT06055920 RECRUITING Pulmonary Embolism DEVICE: FlowTriever System

NCT05315674 Markers of COPD Exacerbations https://clinicaltrials.gov/study/NCT05315674 RECRUITING COPD

NCT05648474 Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure https://clinicaltrials.gov/study/NCT05648474 RECRUITING Intervertebral Disc Degeneration

NCT06449274 RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial https://clinicaltrials.gov/study/NCT06449274 RECRUITING Acute Coronary Syndrome (ACS) DEVICE: Drug-coated balloon

NCT04546074 Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma https://clinicaltrials.gov/study/NCT04546074 RECRUITING Melanoma DRUG: Pembrolizumab and Imatinib mesylate

NCT06175065 Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06175065 RECRUITING Acute Exacerbation of Chronic Obstructive Pulmonary Disease DRUG: RLS-0071

NCT06536465 The Clostridioides Difficile Trial of REC-3964 https://clinicaltrials.gov/study/NCT06536465 RECRUITING Recurrent Clostridioides Difficile Infection DRUG: REC-3964 Recursion Pharmaceuticals Inc.

NCT05587465 Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis https://clinicaltrials.gov/study/NCT05587465 RECRUITING Spinal Lumbar Stenosis

NCT06099665 Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform https://clinicaltrials.gov/study/NCT06099665 RECRUITING Aortic Valve Stenosis

NCT06622174 Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer https://clinicaltrials.gov/study/NCT06622174 NOT_YET_RECRUITING Non Small Cell Lung Cancer

NCT05586074 HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML https://clinicaltrials.gov/study/NCT05586074 RECRUITING Leukemia, Acute Myeloid (AML) DRUG: Clifutinib

NCT05900765 A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05900765 RECRUITING Classical Hodgkin Lymphoma DRUG: Zimberelimab 240mg Sun Yat-sen University Guangzhou Gloria Biosciences Co., Ltd.

NCT06544265 SynKIR-310 for Relapsed/Refractory B-NHL https://clinicaltrials.gov/study/NCT06544265 RECRUITING B Cell Lymphoma

NCT06693765 A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants https://clinicaltrials.gov/study/NCT06693765 NOT_YET_RECRUITING Renal Impairment

NCT04015765 Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence https://clinicaltrials.gov/study/NCT04015765 RECRUITING Colorectal Cancer

NCT06557265 NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1) https://clinicaltrials.gov/study/NCT06557265 RECRUITING Lupus Nephritis

NCT06392165 Evaluation of Adhesion Properties in Wound Care Devices https://clinicaltrials.gov/study/NCT06392165 NOT_YET_RECRUITING Adhesion Properties of Wound Care Devices OTHER: self-adhesive device Molnlycke Health Care AB

NCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease https://clinicaltrials.gov/study/NCT06293365 RECRUITING Sjögrens Disease

NCT06264674 Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS). https://clinicaltrials.gov/study/NCT06264674 RECRUITING Asthma DRUG: CHF5993 200/6/12.5 μg pMDI HFA-152a

NCT05679674 Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer https://clinicaltrials.gov/study/NCT05679674 RECRUITING Pancreas Cancer

NCT05388474 A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab https://clinicaltrials.gov/study/NCT05388474 RECRUITING HIV Infections

NCT06700174 Lifetech AcuMark‚Ñ¢ Sizing Balloon Post-Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT06700174 RECRUITING Atrial Septal Defect (ASD) Lifetech Scientific (Shenzhen) Co., Ltd.

NCT05644665 A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) https://clinicaltrials.gov/study/NCT05644665 RECRUITING Ulcerative Colitis DRUG: Ozanimod

NCT06277765 Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis https://clinicaltrials.gov/study/NCT06277765 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: CM310

NCT06463665 Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer https://clinicaltrials.gov/study/NCT06463665 RECRUITING Advanced Non-squamous Non-small-cell Lung Cancer

NCT05795465 A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS) https://clinicaltrials.gov/study/NCT05795465 RECRUITING Respiratory Distress Syndrome, Acute DRUG: GEn-1124

NCT06308120 A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB https://clinicaltrials.gov/study/NCT06308120 RECRUITING Pulmonary Nodule, Solitary

NCT06304220 Comparison of Two PPOS Models for Pituitary Suppression https://clinicaltrials.gov/study/NCT06304220 NOT_YET_RECRUITING Infertility, Female

NCT06252220 First in Human Study in Subjects With Obesity, But Otherwise Healthy https://clinicaltrials.gov/study/NCT06252220 RECRUITING Obesity DRUG: DA-1726

NCT05850520 A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) https://clinicaltrials.gov/study/NCT05850520 RECRUITING Macular Edema Secondary to Retinal Vein Occlusion DRUG: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose

NCT06709274 Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC https://clinicaltrials.gov/study/NCT06709274 NOT_YET_RECRUITING Non-Small Cell Lung Cancer DRUG: Osimertinib

NCT05102474 Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis https://clinicaltrials.gov/study/NCT05102474 RECRUITING Psoriasis Vulgaris OTHER: Polysomnography (PSG) University of California, San Francisco Novartis Pharmaceuticals

NCT02696265 CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF https://clinicaltrials.gov/study/NCT02696265 RECRUITING Chronic Atrial Fibrillation PROCEDURE: CFAE guided ablation

NCT04205565 Study on Clinical Effectiveness of L-Oxiracetam Injection https://clinicaltrials.gov/study/NCT04205565 RECRUITING Craniocerebral Injury DRUG: Test group: L-oxiracetam Injection

NCT05112965 An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C) https://clinicaltrials.gov/study/NCT05112965 RECRUITING Neoplasms DRUG: Atezolizumab

NCT06188065 Eosinopenia in Severe COPD Exacerbation https://clinicaltrials.gov/study/NCT06188065 RECRUITING Chronic Obstructive Pulmonary Disease DIAGNOSTIC_TEST: Blood eosinophil count Northumbria Healthcare NHS Foundation Trust Newcastle University

NCT04976920 Metabolomics Non Selection Study - Vitrolife Media https://clinicaltrials.gov/study/NCT04976920 RECRUITING Infertility DIAGNOSTIC_TEST: Overture Metabolomics Embryo Selection Overture Life Clinica Juana Crespo

NCT06642220 Ablative Radioembolization of Renal Cell Carcinoma Trial https://clinicaltrials.gov/study/NCT06642220 NOT_YET_RECRUITING Renal Cell Carcinoma (RCC)

NCT05276674 ZNN Bactiguard Retrograde Femoral Nails PMCF Study https://clinicaltrials.gov/study/NCT05276674 RECRUITING Femoral Fracture DEVICE: ZNN Bactiguard Retrograde Femoral Nail Zimmer Biomet

NCT06332274 tislelizUMaB in canceR Patients With molEcuLar residuaL Disease https://clinicaltrials.gov/study/NCT06332274 NOT_YET_RECRUITING Cancer

NCT06376474 To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage https://clinicaltrials.gov/study/NCT06376474 RECRUITING Psoriasis DRUG: Hemay005 Ganzhou Hemay Pharmaceutical Co., Ltd

NCT06297174 Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions https://clinicaltrials.gov/study/NCT06297174 NOT_YET_RECRUITING Healthy Vollunteer DRUG: Racecadotril 100 mg Capsules

NCT06527274 Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization https://clinicaltrials.gov/study/NCT06527274 RECRUITING Nearsightedness DEVICE: Experimental: Myopic defocus soft lens design (MDSL)

NCT05799274 Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT05799274 RECRUITING Healthy Volunteers

NCT03994874 Peritoneal Ultrafiltration in Cardio Renal Syndrome. https://clinicaltrials.gov/study/NCT03994874 NOT_YET_RECRUITING Congestive Heart Failure DRUG: PolyCore (Polydextrin, L-Carnitine, D-xylitol) Iperboreal Pharma Srl

NCT05952674 Treatment Resistant Depression and Vagus Nerve Stimulation https://clinicaltrials.gov/study/NCT05952674 NOT_YET_RECRUITING Treatment Resistant Depression (TRD) DEVICE: Vagus Nerve Stimulation (VNS)

NCT04162665 Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer https://clinicaltrials.gov/study/NCT04162665 RECRUITING Gastric Adenocarcinoma RADIATION: Adaptive short course radiation therapy

NCT06414265 Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation https://clinicaltrials.gov/study/NCT06414265 RECRUITING Heart Failure DEVICE: Transcatheter mitral valve replacement InnovHeart MAXIS, LLC

NCT05713565 A Digital Care Solution for Coronary Artery Disease Patients https://clinicaltrials.gov/study/NCT05713565 RECRUITING Coronary Artery Disease DEVICE: A digital care solution for patients with Coronary Artery Disease

NCT06228365 Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation https://clinicaltrials.gov/study/NCT06228365 RECRUITING Superficial Venous Insufficiency DEVICE: use of a device incorporating virtual reality software

NCT06685965 Double-Blind, Placebo-Controlled, Crossover Study With Roll-over Extension of Two RE03 Doses for PTSD Sleep Disturbances https://clinicaltrials.gov/study/NCT06685965 NOT_YET_RECRUITING Posttraumatic Stress Disorder (PTSD)

NCT02102165 AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. https://clinicaltrials.gov/study/NCT02102165 RECRUITING Metastatic Breast Cancer PROCEDURE: metastatic lesion biopsy Breast International Group Jules Bordet Institute

NCT06351020 LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. https://clinicaltrials.gov/study/NCT06351020 RECRUITING Locally Advanced or Metastatic GC and GCJ Adenocarcinoma DRUG: LM-302

NCT05943574 PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix® Small External Fixation System https://clinicaltrials.gov/study/NCT05943574 RECRUITING Wrist Fracture

NCT05405374 OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study https://clinicaltrials.gov/study/NCT05405374 RECRUITING Lumbar Spine Disease

NCT06503965 Tunisian Registry of Trans Catheter Aortic Valve Implantation https://clinicaltrials.gov/study/NCT06503965 RECRUITING Tunisian Patients Already Implanted With a TAVI Les Laboratoires des Médicaments Stériles Tunisian Society of Cardiology and Cardiovascular Surgery

NCT06116565 A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06116565 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT05216965 A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05216965 RECRUITING Solid Tumors DRUG: 9MW2821 Mabwell (Shanghai) Bioscience Co., Ltd.

NCT04414865 VitaFlow‚Ñ¢ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study https://clinicaltrials.gov/study/NCT04414865 RECRUITING Aortic Valve Stenosis DEVICE: VitaFlow‚Ñ¢ Transcatheter Aortic Valve System Shanghai MicroPort CardioFlow Medtech Co., Ltd.

NCT06541665 Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL https://clinicaltrials.gov/study/NCT06541665 RECRUITING Primary Central Nervous System Lymphoma DRUG: ONO-4059

NCT05435365 Investigating The Experiences of Patients In Immunotherapy Clinical Trials https://clinicaltrials.gov/study/NCT05435365 NOT_YET_RECRUITING Immunotherapy

NCT06532565 Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06532565 RECRUITING Advanced Solid Tumors DRUG: GS-2121

NCT06697665 An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06697665 RECRUITING Solid Cancer BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT04563520 SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis https://clinicaltrials.gov/study/NCT04563520 RECRUITING Hemophilia A DRUG: aPCC-emicizumab

NCT05498220 Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05498220 RECRUITING Diffuse Large B-cell Lymphoma DRUG: Polatuzumab vedotin (PV)

NCT05073120 Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib https://clinicaltrials.gov/study/NCT05073120 RECRUITING Breast Cancer OTHER: Piqray Prescriber's/HCP guide for hyperglycemia Novartis Pharmaceuticals

NCT06490874 Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT https://clinicaltrials.gov/study/NCT06490874 NOT_YET_RECRUITING Gestational Diabetes Mellitus

NCT05320874 A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. https://clinicaltrials.gov/study/NCT05320874 NOT_YET_RECRUITING Advanced Solid Tumor BIOLOGICAL: KM257 Bispecific antibody Xuanzhu Biopharmaceutical Co., Ltd.

NCT04608474 Lipid Management in Renal Transplant Recipients Using Evolocumab. https://clinicaltrials.gov/study/NCT04608474 RECRUITING Hyperlipidemias DRUG: Evolocumab

NCT06486974 Efficacy of Manual Toothbrushes in Removing Tooth Stains https://clinicaltrials.gov/study/NCT06486974 RECRUITING Tooth Discoloration DRUG: NaF

NCT04919265 Mother-Infant Cohort Study in Malaysia and China https://clinicaltrials.gov/study/NCT04919265 RECRUITING Gut Microbiota

NCT06059365 Clinical Trial for a Outpatient Clinical Management for Complicated Acute Appendicitis https://clinicaltrials.gov/study/NCT06059365 NOT_YET_RECRUITING Acute Appendicitis

NCT06372665 Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization https://clinicaltrials.gov/study/NCT06372665 RECRUITING Japanese Encephalitis Liaoning Chengda Biotechnology CO., LTD

NCT05313165 PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia https://clinicaltrials.gov/study/NCT05313165 RECRUITING Critical Limb Ischemia

NCT06719531 SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes https://clinicaltrials.gov/study/NCT06719531 NOT_YET_RECRUITING Type 1 Diabetes Mellitus

NCT06505031 A Study of TAK-861in People With Narcolepsy Type 1 https://clinicaltrials.gov/study/NCT06505031 RECRUITING Narcolepsy Type 1 DRUG: TAK-861

NCT02766231 Physica CR and Physica PS Clinical Trial https://clinicaltrials.gov/study/NCT02766231 RECRUITING Knee Osteoarthritis DEVICE: Physica CR

NCT05790382 Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101 https://clinicaltrials.gov/study/NCT05790382 NOT_YET_RECRUITING Parkinson Disease DRUG: NM-101

NCT06683482 A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain https://clinicaltrials.gov/study/NCT06683482 NOT_YET_RECRUITING Breast Cancer OTHER: No intervention Gilead Sciences

NCT06124482 Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis https://clinicaltrials.gov/study/NCT06124482 RECRUITING Total Knee Arthroplasty DEVICE: Total Knee arthroplasty FH ORTHO Slb Pharma

NCT05751382 Evaluation of Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin in Restorations of NCCLs https://clinicaltrials.gov/study/NCT05751382 RECRUITING Tooth Restoration DEVICE: Surefil one

NCT06641882 Retrospective Chart Review of Patients with Acanthamoeba Keratitis Who Have Received 0.8 Mg/ml Polihexanide https://clinicaltrials.gov/study/NCT06641882 RECRUITING Acanthamoeba Keratitis SIFI SpA

NCT05438420 Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05438420 RECRUITING Esophageal Cancer

NCT04963920 A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock https://clinicaltrials.gov/study/NCT04963920 RECRUITING Septic Shock DEVICE: Cytosorb® 300 ml CytoSorbents Europe GmbH BRAHMS GmbH

NCT06639620 Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting https://clinicaltrials.gov/study/NCT06639620 RECRUITING Advanced Parkinson Disease AbbVie

NCT06254820 Dose, Safety, and Pathogenicity of a New Influenza B Strain https://clinicaltrials.gov/study/NCT06254820 RECRUITING Influenza B BIOLOGICAL: influenza B/Connecticut/1/21 virus part a dose arm 1

NCT06473974 Open-label, Single-arm, Proof of Concept Study in Subjects With Mild-to-moderate Facial Hyperpigmentation https://clinicaltrials.gov/study/NCT06473974 NOT_YET_RECRUITING Facial Hyperpigmentation DRUG: Test cosmetic product Kayuraeffect, LLP COD Research

NCT06095674 ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study https://clinicaltrials.gov/study/NCT06095674 NOT_YET_RECRUITING Cervical Cancer DRUG: Anti-PD-1 antibody balstilimab Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Dutch Cancer Society

NCT02325674 MEASuRE: Metreleptin Effectiveness And Safety Registry https://clinicaltrials.gov/study/NCT02325674 RECRUITING Generalised Lipodystrophy

NCT06717074 A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants with Stable Coronary Artery Disease https://clinicaltrials.gov/study/NCT06717074 RECRUITING Stable Coronary Artery Disease CAD DRUG: RBD4059

NCT06122974 Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia https://clinicaltrials.gov/study/NCT06122974 NOT_YET_RECRUITING Critical Limb Ischemia DEVICE: Drug Eluting Temporary Spur Stent System

NCT05938465 Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) https://clinicaltrials.gov/study/NCT05938465 RECRUITING Ileal Pouch BIOLOGICAL: EXE-346

NCT04421820 BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours https://clinicaltrials.gov/study/NCT04421820 RECRUITING Colorectal Cancer

NCT05129020 Neurostimulation to Improve NOWS Outcomes https://clinicaltrials.gov/study/NCT05129020 RECRUITING Neonatal Opioid Withdrawal Syndrome

NCT06637020 Phase Ib Clinical Study of HDM1005 Injection https://clinicaltrials.gov/study/NCT06637020 RECRUITING Overweight and Obesity DRUG: HDM1005 injection or placebo Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

NCT05902520 Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05902520 RECRUITING HNSCC

NCT03850574 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT03850574 RECRUITING Leukemia, Myeloid, Acute

NCT02720874 Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT02720874 NOT_YET_RECRUITING Arthritis, Rheumatoid BEHAVIORAL: Rheumatoid arthritis educational booklet

NCT06510374 Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT06510374 RECRUITING Intermediate Risk Non-Muscle Invasive Bladder Cancer DRUG: Nadofaragene Firadenovec Ferring Pharmaceuticals

NCT05808374 Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B https://clinicaltrials.gov/study/NCT05808374 RECRUITING Chronic Hepatitis B DRUG: HRS-5635

NCT06171074 Study of CM310 in Subjects With Seasonal Allergic Rhinitis https://clinicaltrials.gov/study/NCT06171074 NOT_YET_RECRUITING Seasonal Allergic Rhinitis BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT06492174 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort https://clinicaltrials.gov/study/NCT06492174 RECRUITING In-Stent Restenosis DEVICE: AGENT DCB 40 mm Boston Scientific Corporation

NCT06594874 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06594874 NOT_YET_RECRUITING Non-Small Cell Lung Cancer

NCT04117074 Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery https://clinicaltrials.gov/study/NCT04117074 RECRUITING Surgery

NCT06442774 MamaConecta: Digital Tool for Maternal Mental Health https://clinicaltrials.gov/study/NCT06442774 NOT_YET_RECRUITING Pregnancy Related

NCT04986865 A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT04986865 RECRUITING Advanced Solid Tumor

NCT06480565 A Phase 1/2 Trial of ADI-270 in CcRCC https://clinicaltrials.gov/study/NCT06480565 RECRUITING Clear Cell Renal Cell Carcinoma DRUG: ADI-270

NCT04657965 LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies https://clinicaltrials.gov/study/NCT04657965 NOT_YET_RECRUITING Infectious Diseases

NCT06488365 In Vivo Liquid Biopsy of Melanoma (Cytophone) https://clinicaltrials.gov/study/NCT06488365 NOT_YET_RECRUITING Melanoma

NCT05369065 Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities https://clinicaltrials.gov/study/NCT05369065 RECRUITING Diabetes Mellitus, Type 2

NCT05699265 Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing https://clinicaltrials.gov/study/NCT05699265 RECRUITING Fabry Disease DIAGNOSTIC_TEST: Measures of arterial stiffness and endothelial function

NCT06412120 Study Evaluating Safety, Tolerability, and Metabolism of Niraparib https://clinicaltrials.gov/study/NCT06412120 NOT_YET_RECRUITING Ovarian Cancer DRUG: Niraparib University of Miami GlaxoSmithKline

NCT06700720 YN001-004 in Patients With Coronary Atherosclerosis in Australia https://clinicaltrials.gov/study/NCT06700720 NOT_YET_RECRUITING Coronary Artery Disease

NCT06319820 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer https://clinicaltrials.gov/study/NCT06319820 RECRUITING Non-Muscle Invasive Bladder Cancer COMBINATION_PRODUCT: TAR-210

NCT03255174 The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study https://clinicaltrials.gov/study/NCT03255174 RECRUITING Controlling Mild to Moderate Bleeding During Surgery BIOLOGICAL: EVARREST® Fibrin Sealant Patch Ethicon, Inc.

NCT06642974 Development, Validation and Testing of an Education Program for Identification of Learning Disabilities Among School Children by Primary School Teachers in Qatar https://clinicaltrials.gov/study/NCT06642974 NOT_YET_RECRUITING Learning Disabilities, Child OTHER: Education module on learning disabilities

NCT05435274 Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05435274 RECRUITING Advanced Non-Small-Cell Lung Cancer DRUG: HS-10376 Jiangsu Hansoh Pharmaceutical Co., Ltd.

NCT04471974 ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT04471974 RECRUITING Castration-Resistant Prostate Carcinoma

NCT06268574 Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML https://clinicaltrials.gov/study/NCT06268574 RECRUITING Acute Myeloid Leukemia (AML)

NCT05652374 Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study https://clinicaltrials.gov/study/NCT05652374 RECRUITING Recurrent Urinary Tract Infection DEVICE: Ialuril 50ml Prefill

NCT00438074 A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer https://clinicaltrials.gov/study/NCT00438074 RECRUITING Breast Cancer Sunnybrook Health Sciences Centre ART Advanced Research Technologies Inc.

NCT06485674 Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06485674 RECRUITING Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus AstraZeneca IQVIA Pvt. Ltd

NCT06590974 A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants with Congenital Protein C Deficiency https://clinicaltrials.gov/study/NCT06590974 RECRUITING Protein C Deficiency DRUG: Freeze-dried Human Protein C Concentrate Takeda

NCT06298565 A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa https://clinicaltrials.gov/study/NCT06298565 NOT_YET_RECRUITING Myasthenia Gravis BIOLOGICAL: efgartigimod argenx

NCT02895165 PREgnancy and FERtility Registry https://clinicaltrials.gov/study/NCT02895165 RECRUITING Breast Neoplasms

NCT03383965 CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas https://clinicaltrials.gov/study/NCT03383965 RECRUITING Hodgkin Lymphoma

NCT05740631 The Effect of Obeticholic Acid in Healthy Volunteers https://clinicaltrials.gov/study/NCT05740631 RECRUITING Healthy DRUG: Ocaliva

NCT06463782 Clinical Study of 68Ga-LNC1007 Injection PET/CT https://clinicaltrials.gov/study/NCT06463782 NOT_YET_RECRUITING Healthy Volunteers

NCT04762082 A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers https://clinicaltrials.gov/study/NCT04762082 NOT_YET_RECRUITING Erectile Dysfunction DRUG: Tadalafil 10 MG Seattle Gummy Company

NCT04814082 Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT04814082 RECRUITING Osteoarthritis, Knee

NCT05187182 CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer https://clinicaltrials.gov/study/NCT05187182 RECRUITING Gastric Cancer

NCT06678282 JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia https://clinicaltrials.gov/study/NCT06678282 RECRUITING B-NHL

NCT05245682 Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer https://clinicaltrials.gov/study/NCT05245682 RECRUITING Head and Neck Carcinoma of Unknown Primary

NCT04856982 A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation https://clinicaltrials.gov/study/NCT04856982 RECRUITING Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation DRUG: Tofersen

NCT06300320 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease https://clinicaltrials.gov/study/NCT06300320 RECRUITING Chronic Graft Versus Host Disease DRUG: TQ05105 tablets Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06178120 Disease Progression in Women With X-linked Adrenoleukodystrophy https://clinicaltrials.gov/study/NCT06178120 RECRUITING X-linked Adrenoleukodystrophy Minoryx Therapeutics, S.L.

NCT06301074 The Phase I Study of HS-10509 in Chinese Adult Subjects https://clinicaltrials.gov/study/NCT06301074 NOT_YET_RECRUITING Schizophrenia DRUG: HS-10509

NCT04764474 A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH https://clinicaltrials.gov/study/NCT04764474 RECRUITING Isocitrate Dehydrogenase Gene Mutation DRUG: HMPL-306 Hutchmed

NCT03941574 A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy https://clinicaltrials.gov/study/NCT03941574 RECRUITING MSI-H Solid Malignant Tumor DRUG: HLX10 Shanghai Henlius Biotech

NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06304974 RECRUITING Esophageal Squamous Cell Carcinoma DRUG: BL-B01D1

NCT05933265 Study of LP-184 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05933265 RECRUITING Advanced Solid Tumor DRUG: LP-184 Lantern Pharma Inc.

NCT06549465 Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06549465 RECRUITING PSMA PET-Positive Castration-Resistant Prostate Cancer BIOLOGICAL: In-111 rosopatamab tetraxetan

NCT05578976 A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT05578976 RECRUITING Diffuse Large B-Cell Lymphoma DRUG: Epcoritamab

NCT05782127 Oral Azacitidine Combined with Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT05782127 RECRUITING Untreated Myelodysplastic Syndrome DRUG: Onureg + Venetoclax Groupe Francophone des Myelodysplasies Bristol-Myers Squibb

NCT06567327 A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese https://clinicaltrials.gov/study/NCT06567327 RECRUITING Obesity DRUG: Danuglipron

NCT05412927 AngelMed Guardian® System PMA Post Approval Study https://clinicaltrials.gov/study/NCT05412927 RECRUITING Acute Coronary Syndrome DEVICE: PMA P150009 AngelMed Guardian® System Angel Medical Systems

NCT05501327 Dose Regimen Study of SLI-F06 in Healthy Volunteers https://clinicaltrials.gov/study/NCT05501327 RECRUITING Scar

NCT04715373 LISA in the Delivery Room for Extremely Preterm Infants https://clinicaltrials.gov/study/NCT04715373 RECRUITING Extreme Prematurity

NCT05362773 A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies https://clinicaltrials.gov/study/NCT05362773 RECRUITING Leukemia, Acute Myeloid

NCT05983276 Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer https://clinicaltrials.gov/study/NCT05983276 RECRUITING Ovarian Cancer DRUG: Decitabine

NCT05868876 A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05868876 RECRUITING Advanced Malignant Tumors DRUG: AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion Akeso

NCT06110676 A Study to Evaluate the Efficacy and Safety of LZM012 https://clinicaltrials.gov/study/NCT06110676 RECRUITING Psoriasis BIOLOGICAL: LZM012

NCT05763576 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection https://clinicaltrials.gov/study/NCT05763576 RECRUITING Chronic Hepatitis B DRUG: RO7565020

NCT06074276 The Effects of Almond on Facial Skin Collagen and Wrinkles https://clinicaltrials.gov/study/NCT06074276 RECRUITING Collagen Degeneration

NCT06694727 A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure https://clinicaltrials.gov/study/NCT06694727 NOT_YET_RECRUITING Heart Failure DIETARY_SUPPLEMENT: Coenzyme Q10 100 Milligrams Oral Capsule

NCT06576427 Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II https://clinicaltrials.gov/study/NCT06576427 RECRUITING Pulmonary Embolism DEVICE: Vertex Pulmonary Embolectomy System Neptune Medical

NCT05745727 A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels https://clinicaltrials.gov/study/NCT05745727 RECRUITING Gout DRUG: PRX-115

NCT05815927 Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer https://clinicaltrials.gov/study/NCT05815927 NOT_YET_RECRUITING Oligometastatic Squamous Cell Carcinoma of the Head and Neck DRUG: Pembrolizumab

NCT06637527 The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain https://clinicaltrials.gov/study/NCT06637527 RECRUITING Neuropathic Pain DRUG: OK-101 0.05%

NCT06719973 Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521) https://clinicaltrials.gov/study/NCT06719973 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: M9466

NCT05774873 IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05774873 RECRUITING Solid Tumors DRUG: IBI334 D

NCT06447376 Study of Cytokine Release Syndrome Prophylaxis and Treatment with Siltuximab Prior to Epcoritamab https://clinicaltrials.gov/study/NCT06447376 NOT_YET_RECRUITING Non-Hodgkin Lymphoma

NCT05707676 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） https://clinicaltrials.gov/study/NCT05707676 RECRUITING Solid Tumor DRUG: LB4330 L & L biopharma Co., Ltd., Shanghai China

NCT03965676 Evolution of Tophus and Erosions of Hands and Feet at DECT https://clinicaltrials.gov/study/NCT03965676 RECRUITING Tophaceous Gout OTHER: Dual-Energy Computed Tomography examination Assistance Publique - Hôpitaux de Paris Canon U.S.A., Inc.

NCT05348876 A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) https://clinicaltrials.gov/study/NCT05348876 RECRUITING Non-metastatic Castration-resistant Prostate Cancer DRUG: Darolutamide (Nubeqa, BAY1841788) Bayer

NCT04126876 A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma https://clinicaltrials.gov/study/NCT04126876 RECRUITING Malignant Melanoma DRUG: Tilsotolimod

NCT06019676 Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients https://clinicaltrials.gov/study/NCT06019676 RECRUITING Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Royal Marsden NHS Foundation Trust Janssen, LP

NCT05318976 A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation https://clinicaltrials.gov/study/NCT05318976 RECRUITING Alzheimer Disease

NCT05724576 Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients https://clinicaltrials.gov/study/NCT05724576 RECRUITING Safety Issues BIOLOGICAL: OmniMSC-AMI Taiwan Bio Therapeutics Inc.

NCT04921527 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer https://clinicaltrials.gov/study/NCT04921527 RECRUITING Ovarian Cancer

NCT05254327 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001 https://clinicaltrials.gov/study/NCT05254327 RECRUITING Rectal Cancer DRUG: BMX-001 University of Nebraska BioMimetix JV, LLC

NCT05419427 Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis https://clinicaltrials.gov/study/NCT05419427 RECRUITING Osteoporosis, Postmenopausal DRUG: Denosumab

NCT05744427 To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05744427 RECRUITING Advanced Solid Tumor DRUG: JSKN003 Jiangsu Alphamab Biopharmaceuticals Co., Ltd

NCT06322927 PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma https://clinicaltrials.gov/study/NCT06322927 NOT_YET_RECRUITING Multiple Myeloma OTHER: Patient Interview The Christie NHS Foundation Trust CellCentric Ltd.

NCT05729373 A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder https://clinicaltrials.gov/study/NCT05729373 RECRUITING Generalized Anxiety Disorder DRUG: SEP-363856

NCT06186076 A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients https://clinicaltrials.gov/study/NCT06186076 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT05516576 Endoscopic Sutured Gastroplasty With Endomina® Device Versus Standard of Care in Patients With Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial https://clinicaltrials.gov/study/NCT05516576 RECRUITING Diabetes Mellitus, Type 2

NCT05701527 A Study of EBC-129 in Advanced Solid Tumours https://clinicaltrials.gov/study/NCT05701527 RECRUITING Advanced Solid Tumours DRUG: EBC-129

NCT04389827 Global Kidney Patient Trials Network https://clinicaltrials.gov/study/NCT04389827 RECRUITING Kidney Diseases The George Institute George Clinical Pty Ltd

NCT06144827 A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer https://clinicaltrials.gov/study/NCT06144827 NOT_YET_RECRUITING Cancer, Hepatocellular

NCT06558227 Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06558227 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: ZG005 for Injection

NCT04856176 A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy https://clinicaltrials.gov/study/NCT04856176 RECRUITING Advanced Lung Non-Small Cell Carcinoma

NCT05552976 A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) https://clinicaltrials.gov/study/NCT05552976 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Mezigdomide

NCT06118827 A Study of HS-10518 in Healthy Female Participants https://clinicaltrials.gov/study/NCT06118827 NOT_YET_RECRUITING Endometriosis DRUG: HS-10518

NCT06094127 Zenith Thoracic Alpha (ZTA) Post-Market Data Collection https://clinicaltrials.gov/study/NCT06094127 RECRUITING Thoracic Aortic Aneurysm

NCT04307927 Lifetech LAmbre‚Ñ¢ Left Atrial Appendage Closure System Post-Market Registry https://clinicaltrials.gov/study/NCT04307927 RECRUITING Atrial Fibrillation Lifetech Scientific (Shenzhen) Co., Ltd.

NCT06463327 ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML https://clinicaltrials.gov/study/NCT06463327 NOT_YET_RECRUITING Acute Myeloid Leukemia

NCT05944627 Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis https://clinicaltrials.gov/study/NCT05944627 NOT_YET_RECRUITING Knee Osteoarthritis BIOLOGICAL: FURESTEM-OA Kit Inj.

NCT04469127 A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. https://clinicaltrials.gov/study/NCT04469127 NOT_YET_RECRUITING Breast Cancer Stage IV DRUG: Lutetium-177-DOTAGA-IAC Advanced Imaging Projects, LLC University of Witwatersrand, South Africa

NCT06040476 Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS) https://clinicaltrials.gov/study/NCT06040476 NOT_YET_RECRUITING Acute Ischemic Stroke BIOLOGICAL: hUCB StemCyte International, Ltd. StemCyte Taiwan Co., Ltd.

NCT06472076 A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06472076 RECRUITING Lung Cancer, Non-Small Cell BIOLOGICAL: Dostarlimab

NCT06435676 A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects https://clinicaltrials.gov/study/NCT06435676 RECRUITING Overweight or Obesity; Type 2 Diabetes DRUG: HRS9531

NCT05038527 ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery https://clinicaltrials.gov/study/NCT05038527 RECRUITING Spine Deformity

NCT06494527 A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults https://clinicaltrials.gov/study/NCT06494527 NOT_YET_RECRUITING Safety Issues DRUG: RG002C0106 Rigerna Therapeutics, BeijingÔºõ Rigerna Therapeutics, SuzhouÔºõ Rigerna OA Therapeutics Pty Ltd

NCT06577727 A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children https://clinicaltrials.gov/study/NCT06577727 NOT_YET_RECRUITING Iron Deficiency OTHER: Gold standard blood test

NCT04934527 Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection https://clinicaltrials.gov/study/NCT04934527 RECRUITING Kidney Transplantation

NCT05034627 Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT05034627 RECRUITING Locally Advanced Pancreatic Adenocarcinoma

NCT05867927 GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications https://clinicaltrials.gov/study/NCT05867927 RECRUITING GYN Disorders DEVICE: Robotic-assisted surgery (da Vinci)

NCT05856227 Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age https://clinicaltrials.gov/study/NCT05856227 RECRUITING Neonatal Sepsis DRUG: Ceftobiprole medocaril Basilea Pharmaceutica

NCT06038227 Lung cAncer Robotic Comparative Study https://clinicaltrials.gov/study/NCT06038227 RECRUITING Lung Cancer PROCEDURE: Robotic Assisted Thoracic Surgery

NCT06066476 Evaluating Efficacy and Safety of GENOSS Stent in Patients With Coronary Artery Disease https://clinicaltrials.gov/study/NCT06066476 RECRUITING Coronary Artery Disease DEVICE: Genoss DES Genoss Co., Ltd.

NCT05812976 Novel Index (PIMR) in PAH https://clinicaltrials.gov/study/NCT05812976 RECRUITING Pulmonary Hypertension OTHER: Pulmonary Index of Microcirculatory Resistance

NCT05117476 A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05117476 RECRUITING Advanced Solid Tumor DRUG: CLN-619

NCT06052176 Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement https://clinicaltrials.gov/study/NCT06052176 RECRUITING Cirrhosis

NCT05690776 PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband https://clinicaltrials.gov/study/NCT05690776 RECRUITING Rotator Cuff Tears

NCT06254027 Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment https://clinicaltrials.gov/study/NCT06254027 NOT_YET_RECRUITING Onychomycosis DEVICE: Forte

NCT06087627 A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine https://clinicaltrials.gov/study/NCT06087627 RECRUITING Prurigo Nodularis DRUG: Dupilumab SAR231893 (REGN668) Sanofi

NCT06543576 External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer https://clinicaltrials.gov/study/NCT06543576 NOT_YET_RECRUITING Cervical Adenocarcinoma

NCT06326827 In'Oss™ (MBCP® Putty) Ortho https://clinicaltrials.gov/study/NCT06326827 NOT_YET_RECRUITING Orthopedic Disorder

NCT06568627 A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE) https://clinicaltrials.gov/study/NCT06568627 NOT_YET_RECRUITING Venous Leg Ulcer (VLU) DRUG: EscharEx (EX-03)

NCT05537727 Robotic MIS With Dexter https://clinicaltrials.gov/study/NCT05537727 RECRUITING Hysterectomy

NCT05347927 Observational Study to Evaluate the Influence of Undercast Material Types on Skin Microbiome https://clinicaltrials.gov/study/NCT05347927 RECRUITING Skin Microbiome

NCT05288127 Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature https://clinicaltrials.gov/study/NCT05288127 RECRUITING HRD 100 Gene Expression High

NCT06497127 A Study in Patients With Mixed Dyslipidemia https://clinicaltrials.gov/study/NCT06497127 NOT_YET_RECRUITING Mixed Dyslipidemia DRUG: BW-00112 Shanghai Argo Biopharmaceutical Co., Ltd.

NCT06065176 The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection https://clinicaltrials.gov/study/NCT06065176 RECRUITING COVID-19

NCT05997576 A Study of TG103 Injection in Non-diabetic Overweight or Obesity https://clinicaltrials.gov/study/NCT05997576 NOT_YET_RECRUITING Overweight or Obesity DRUG: TG103 22.5 mg

NCT05872776 BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation https://clinicaltrials.gov/study/NCT05872776 RECRUITING Paroxysmal Atrial Fibrillation DEVICE: Neuromodulation with RR2 device

NCT06706076 A Study of BH-30643 in Subjects with Locally Advanced or Metastatic NSCLC Harboring EGFR And/or HER2 Mutations https://clinicaltrials.gov/study/NCT06706076 RECRUITING NSCLC (advanced Non-small Cell Lung Cancer) DRUG: BH-30643

NCT05920876 A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05920876 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: QLS32015 Qilu Pharmaceutical Co., Ltd.

NCT05542576 AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy https://clinicaltrials.gov/study/NCT05542576 RECRUITING Parkinson Disease

NCT05996627 Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease https://clinicaltrials.gov/study/NCT05996627 RECRUITING Chronic Graft Versus Host Disease DRUG: Belumosudil

NCT05984927 NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration https://clinicaltrials.gov/study/NCT05984927 RECRUITING Age-Related Macular Degeneration GENETIC: NG101 AAV gene therapy Neuracle Genetics, Inc ORA, Inc.

NCT03916627 Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients https://clinicaltrials.gov/study/NCT03916627 RECRUITING Non-small Cell Lung Cancer

NCT06662227 Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors https://clinicaltrials.gov/study/NCT06662227 RECRUITING B Cell Lymphoma

NCT05561127 Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel https://clinicaltrials.gov/study/NCT05561127 RECRUITING Bowel; Stricture COMBINATION_PRODUCT: GIE Medical ProTractX3 TTS DCB

NCT06397976 The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study https://clinicaltrials.gov/study/NCT06397976 RECRUITING Eyes With Normal Anterior Segment

NCT06135376 E-PAUse: Encouraging Proper Antibiotic Use in Outpatient Setting https://clinicaltrials.gov/study/NCT06135376 RECRUITING Drug Use BEHAVIORAL: comprehensive multi-component interventions Hamad Medical Corporation Primary Health Care Corporation, Qatar

NCT04338776 Comparing UroLift Experience Against Rez≈´m https://clinicaltrials.gov/study/NCT04338776 RECRUITING Benign Prostatic Hyperplasia DEVICE: UroLift

NCT05248776 Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05248776 RECRUITING Type 2 Diabetes DRUG: CPL207280

NCT06629376 Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia https://clinicaltrials.gov/study/NCT06629376 RECRUITING Gout

NCT04802876 Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors https://clinicaltrials.gov/study/NCT04802876 RECRUITING MSI-H Colorectal Cancer

NCT04855227 A Prospective Evaluation of Pain After Non-complex Ventral Hernia Repair https://clinicaltrials.gov/study/NCT04855227 RECRUITING Ventral Hernia PROCEDURE: robotic-assisted ventral hernia repair Intuitive Surgical

NCT06315127 The CanDo (Canadian Donor Milk) Trial https://clinicaltrials.gov/study/NCT06315127 RECRUITING Small for Gestational Age at Delivery

NCT06036927 A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT06036927 RECRUITING Chronic Sinusitis

NCT05814627 Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05814627 RECRUITING Rheumatoid Arthritis DRUG: Upadacitinib

NCT06559527 A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function https://clinicaltrials.gov/study/NCT06559527 NOT_YET_RECRUITING Diabetes Mellitus, Type 2

NCT06248827 Creation of a Clinical Database of Lumbar Spine MRI https://clinicaltrials.gov/study/NCT06248827 NOT_YET_RECRUITING Low Back Pain OTHER: Data Collection Caerus Medical Centre hospitalier de l'Université de Montréal (CHUM)

NCT05832827 First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) https://clinicaltrials.gov/study/NCT05832827 RECRUITING Untreated Advanced or Recurrent Thymic Carcinomas DRUG: MK-3475

NCT05540327 The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) https://clinicaltrials.gov/study/NCT05540327 RECRUITING Systemic Lupus Erythematosus DRUG: M5049 low dose

NCT06608927 Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT06608927 RECRUITING Metastatic Pancreatic Ductal Adenocarcinoma DRUG: Quemliclustat

NCT06559176 A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants with P47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) https://clinicaltrials.gov/study/NCT06559176 RECRUITING Chronic Granulomatous Disease

NCT04307576 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia https://clinicaltrials.gov/study/NCT04307576 RECRUITING Leukemia, Acute Lymphoblastic DRUG: Omitted Doxorubicin

NCT06578676 To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults https://clinicaltrials.gov/study/NCT06578676 RECRUITING Type 2 Diabetes

NCT06663176 Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients with Pseudomonas Aeruginosa (Pa) https://clinicaltrials.gov/study/NCT06663176 RECRUITING Non-Cystic Fibrosis Bronchiectasis DRUG: RESP302

NCT05797376 Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation https://clinicaltrials.gov/study/NCT05797376 RECRUITING Atherosclerosis of Artery

NCT05636176 A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation https://clinicaltrials.gov/study/NCT05636176 RECRUITING Heart Failure DRUG: Ziltivekimab

NCT06284876 Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer https://clinicaltrials.gov/study/NCT06284876 NOT_YET_RECRUITING Peptic Ulcer DRUG: Ilaprazole

NCT06093776 Rib Fracture Cryoanalgesia https://clinicaltrials.gov/study/NCT06093776 RECRUITING Pain Management Improvement DEVICE: ioveraº system Methodist Health System Pacira Pharmaceuticals, Inc

NCT03050476 Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase https://clinicaltrials.gov/study/NCT03050476 RECRUITING Systemic Inflammation

NCT05924776 Plasmodium Immunotherapy for Advanced Ovarian Cancer https://clinicaltrials.gov/study/NCT05924776 NOT_YET_RECRUITING Advanced Ovarian Cancer BIOLOGICAL: Plasmodium immunotherapy CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. The Third Affiliated Hospital of Southern Medical University

NCT06172127 PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06172127 RECRUITING HER2-positive Breast Cancer DRUG: Trastuzumab deruxtecan

NCT05004727 Multi-Center PAMPA Study https://clinicaltrials.gov/study/NCT05004727 RECRUITING Psoriasis DRUG: Guselkumab

NCT04110327 An All-Comers Observational Study of the MicroStent‚Ñ¢ Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease https://clinicaltrials.gov/study/NCT04110327 RECRUITING Peripheral Arterial Disease

NCT05330520 Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL) https://clinicaltrials.gov/study/NCT05330520 RECRUITING BPH

NCT04580420 Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD https://clinicaltrials.gov/study/NCT04580420 RECRUITING Primary Hyperoxaluria Type 1

NCT05685420 Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia https://clinicaltrials.gov/study/NCT05685420 NOT_YET_RECRUITING Immune Thrombocytopenia DRUG: Herombopag Jiangsu HengRui Medicine Co., Ltd.

NCT06393920 PulseSelect‚Ñ¢ PFA Global Registry https://clinicaltrials.gov/study/NCT06393920 RECRUITING Atrial Fibrillation Medtronic Cardiac Rhythm and Heart Failure

NCT06397274 Stemchymal® for Polyglutamine Spinocerebellar Ataxia https://clinicaltrials.gov/study/NCT06397274 NOT_YET_RECRUITING Spinocerebellar Ataxias BIOLOGICAL: Stemchymal

NCT06523374 A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer https://clinicaltrials.gov/study/NCT06523374 NOT_YET_RECRUITING Barrett's Esophagus

NCT05800574 Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer https://clinicaltrials.gov/study/NCT05800574 RECRUITING Oropharynx Cancer RADIATION: Radiation therapy (5 days for 7 weeks)

NCT06096974 Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS https://clinicaltrials.gov/study/NCT06096974 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: YL-17231 Shanghai YingLi Pharmaceutical Co. Ltd.

NCT06284265 Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis https://clinicaltrials.gov/study/NCT06284265 RECRUITING Cystitis Chronic

NCT06433765 A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT06433765 RECRUITING Multiple Sclerosis OTHER: No intervention TG Therapeutics, Inc.

NCT05941065 Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin https://clinicaltrials.gov/study/NCT05941065 RECRUITING Skin Microboime

NCT06645665 A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above https://clinicaltrials.gov/study/NCT06645665 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: Bivalent RSV Vaccine (IN006)

NCT04721665 German SLD-Registry (Deutsches SLD-Register) https://clinicaltrials.gov/study/NCT04721665 RECRUITING Steatotic Liver Disease Leberstiftungs-GmbH Deutschland

NCT06246565 A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC) https://clinicaltrials.gov/study/NCT06246565 NOT_YET_RECRUITING Cough DRUG: HS-10383

NCT05483465 The Effect of NAD Supplementation on Brain Vascular Health in Aging https://clinicaltrials.gov/study/NCT05483465 RECRUITING Aging DRUG: Nicotinamide riboside

NCT06078865 FX Shoulder Prospective Clinical Study https://clinicaltrials.gov/study/NCT06078865 RECRUITING Osteoarthritis Shoulder

NCT06402565 NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06402565 NOT_YET_RECRUITING Diabetic Foot Ulcer DRUG: NOX1416 plus SOC

NCT06189365 Amplatzer Amulet China Post Market Study (PMS) https://clinicaltrials.gov/study/NCT06189365 RECRUITING Non-Valvular Atrial Fibrillation DEVICE: Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder Abbott Medical Devices

NCT05452720 MASA Valve Early Feasibility Study https://clinicaltrials.gov/study/NCT05452720 RECRUITING Tetrology of Fallot

NCT06591520 AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer https://clinicaltrials.gov/study/NCT06591520 NOT_YET_RECRUITING Biliary Tract Cancer DRUG: AK112, Gemcitabine, Cisplatin

NCT06368674 Bridging the Gap: Creating a Continuum of Care https://clinicaltrials.gov/study/NCT06368674 NOT_YET_RECRUITING Frailty

NCT06117774 Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) https://clinicaltrials.gov/study/NCT06117774 RECRUITING Limited Stage Small Cell Lung Cancer

NCT05865574 A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection https://clinicaltrials.gov/study/NCT05865574 NOT_YET_RECRUITING Healthy Men DRUG: BAT1706 Injection Bio-Thera Solutions

NCT06554574 A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants https://clinicaltrials.gov/study/NCT06554574 RECRUITING Healthy DRUG: LTG-305 Latigo Biotherapeutics

NCT06147674 Evaluation of VQm PHM on Pulmonary Health Parameters for ICU https://clinicaltrials.gov/study/NCT06147674 NOT_YET_RECRUITING Ventilators, Mechanical

NCT06393374 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) https://clinicaltrials.gov/study/NCT06393374 RECRUITING Triple-Negative Breast Cancer BIOLOGICAL: Pembrolizumab

NCT06558474 Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation https://clinicaltrials.gov/study/NCT06558474 RECRUITING Coronary Artery Disease BEHAVIORAL: Liberal post-dilatation strategy during PCI Cathreine BV Medtronic

NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation https://clinicaltrials.gov/study/NCT03433274 RECRUITING Mitral Regurgitation

NCT03812874 A Study of PTX-9908 Injection for Non-resectable HCC with TACE https://clinicaltrials.gov/study/NCT03812874 RECRUITING Carcinoma, Hepatocellular DRUG: PTX-9908 Injection

NCT06052865 Serial Brain MRI in Hospitalized Preterm Infants https://clinicaltrials.gov/study/NCT06052865 RECRUITING Preterm Birth Complication BEHAVIORAL: SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

NCT05824065 Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss https://clinicaltrials.gov/study/NCT05824065 NOT_YET_RECRUITING Female Pattern Baldness DRUG: OMA102

NCT05501665 Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer https://clinicaltrials.gov/study/NCT05501665 RECRUITING Lung Non-Small Cell Carcinoma

NCT06698965 Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin https://clinicaltrials.gov/study/NCT06698965 RECRUITING Lung Cancer, Small Cell DRUG: Chemotherapy （Etoposide and Carboplatin）

NCT05566665 Nosocomial Infections in ECMO Patients https://clinicaltrials.gov/study/NCT05566665 RECRUITING Acute Respiratory Distress Syndrome

NCT06081465 A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects https://clinicaltrials.gov/study/NCT06081465 RECRUITING Healthy Volunteers DRUG: VG290131 Zhejiang Vimgreen Pharmaceuticals, Ltd. Tigermed Consulting Co., Ltd

NCT03394365 Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy https://clinicaltrials.gov/study/NCT03394365 RECRUITING Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

NCT05790265 Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women https://clinicaltrials.gov/study/NCT05790265 NOT_YET_RECRUITING Blood Pressure DEVICE: ANNE One Sibel Health Inc. University of North Carolina

NCT06024265 The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease https://clinicaltrials.gov/study/NCT06024265 RECRUITING Huntington Disease DRUG: ER2001 injection ExoRNA Bioscience

NCT05716165 Effect of Proprioceptive Knee Braces on the Performance and Endurance of Recreational Soccer Players Aged 60-80 Years https://clinicaltrials.gov/study/NCT05716165 RECRUITING Healthy Volunteers DEVICE: proprioceptive knee braces

NCT06389474 Efficacy of INM004 in Children With STEC-HUS https://clinicaltrials.gov/study/NCT06389474 RECRUITING Hemolytic-Uremic Syndrome BIOLOGICAL: INM004

NCT05706974 Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05706974 NOT_YET_RECRUITING Bile Duct Cancer Power Life Sciences Inc.

NCT06180174 Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma https://clinicaltrials.gov/study/NCT06180174 RECRUITING B Cell Lymphoma

NCT06172374 A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials https://clinicaltrials.gov/study/NCT06172374 RECRUITING Primary Ciliary Dyskinesia GENETIC: Sano Genetics Testing Kit ReCode Therapeutics Sano Genetics

NCT06542874 A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06542874 RECRUITING Type 2 Diabetes (T2D) DRUG: NNC0487-0111 subcutanous

NCT03288974 Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea https://clinicaltrials.gov/study/NCT03288974 RECRUITING Multiple Myeloma DRUG: POMALYST® (Pomalidomide) Celgene

NCT05920174 Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability https://clinicaltrials.gov/study/NCT05920174 RECRUITING Tetraplegia DEVICE: NEO Neuracle Medical Technology(Shanghai) Co.,Ltd. Xuanwu Hospital, Beijing

NCT06537674 Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer https://clinicaltrials.gov/study/NCT06537674 NOT_YET_RECRUITING HER2+ Breast Cancer DRUG: Trastuzumab intravenous drip/Trastuzumab Subcutaneous Injection Jiangsu Famous Medical Technology Co., Ltd.

NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment https://clinicaltrials.gov/study/NCT06151574 RECRUITING Lung Cancer, Non-squamous, Non-small Cell DRUG: zongertinib

NCT06213974 A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina https://clinicaltrials.gov/study/NCT06213974 RECRUITING Cytomegalovirus (CMV) OTHER: No Intervention Takeda

NCT05361174 A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer https://clinicaltrials.gov/study/NCT05361174 RECRUITING Unresectable Melanoma

NCT05729074 A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients https://clinicaltrials.gov/study/NCT05729074 NOT_YET_RECRUITING Mild to Moderate Atopic Dermatitis DRUG: IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment

NCT05067374 Hepatitis C Screening Paired With Mammography https://clinicaltrials.gov/study/NCT05067374 RECRUITING Hepatitis C

NCT06416865 Efficacy and Safety of AJU-C52 in Essential Hypertension Patients https://clinicaltrials.gov/study/NCT06416865 RECRUITING Essential Hypertension DRUG: AJU-C52L, AJU-C52

NCT06657365 Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles https://clinicaltrials.gov/study/NCT06657365 RECRUITING Facial Wrinkles

NCT06625320 Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) https://clinicaltrials.gov/study/NCT06625320 RECRUITING Pancreatic Cancer

NCT05003674 A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients https://clinicaltrials.gov/study/NCT05003674 RECRUITING Hearing Impairment DEVICE: Focused stimulation strategy

NCT03308474 Myeloma Registry Platform (MYRIAM) https://clinicaltrials.gov/study/NCT03308474 RECRUITING Multiple Myeloma OTHER: Routine care as per site standard. iOMEDICO AG Deutsche Studiengruppe Multiples Myelom (DSMM)

NCT06028074 Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT06028074 RECRUITING Advanced Solid Malignancies DRUG: GIM122 Georgiamune Inc

NCT05566574 A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer https://clinicaltrials.gov/study/NCT05566574 RECRUITING Solid Tumor

NCT06564974 Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy. https://clinicaltrials.gov/study/NCT06564974 RECRUITING Duchenne Muscular Dystrophy DRUG: Vamorolone Catalyst Pharmaceuticals, Inc.

NCT05357274 A System to Classify Treatable Traits in Primary Care https://clinicaltrials.gov/study/NCT05357274 NOT_YET_RECRUITING Respiratory Disease

NCT06245174 A Smartphone Application for Neurology and Telemedicine https://clinicaltrials.gov/study/NCT06245174 RECRUITING Parkinson Disease(PD) Altec Inc. National Institute of Neurological Disorders and Stroke (NINDS)

NCT04988074 Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca https://clinicaltrials.gov/study/NCT04988074 RECRUITING HPV-Related Squamous Cell Carcinoma DRUG: Cemiplimab Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Regeneron Pharmaceuticals

NCT05501574 An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients https://clinicaltrials.gov/study/NCT05501574 RECRUITING Lung Transplant Rejection DRUG: Tacrolimus Inhalation Powder TFF Pharmaceuticals, Inc.

NCT06387420 A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06387420 NOT_YET_RECRUITING ACUTE MYELOID LEUKEMIA; AML DRUG: AK117

NCT05756920 This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT05756920 RECRUITING Healthy DRUG: ABL301

NCT06323174 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise https://clinicaltrials.gov/study/NCT06323174 RECRUITING Type 2 Diabetes DRUG: Cagrilintide

NCT05505474 Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation https://clinicaltrials.gov/study/NCT05505474 RECRUITING Infertility, Female DEVICE: IVF with the Neria‚Ñ¢ Guard Subcutaneous Catheter University of Southern California ConvaTec Inc.

NCT05687474 Baby Detect : Genomic Newborn Screening https://clinicaltrials.gov/study/NCT05687474 RECRUITING Congenital Adrenal Hyperplasia

NCT06210074 Performance of Tampons as a Biospecimen Collection Tool for the Detection of Human Papillomavirus in a Colposcopy Setting https://clinicaltrials.gov/study/NCT06210074 NOT_YET_RECRUITING CIN2 DEVICE: Daye Diagnostic Tampon Tampon Innovations Ltd University of Edinburgh

NCT06043674 A Ph 2 Study of Glofitamab Alone or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation https://clinicaltrials.gov/study/NCT06043674 RECRUITING Chronic Lymphocytic Leukemia

NCT04912674 Evaluation of Symphony‚Ñ¢ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity https://clinicaltrials.gov/study/NCT04912674 RECRUITING Cervical Deformity DEVICE: Symphony OCT System International Spine Study Group Foundation DePuy Synthes

NCT06202274 Clinical Study to Evaluate the Safety and Efficacy of Candela Technology https://clinicaltrials.gov/study/NCT06202274 RECRUITING Hair Reduction

NCT06233474 Study of Intra-articular Allocetra in Knee Osteoarthritis https://clinicaltrials.gov/study/NCT06233474 RECRUITING Osteoarthritis, Knee DRUG: Allocetra

NCT06675565 A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06675565 NOT_YET_RECRUITING Healthy Volunteers DRUG: ALN-AGT01 RVR

NCT06260865 A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome https://clinicaltrials.gov/study/NCT06260865 RECRUITING Patellofemoral Pain Syndrome DEVICE: MORA Cure

NCT05350865 Thailand HDV Cohort https://clinicaltrials.gov/study/NCT05350865 RECRUITING HDV The HIV Netherlands Australia Thailand Research Collaboration King Chulalongkorn Memorial Hospital

NCT06153420 Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). https://clinicaltrials.gov/study/NCT06153420 RECRUITING Irritable Bowel Syndrome With Diarrhea DRUG: CIN-103

NCT06592820 Shear Wave Elastography Registry Study https://clinicaltrials.gov/study/NCT06592820 NOT_YET_RECRUITING MASLD

NCT04292574 UK SMA Patient Registry https://clinicaltrials.gov/study/NCT04292574 RECRUITING Spinal Muscular Atrophy

NCT05485974 A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation https://clinicaltrials.gov/study/NCT05485974 RECRUITING Lung Cancer

NCT06143774 Study of TRX-920 for Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06143774 RECRUITING Advanced Solid Tumor DRUG: TRX-920 Oral Gel (10 mg and 30 mg) TaiRx, Inc.

NCT06260774 Study of TTX-MC138 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06260774 RECRUITING Advanced Solid Tumor DRUG: TTX-MC138 TransCode Therapeutics

NCT04893174 Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). https://clinicaltrials.gov/study/NCT04893174 RECRUITING Osteoarthritis, Knee BIOLOGICAL: UMC119-06-05

NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://clinicaltrials.gov/study/NCT03452774 RECRUITING Cancer, Metastatic

NCT04655365 Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. https://clinicaltrials.gov/study/NCT04655365 RECRUITING Prostate Cancer DRUG: Enzalutamide capsule CHU de Quebec-Universite Laval Astellas Pharma Europe Ltd.

NCT05444465 Use of the REGENETEN‚Ñ¢ Bioinductive Implant System in High Grade Partial-thickness Tears https://clinicaltrials.gov/study/NCT05444465 RECRUITING Rotator Cuff Injuries DEVICE: Isolated Bioinductive Repair

NCT06117020 Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals https://clinicaltrials.gov/study/NCT06117020 RECRUITING Muscle Spasticity

NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study https://clinicaltrials.gov/study/NCT04761120 RECRUITING Mitral Regurgitation

NCT04705220 Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome https://clinicaltrials.gov/study/NCT04705220 RECRUITING Mild Cognitive Impairment DIETARY_SUPPLEMENT: MERIVA® Tablets

NCT05764720 Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach https://clinicaltrials.gov/study/NCT05764720 RECRUITING Pancreatic Cancer RADIATION: Daily Adaptive External Beam Radiation Therapy Varian, a Siemens Healthineers Company Washington University School of Medicine

NCT06520774 Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases https://clinicaltrials.gov/study/NCT06520774 NOT_YET_RECRUITING Aortic Arch Aneurysm

NCT05107674 A Study of NX-1607 in Adults With Advanced Malignancies https://clinicaltrials.gov/study/NCT05107674 RECRUITING Ovarian Cancer, Epithelial

NCT05517174 A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults https://clinicaltrials.gov/study/NCT05517174 RECRUITING Influenza BIOLOGICAL: High-Dose Quadrivalent Influenza Vaccine

NCT05691374 Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair https://clinicaltrials.gov/study/NCT05691374 RECRUITING Arthroscopic Rotator Cuff Repair (ARCR) PROCEDURE: Ultrasound (US) examination

NCT05358574 PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System https://clinicaltrials.gov/study/NCT05358574 RECRUITING Revision of a Shoulder Prosthesis Zimmer Biomet

NCT06343220 Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research https://clinicaltrials.gov/study/NCT06343220 RECRUITING Huntington Disease Huntington Study Group Roche Products Limited

NCT05959720 Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil https://clinicaltrials.gov/study/NCT05959720 RECRUITING Acute Lymphoid Leukemia

NCT05775874 A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC https://clinicaltrials.gov/study/NCT05775874 RECRUITING Urothelial Carcinoma DRUG: AZD4547

NCT05461274 Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients https://clinicaltrials.gov/study/NCT05461274 NOT_YET_RECRUITING Diabetic Neuropathies

NCT00540774 Optical Sensor for Photodynamic Detection of Oral Pathology https://clinicaltrials.gov/study/NCT00540774 RECRUITING Mouth Diseases DEVICE: detection of oral pathology University of California, Irvine National Institutes of Health (NIH)

NCT06206174 TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies https://clinicaltrials.gov/study/NCT06206174 RECRUITING Hematologic Malignancy

NCT06091774 Clinical Study for the Investigation and Validation of a Therapy Procedure for the Adjustment of Risk Factors in Patients With Coronary Heart Disease by Means of Digital Therapy Control https://clinicaltrials.gov/study/NCT06091774 RECRUITING Coronary Artery Disease

NCT05458674 Tucatinib+Trastuzumab+Eribulin in HER2+ MBC https://clinicaltrials.gov/study/NCT05458674 RECRUITING Breast Cancer DRUG: Tucatinib

NCT05839873 Abbott Ventricular Tachycardia PAS https://clinicaltrials.gov/study/NCT05839873 RECRUITING Ventricular Tachycardia DEVICE: FlexAbility SE Ablation Catheter Abbott Medical Devices

NCT06571331 A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder https://clinicaltrials.gov/study/NCT06571331 NOT_YET_RECRUITING Stress

NCT05258331 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis https://clinicaltrials.gov/study/NCT05258331 RECRUITING Moderate to Severe Plaque Psoriasis GENETIC: CT303 GC Cell Corporation

NCT06085131 Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study https://clinicaltrials.gov/study/NCT06085131 RECRUITING Cataract DEVICE: Argos Shammas Eye Medical Center Sengi

NCT06141031 Trial of Radiotherapy in Combination with TTI-101 in Patients with Borderline Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT06141031 RECRUITING Pancreatic Cancer DRUG: TTI-101 University of Colorado, Denver Tvardi Therapeutics, Incorporated

NCT06169631 The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology https://clinicaltrials.gov/study/NCT06169631 RECRUITING Anxiety Disorders DEVICE: Gen0b Sanmai Technologies PBC dba Sanmai

NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants with Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression https://clinicaltrials.gov/study/NCT05736731 RECRUITING Solid Tumor, Adult

NCT05893082 Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR https://clinicaltrials.gov/study/NCT05893082 RECRUITING Aortic Stenosis DEVICE: F2 Filter and Delivery System EnCompass Technologies, Inc.

NCT05995782 A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 https://clinicaltrials.gov/study/NCT05995782 RECRUITING Parkinson Disease Psychosis

NCT06185673 A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia https://clinicaltrials.gov/study/NCT06185673 RECRUITING Oculopharyngeal Muscular Dystrophy GENETIC: BB-301: Dose escalation phase 1b cohort 1

NCT06678373 Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas https://clinicaltrials.gov/study/NCT06678373 NOT_YET_RECRUITING Japanese Encephalitis BIOLOGICAL: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine

NCT06267131 Transcutaneous Pulse Oximetry Brain Monitoring Study (US) https://clinicaltrials.gov/study/NCT06267131 RECRUITING Acute Brain Injury DEVICE: Brain Pulse Oximeter Cyban Pty Ltd

NCT06397131 A Study to Determine the Safety and Efficacy of NT-501 With MHFM https://clinicaltrials.gov/study/NCT06397131 NOT_YET_RECRUITING Macular Telangiectasia Type 2 COMBINATION_PRODUCT: NT-501 CNTF Implant Neurotech Pharmaceuticals

NCT05838131 Study of CT071 Injection in RRMM or PPCL https://clinicaltrials.gov/study/NCT05838131 RECRUITING Multiple Myeloma

NCT06038331 Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis https://clinicaltrials.gov/study/NCT06038331 RECRUITING Osteoarthritis Hand BIOLOGICAL: SclerFIX-IP TBF Genie Tissulaire

NCT05856331 Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema https://clinicaltrials.gov/study/NCT05856331 RECRUITING Alpha 1-Antitrypsin Deficiency

NCT06180382 Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. https://clinicaltrials.gov/study/NCT06180382 RECRUITING Crohn's Disease DRUG: Adalimumab

NCT06703073 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) https://clinicaltrials.gov/study/NCT06703073 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome (ARDS)

NCT03399773 Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT03399773 RECRUITING Acute Biphenotypic Leukemia

NCT05852431 To Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia https://clinicaltrials.gov/study/NCT05852431 RECRUITING Severe Hypertriglyceridemia DRUG: Pegozafermin

NCT05611931 Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma https://clinicaltrials.gov/study/NCT05611931 RECRUITING Endometrial Cancer DRUG: Selinexor

NCT06503731 A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients with Antibody-Mediated Rejection (AMR) https://clinicaltrials.gov/study/NCT06503731 RECRUITING Antibody-mediated Rejection COMBINATION_PRODUCT: Efgartigimod PH20 SC - prefilled syringe

NCT06346431 Efficacy of Digital Problem Solving Application in Reduction of Anxiety, Depression and Substance Use Disorder Symptoms https://clinicaltrials.gov/study/NCT06346431 NOT_YET_RECRUITING Anxiety

NCT06532331 A Phase‚Ö†Study of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT06532331 RECRUITING Metastatic Pancreatic Cancer DRUG: ONO-7475

NCT06218082 Vitiligo Registry for Adults and Children in the UK https://clinicaltrials.gov/study/NCT06218082 RECRUITING Dermatologic Disease

NCT05844982 Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy https://clinicaltrials.gov/study/NCT05844982 RECRUITING Radiation Retinopathy

NCT06364631 CARE1 Pragmatic Clinical Trial https://clinicaltrials.gov/study/NCT06364631 RECRUITING Metastatic Kidney Cancer

NCT05493631 A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient https://clinicaltrials.gov/study/NCT05493631 RECRUITING Hemophilia BIOLOGICAL: MG1113 GC Biopharma Corp

NCT04175431 Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study https://clinicaltrials.gov/study/NCT04175431 RECRUITING Prostate Adenocarcinoma PROCEDURE: Positron Emission Tomography

NCT06173531 Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome https://clinicaltrials.gov/study/NCT06173531 RECRUITING Hyperphagia in Prader-Willi Syndrome DRUG: Carbetocin

NCT05934331 A LM-302 Combined With Toripalimab Phase II Study https://clinicaltrials.gov/study/NCT05934331 RECRUITING Gastric Cancer

NCT05709431 A Study Evaluating the French Version of the CIQoL-35 Quality of Life Questionnaire in Adult Cochlear Implant Use. https://clinicaltrials.gov/study/NCT05709431 RECRUITING PROM

NCT06650631 The Effectiveness of Heat Treatment on Knee Pain in Patients with Osteoarthritis - an International, Multicenter Clinical Investigation https://clinicaltrials.gov/study/NCT06650631 RECRUITING Pain Management

NCT06160531 Influenza Viral Challenge Study of CC-42344 in Healthy Participants https://clinicaltrials.gov/study/NCT06160531 RECRUITING Influenza A DRUG: CC-42344

NCT05394831 A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC https://clinicaltrials.gov/study/NCT05394831 RECRUITING EGFR Mutant Advanced Non-small Cell Lung Cancer DRUG: JIN-A02 J Ints Bio

NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia https://clinicaltrials.gov/study/NCT05708131 RECRUITING Ventricular Tachycardia Mid and South Essex NHS Foundation Trust Abbott

NCT06648031 Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants https://clinicaltrials.gov/study/NCT06648031 NOT_YET_RECRUITING Type2diabetes DRUG: Arm 1 - DehydraTECH-CBD alone

NCT04991831 A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease https://clinicaltrials.gov/study/NCT04991831 RECRUITING Tremor Associated With Tremor Dominant Parkinson's Disease DEVICE: Unilateral thalamotomy InSightec

NCT06525831 Rein 3D PRINT MECHANICS https://clinicaltrials.gov/study/NCT06525831 NOT_YET_RECRUITING Kidney Cancer DIAGNOSTIC_TEST: MR-elastography exam

NCT06602531 Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults https://clinicaltrials.gov/study/NCT06602531 NOT_YET_RECRUITING Influenza, Human BIOLOGICAL: ARCT-2304

NCT06377982 Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy https://clinicaltrials.gov/study/NCT06377982 NOT_YET_RECRUITING Cerebral Palsy BIOLOGICAL: hUCB StemCyte International, Ltd. StemCyte Taiwan Co., Ltd.

NCT06508931 Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With Relapsed or Refractory B-Cell Neoplasms https://clinicaltrials.gov/study/NCT06508931 NOT_YET_RECRUITING B-Cell Neoplasm DRUG: zamtocabtagene autoleucel (MB-CART2019.1) Miltenyi Biomedicine GmbH

NCT03734731 Cannabis Vs Opioids Pain Management Objective Testing Comparisons https://clinicaltrials.gov/study/NCT03734731 NOT_YET_RECRUITING Chronic Pain

NCT06521931 A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients https://clinicaltrials.gov/study/NCT06521931 RECRUITING Thrombocytopenia DRUG: PN20 Chongqing Peg-Bio Biopharm Co., Ltd.

NCT03319082 Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery https://clinicaltrials.gov/study/NCT03319082 RECRUITING Corneal Ectasia COMBINATION_PRODUCT: Corneal Collagen Cross-linking Glaukos Corporation

NCT03867682 Venetoclax and Lintuzumab-Ac225 in AML Patients https://clinicaltrials.gov/study/NCT03867682 RECRUITING Acute Myeloid Leukemia

NCT05655182 A Study of BLB-201 RSV Vaccine in Infants and Children https://clinicaltrials.gov/study/NCT05655182 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: PIV5-vectored RSV Vaccine (BLB-201) Low Dose

NCT05859373 To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT05859373 NOT_YET_RECRUITING Non-small Cell Lung Cancer COMBINATION_PRODUCT: TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation

NCT03746431 A Phase 1/2 Study of [225Ac]-FPI-1434 Injection https://clinicaltrials.gov/study/NCT03746431 RECRUITING Advanced Solid Tumours

NCT04772131 Desara ® One Single Incision Sling 522 Study https://clinicaltrials.gov/study/NCT04772131 RECRUITING Stress Urinary Incontinence DEVICE: Desara® One Single Incision Sling

NCT05502731 Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05502731 NOT_YET_RECRUITING Rheumatoid Arthritis DRUG: Filgotinib

NCT06693531 A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care https://clinicaltrials.gov/study/NCT06693531 NOT_YET_RECRUITING Eosinophilic Esophagitis (EoE) DRUG: dupilumab Regeneron Pharmaceuticals Sanofi

NCT06410131 Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 https://clinicaltrials.gov/study/NCT06410131 NOT_YET_RECRUITING Solid Tumors DRUG: FTL008.16 Sound Biopharmaceuticals Ltd.

NCT05860231 Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization https://clinicaltrials.gov/study/NCT05860231 RECRUITING Catheter-Associated Urinary Tract Infection

NCT06557031 Clinical Performance Study of the ABTest Card® Device. https://clinicaltrials.gov/study/NCT06557031 NOT_YET_RECRUITING Transfusion Reaction DIAGNOSTIC_TEST: ABTest Card®REF and ABTest Card®NEW Diagast Soladis

NCT06294431 Radicle Clarity 24: A Study of Health and Wellness Products on Cognitive Function and Related Health Outcomes https://clinicaltrials.gov/study/NCT06294431 RECRUITING Cognitive Function DIETARY_SUPPLEMENT: Placebo Control Form 1

NCT05123482 A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies https://clinicaltrials.gov/study/NCT05123482 RECRUITING Breast Cancer

NCT00001373 Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics https://clinicaltrials.gov/study/NCT00001373 RECRUITING Familial Mediterranean Fever (FMF)

NCT04812431 Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI https://clinicaltrials.gov/study/NCT04812431 RECRUITING Spinal Cord Injury, Acute

NCT06402331 FPI-2265 (225Ac-PSMA-I&T) for Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) https://clinicaltrials.gov/study/NCT06402331 RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: FPI-2265 Fusion Pharmaceuticals Inc.

NCT06047431 A Study of QL1706H in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06047431 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: QL1706H Qilu Pharmaceutical Co., Ltd.

NCT04725331 A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04725331 RECRUITING Metastatic Cancer

NCT05522231 Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) https://clinicaltrials.gov/study/NCT05522231 RECRUITING Advanced Renal Cell Carcinoma DRUG: fruquintinib+sintilimab

NCT06316531 A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer https://clinicaltrials.gov/study/NCT06316531 RECRUITING HER2-positive Breast Cancer DRUG: BL-M07D1

NCT04109131 A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours https://clinicaltrials.gov/study/NCT04109131 RECRUITING CNS Metastases OTHER: Samples collection: Plasma

NCT06294873 Stool Sample Collection Study https://clinicaltrials.gov/study/NCT06294873 RECRUITING Colorectal Cancer DIAGNOSTIC_TEST: A screening device for the detection of colorectal and other aerodigestive tract cancers Innovis LLC Exact Sciences Corporation

NCT05257473 Defining Endpoints in Becker Muscular Dystrophy https://clinicaltrials.gov/study/NCT05257473 RECRUITING Becker Muscular Dystrophy

NCT06220773 A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy https://clinicaltrials.gov/study/NCT06220773 RECRUITING Essential Hypertension

NCT06315673 Digital Assessment of Speech and Fine Motor Control in ALS https://clinicaltrials.gov/study/NCT06315673 RECRUITING Amyotrophic Lateral Sclerosis

NCT04844073 A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT04844073 RECRUITING Squamous Cell Cancer of Head and Neck (SCCHN)

NCT04918173 Efficacy of Atenativ in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Delivery https://clinicaltrials.gov/study/NCT04918173 RECRUITING Congenital Antithrombin Deficiency DRUG: Atenativ Octapharma

NCT06375031 Comparison of HR011408 and NovoRapid® in Subjects With Diabetics https://clinicaltrials.gov/study/NCT06375031 RECRUITING Diabetes DRUG: HR011408 injection; HR011408 injection Placebo

NCT05485831 Epidyolex® in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY https://clinicaltrials.gov/study/NCT05485831 NOT_YET_RECRUITING Lennox Gastaut Syndrome

NCT04558931 Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma https://clinicaltrials.gov/study/NCT04558931 RECRUITING Multiple Myeloma DRUG: CellProtect

NCT04716231 Atacicept in Subjects with IgA Nephropathy https://clinicaltrials.gov/study/NCT04716231 RECRUITING IgA Nephropathy

NCT06564831 Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care https://clinicaltrials.gov/study/NCT06564831 RECRUITING Diabetic Foot Ulcer

NCT06183931 Study of ALXN2220 Versus Placebo in Adults With ATTR-CM https://clinicaltrials.gov/study/NCT06183931 RECRUITING Transthyretin Amyloid Cardiomyopathy DRUG: ALXN2220

NCT06433531 A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) https://clinicaltrials.gov/study/NCT06433531 RECRUITING Generalized Pustular Psoriasis DRUG: TQH2929 Injection Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

NCT04278131 BS01 in Patients With Retinitis Pigmentosa https://clinicaltrials.gov/study/NCT04278131 RECRUITING Retinitis Pigmentosa DRUG: BS01 Bionic Sight LLC

NCT05748873 Promising ROd-cone DYstrophy Gene TherapY https://clinicaltrials.gov/study/NCT05748873 RECRUITING Retinitis Pigmentosa DRUG: SPVN06 SparingVision

NCT06459973 A Clinical Study of YL205 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06459973 RECRUITING Advanced Solid Tumors DRUG: intravenous (IV) infusion MediLink Therapeutics (Suzhou) Co., Ltd.

NCT05834673 VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) https://clinicaltrials.gov/study/NCT05834673 RECRUITING Atherosclerotic Cardiovascular Disease (ASCVD)

NCT06523231 Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants. https://clinicaltrials.gov/study/NCT06523231 NOT_YET_RECRUITING Shigellosis BIOLOGICAL: Shigella4V2

NCT05693831 myCare-102: Clinical Utility and Usability of Cellworks Singula‚Ñ¢ and Cellworks Ventura‚Ñ¢ Reports https://clinicaltrials.gov/study/NCT05693831 RECRUITING Cancer

NCT05123131 Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma https://clinicaltrials.gov/study/NCT05123131 RECRUITING Multiple Myeloma DRUG: Isatuximab

NCT06237231 Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars https://clinicaltrials.gov/study/NCT06237231 NOT_YET_RECRUITING Moderate Pain

NCT04282031 A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT04282031 RECRUITING Advanced Solid Tumor

NCT05799131 Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) https://clinicaltrials.gov/study/NCT05799131 NOT_YET_RECRUITING Peripheral Arterial Disease DEVICE: QBX (5F/6F) Peripheral Balloon Expandable Stent System QualiMed Innovative Medizinprodukte GmbH

NCT05397431 A Survey of Lanadelumab in Participants With Hereditary Angioedema https://clinicaltrials.gov/study/NCT05397431 RECRUITING Hereditary Angioedema (HAE) DRUG: Lanadelumab Takeda

NCT05575973 Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05575973 NOT_YET_RECRUITING Diffuse Large B-cell Lymphoma DRUG: Mitoxantrone Hydrochloride Liposome

NCT05024773 Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) https://clinicaltrials.gov/study/NCT05024773 RECRUITING Bladder Carcinoma in Situ (CIS) DRUG: ONCOFID P-B (PACLITAXEL-HYALURONIC ACID) Fidia Farmaceutici s.p.a.

NCT04892173 NBTXR3 With or Without Cetuximab in LA-HNSCC https://clinicaltrials.gov/study/NCT04892173 RECRUITING Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT06579573 ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures. https://clinicaltrials.gov/study/NCT06579573 RECRUITING Epilepsy, Generalized DRUG: Cenobamate Ono Pharmaceutical Co. Ltd

NCT05888831 A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05888831 RECRUITING Advanced Solid Tumors DRUG: BMS-986449

NCT04562831 The NO-ALS Study: a Trial of Nicotinamide/pterostilbene Supplement in ALS. https://clinicaltrials.gov/study/NCT04562831 RECRUITING Amyotrophic Lateral Sclerosis DIETARY_SUPPLEMENT: EH301 (Nicotinamide Riboside/Pterostilbene) Haukeland University Hospital Elysium Health

NCT05908331 MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions https://clinicaltrials.gov/study/NCT05908331 RECRUITING In-Stent Restenosis

NCT06069531 Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health https://clinicaltrials.gov/study/NCT06069531 RECRUITING Vaginitis Bacterial

NCT06372431 PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia https://clinicaltrials.gov/study/NCT06372431 RECRUITING Arterial Hypertension, Chronic Kidney Disease AstraZeneca

NCT04969731 Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT04969731 RECRUITING Pancreatic Ductal Adenocarcinoma DRUG: Immuncell-LC

NCT04886531 Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers https://clinicaltrials.gov/study/NCT04886531 RECRUITING Breast Cancer

NCT06355531 A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) https://clinicaltrials.gov/study/NCT06355531 RECRUITING Progressive Supranuclear Palsy DRUG: FNP-223

NCT05302531 Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome https://clinicaltrials.gov/study/NCT05302531 RECRUITING Short Bowel Syndrome

NCT04547231 Impact of Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes https://clinicaltrials.gov/study/NCT04547231 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: Fractional flow reserve, Coronary CT angiography Seoul National University Hospital Seoul National University Bundang Hospital

NCT06233266 Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg https://clinicaltrials.gov/study/NCT06233266 NOT_YET_RECRUITING Healthy Subjects DRUG: Ticagrelor-Test product

NCT04677166 Coupling Negative Pressure Wound Therapy With Instillation https://clinicaltrials.gov/study/NCT04677166 RECRUITING Wound

NCT06377566 A Study of BV-AVD in People With Bulky Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06377566 RECRUITING Hodgkin Lymphoma DRUG: Brentuximab vedotin

NCT04562766 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) https://clinicaltrials.gov/study/NCT04562766 RECRUITING Immune Thrombocytopenia DRUG: Rilzabrutinib

NCT05329766 A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies https://clinicaltrials.gov/study/NCT05329766 RECRUITING Gastrointestinal Tract Malignancies DRUG: Domvanalimab

NCT04872166 A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer https://clinicaltrials.gov/study/NCT04872166 RECRUITING Advanced Solid Tumor

NCT04417166 Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma https://clinicaltrials.gov/study/NCT04417166 RECRUITING Lymphoma, Extranodal NK-T-Cell DRUG: Pembrolizumab

NCT06448026 Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC). https://clinicaltrials.gov/study/NCT06448026 NOT_YET_RECRUITING Locally Recurrent Oral Cavity Squamous Cell Carcinoma DRUG: Cemiplimab

NCT06698926 A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06698926 RECRUITING Healthy Volunteer DRUG: ABBV-CLS-616

NCT05179226 Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age with Iron Deficiency Anemia https://clinicaltrials.gov/study/NCT05179226 RECRUITING Iron Deficiency, Anaemia in Children DRUG: Ferric Derisomaltose Pharmacosmos A/S

NCT06656026 Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A https://clinicaltrials.gov/study/NCT06656026 NOT_YET_RECRUITING Influenza a DRUG: ZSP1273 granules Guangdong Raynovent Biotech Co., Ltd

NCT05287126 A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis https://clinicaltrials.gov/study/NCT05287126 RECRUITING Ulcerative Colitis DRUG: Etrasimod Pfizer Arena is a wholly owned subsidiary of Pfizer

NCT05753566 Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer https://clinicaltrials.gov/study/NCT05753566 RECRUITING Prostate Cancer

NCT06133166 A Study for the Treatment of Dry Eye in Postmenopausal Women https://clinicaltrials.gov/study/NCT06133166 RECRUITING Postmenopausal Women With DED DRUG: EG017 ointment

NCT06257966 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin https://clinicaltrials.gov/study/NCT06257966 RECRUITING Type2 Diabetes Mellitus DRUG: Exendin-4 Fc fusion protein injection(1.2mg）

NCT04262466 Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors https://clinicaltrials.gov/study/NCT04262466 RECRUITING Select Advanced Solid Tumors DRUG: Brenetafusp

NCT06008366 A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06008366 RECRUITING Advanced Solid Tumor DRUG: 7MW3711 for injection

NCT06387966 A Randomized, Double-blind,Dose-escalating, Single-dose, Oral Phase I Clinical Study of Flunotinib Healthy People https://clinicaltrials.gov/study/NCT06387966 RECRUITING Healthy Person DRUG: flunotinib

NCT05618366 Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05618366 RECRUITING Lymphoma, Non-Hodgkin

NCT04609566 Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04609566 RECRUITING Melanoma

NCT06602466 A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health https://clinicaltrials.gov/study/NCT06602466 RECRUITING Dental Plaque

NCT05674526 A Phase 1b Study of WU-NK-101 in Combination With Cetuximab https://clinicaltrials.gov/study/NCT05674526 RECRUITING Colorectal Cancer Metastatic

NCT05696626 Evaluation of Lasofoxifene Combined with Abemaciclib Compared with Fulvestrant Combined with Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation https://clinicaltrials.gov/study/NCT05696626 RECRUITING Metastatic Breast Cancer DRUG: Lasofoxifene in combination with abemaciclib

NCT05934526 Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) https://clinicaltrials.gov/study/NCT05934526 RECRUITING Pulmonary Arterial Hypertension DRUG: Placebo

NCT06701526 A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications https://clinicaltrials.gov/study/NCT06701526 NOT_YET_RECRUITING Migraine DRUG: Eptinezumab H. Lundbeck A/S

NCT06212466 MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2) https://clinicaltrials.gov/study/NCT06212466 RECRUITING Ischemic Heart Disease

NCT05831566 Expertise Asthma COPD Program With Digital Support https://clinicaltrials.gov/study/NCT05831566 RECRUITING Asthma DRUG: Budesonide/Formoterol fumarate dihydrate Franciscus Gasthuis Teva Pharmaceuticals USA

NCT06118866 A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects with Androgenetic Alopecia https://clinicaltrials.gov/study/NCT06118866 RECRUITING Androgenetic Alopecia DRUG: placebo-Q2W

NCT05996666 Primary Liver Cancer Early Detection https://clinicaltrials.gov/study/NCT05996666 RECRUITING Liver Cancer DEVICE: Liver-cancer early detection test The First Hospital of Jilin University Guangzhou Burning Rock Dx Co., Ltd.

NCT05709626 PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction https://clinicaltrials.gov/study/NCT05709626 RECRUITING ST-segment Elevation Myocardial Infarction (STEMI) DRUG: No aspirin (Prasugurel monotherapy)

NCT04756726 Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma https://clinicaltrials.gov/study/NCT04756726 RECRUITING Multiple Myeloma

NCT06188026 A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children. https://clinicaltrials.gov/study/NCT06188026 RECRUITING Healthy Volunteers (Non-alcoholic Steatohepatitis) DRUG: NNC0194-0499

NCT05432466 Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome https://clinicaltrials.gov/study/NCT05432466 RECRUITING Vascular Ehlers-Danlos Syndrome DRUG: ACER-002 (celiprolol) 200 mg BID

NCT05584566 Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason® https://clinicaltrials.gov/study/NCT05584566 RECRUITING Ridge Augmentation DEVICE: OSSIX Breeze

NCT05366166 Pembrolizumab Plus Olaparib in LA-HNSCC https://clinicaltrials.gov/study/NCT05366166 RECRUITING Squamous Cell Carcinoma of Head and Neck BIOLOGICAL: Pembrolizumab

NCT06094426 Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06094426 RECRUITING Solid Tumor

NCT05280626 First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP https://clinicaltrials.gov/study/NCT05280626 NOT_YET_RECRUITING Diffuse Large B-Cell Lymphoma DRUG: Sintilimab

NCT06432166 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients https://clinicaltrials.gov/study/NCT06432166 NOT_YET_RECRUITING Alzheimer Disease

NCT04097366 Breast Screening - Risk Adaptive Imaging for Density https://clinicaltrials.gov/study/NCT04097366 RECRUITING Breast Cancer DIAGNOSTIC_TEST: ABUS

NCT06645366 Device for Improving Skin Quality and Texture on the Face and Neck https://clinicaltrials.gov/study/NCT06645366 RECRUITING Wrinkle

NCT04670666 Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus https://clinicaltrials.gov/study/NCT04670666 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: MADALENA ASSOCIATION

NCT06296966 A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye https://clinicaltrials.gov/study/NCT06296966 RECRUITING Dry Eye DRUG: VSJ-110

NCT04422366 Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females https://clinicaltrials.gov/study/NCT04422366 RECRUITING Cervical Cancer

NCT05839626 A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) https://clinicaltrials.gov/study/NCT05839626 RECRUITING Relapsed/Refractory Multiple Myeloma

NCT04275726 LANDMARK Trial: a Randomised Controlled Trial of Myval THV https://clinicaltrials.gov/study/NCT04275726 RECRUITING Aortic Valve Stenosis DEVICE: Myval THV Series

NCT05579626 Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) https://clinicaltrials.gov/study/NCT05579626 RECRUITING Pre Diabetes

NCT06372626 Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. https://clinicaltrials.gov/study/NCT06372626 RECRUITING Neuroendocrine Carcinoma BIOLOGICAL: ZG005

NCT05968326 A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC https://clinicaltrials.gov/study/NCT05968326 RECRUITING Adenocarcinoma, Pancreatic Ductal DRUG: Autogene cevumeran

NCT05324826 Effectiveness of Handheld Ultrasound for Diagnosing Patients With TMD https://clinicaltrials.gov/study/NCT05324826 RECRUITING Temporomandibular Joint Disorders

NCT04869826 Calibration of a Wrist Cuff Blood Pressure Device, According to the AAMI/ESH/ISO Universal Standard https://clinicaltrials.gov/study/NCT04869826 RECRUITING Hypertension DEVICE: Pulsewave Health Monitor (PAD-2A) Device Cardiovascular Research New Brunswick Cloud DX Inc.

NCT05829226 A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) https://clinicaltrials.gov/study/NCT05829226 RECRUITING AML, Adult Recurrent

NCT05844826 Evaluation of the Microbiome in Multiple Sclerosis https://clinicaltrials.gov/study/NCT05844826 RECRUITING Multiple Sclerosis DEVICE: SIMBA Capsule Nimble Science Ltd. IGY Life Sciences

NCT06604026 Investigational Study with the BD PosiFlush‚Ñ¢ SafeScrub on NADs https://clinicaltrials.gov/study/NCT06604026 NOT_YET_RECRUITING Prevention of Catheter-related Blood Stream Infections (CRBSI) DEVICE: BD PosiFlush‚Ñ¢ SafeScrub

NCT06078566 Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 https://clinicaltrials.gov/study/NCT06078566 RECRUITING Microtia COMBINATION_PRODUCT: AUR-201 Auregen Biotherapeutics, SA

NCT05498766 Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients https://clinicaltrials.gov/study/NCT05498766 NOT_YET_RECRUITING Gastric Cancer DRUG: Huaier granule

NCT06216366 Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers https://clinicaltrials.gov/study/NCT06216366 NOT_YET_RECRUITING Decompression Sickness DRUG: Sodium Chloride 0.9% Inj pre-exposure

NCT06254066 Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06254066 NOT_YET_RECRUITING Female Breast Cancer Patients

NCT05848466 Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients https://clinicaltrials.gov/study/NCT05848466 RECRUITING Advanced or Metastatic Solid Tumors DRUG: BAT8010 for Injection Bio-Thera Solutions

NCT06043466 A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06043466 RECRUITING Colorectal Cancer

NCT06174766 A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients https://clinicaltrials.gov/study/NCT06174766 NOT_YET_RECRUITING Hypertension DRUG: HGP2102-1

NCT06299826 A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure https://clinicaltrials.gov/study/NCT06299826 RECRUITING Chronic Heart Failure DRUG: AZD5462

NCT05904626 Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA https://clinicaltrials.gov/study/NCT05904626 NOT_YET_RECRUITING Intestinal Malabsorption DRUG: ELGN-2112

NCT05942066 Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications https://clinicaltrials.gov/study/NCT05942066 RECRUITING Healthy Participants Tethis S.p.A.

NCT05866666 Cardiac Performance System Data Collection Study https://clinicaltrials.gov/study/NCT05866666 RECRUITING Cardiac Disease DEVICE: Cardiac Performance System (NSR) Sensydia Corporation Orlando Health, Inc.

NCT06586866 JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases https://clinicaltrials.gov/study/NCT06586866 NOT_YET_RECRUITING Triple Negative Breast Cancer (TNBC)

NCT04703166 Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. https://clinicaltrials.gov/study/NCT04703166 NOT_YET_RECRUITING Atrial Fibrillation DEVICE: Samsung Galaxy Watch Active2 Tulane University School of Medicine Samsung

NCT06430866 Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) https://clinicaltrials.gov/study/NCT06430866 RECRUITING Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) DRUG: ABP 234

NCT06307626 A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease. https://clinicaltrials.gov/study/NCT06307626 RECRUITING Thyroid Eye Disease COMBINATION_PRODUCT: Efgartigimod PH20 SC

NCT06659926 The Radium-select Study https://clinicaltrials.gov/study/NCT06659926 NOT_YET_RECRUITING mCRPC

NCT05827666 The Effect of Dairy and Dairy-Free Alternative Beverages on Post-Exercise Anabolism in Active Youth https://clinicaltrials.gov/study/NCT05827666 RECRUITING Dietary Proteins

NCT06308666 Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use https://clinicaltrials.gov/study/NCT06308666 RECRUITING Myopia DEVICE: Delefilcon A contact lenses University of Waterloo Alcon Research

NCT05485766 Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT05485766 RECRUITING Triple Negative Breast Neoplasms

NCT06117566 A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06117566 RECRUITING Solid Tumor DRUG: WX390

NCT06641466 A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine https://clinicaltrials.gov/study/NCT06641466 NOT_YET_RECRUITING Menstrual Migraine DRUG: Rimegepant

NCT05282966 Assessment of QSant‚Ñ¢ for Underlying Allograft Rejection https://clinicaltrials.gov/study/NCT05282966 NOT_YET_RECRUITING Kidney Transplant Failure and Rejection DIAGNOSTIC_TEST: QSant-TM Urine Test NephroSant

NCT05732766 To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) https://clinicaltrials.gov/study/NCT05732766 RECRUITING Cholera BIOLOGICAL: Hillchol vaccine Bharat Biotech International Limited

NCT05988866 Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels https://clinicaltrials.gov/study/NCT05988866 NOT_YET_RECRUITING Hypercholesterolemia

NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05592626 RECRUITING Advanced Solid Tumors

NCT05292326 Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation. https://clinicaltrials.gov/study/NCT05292326 RECRUITING Hemorrhagic Complications

NCT06111326 BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06111326 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: BC3402 injection

NCT05325866 A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression https://clinicaltrials.gov/study/NCT05325866 RECRUITING Solid Tumors DRUG: Bemarituzumab Amgen

NCT04985266 A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT04985266 RECRUITING ER+ Breast Cancer

NCT04079166 SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) https://clinicaltrials.gov/study/NCT04079166 RECRUITING Malignant Melanoma

NCT06013566 SSVEP Evaluation of Brain Function (PRO) https://clinicaltrials.gov/study/NCT06013566 RECRUITING Mild Traumatic Brain Injury DEVICE: SSVEP Headsafe MFG

NCT06622226 A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06622226 RECRUITING Non Hodgkin Lymphoma DRUG: ONO-7018 Ono Pharmaceutical Co. Ltd

NCT05318326 A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets https://clinicaltrials.gov/study/NCT05318326 RECRUITING Type 2 Diabetes DRUG: placebo group

NCT06259526 A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression https://clinicaltrials.gov/study/NCT06259526 RECRUITING Depression DRUG: Placebo group

NCT05738226 EpiCare@Home Validation Study for Focal Onset Seizures https://clinicaltrials.gov/study/NCT05738226 RECRUITING Epilepsy

NCT06680726 Research Collaboration for a Precision Oncology Program (POP) https://clinicaltrials.gov/study/NCT06680726 RECRUITING Cancer OTHER: Matching with RWD

NCT05835466 Reparixin in Patients with Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) https://clinicaltrials.gov/study/NCT05835466 RECRUITING Myelofibrosis (PMF)

NCT06540066 A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06540066 RECRUITING Advanced Cancer

NCT06126666 A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06126666 RECRUITING Advanced Solid Tumor DRUG: ABL103 ABL Bio, Inc.

NCT05074420 A Study of Baricitinib (LY3009104) in Children With COVID-19 https://clinicaltrials.gov/study/NCT05074420 RECRUITING Covid19

NCT06492720 A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS‚Ñ¢ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy https://clinicaltrials.gov/study/NCT06492720 RECRUITING Drug Resistant Epilepsy

NCT05332574 A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor https://clinicaltrials.gov/study/NCT05332574 RECRUITING NSCLC

NCT06298474 The BRAIN App (Phase 2 SBIR) https://clinicaltrials.gov/study/NCT06298474 NOT_YET_RECRUITING Dementia

NCT05868174 Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors https://clinicaltrials.gov/study/NCT05868174 RECRUITING Solid Tumor, Adult

NCT05947474 ORB-011 In Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05947474 RECRUITING Advanced Solid Cancer DRUG: ORB-011 Orionis Biosciences Inc

NCT06038474 Descartes-08 for Patients With Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06038474 RECRUITING Systemic Lupus Erythematosus (SLE) DRUG: Descartes-08 Cartesian Therapeutics

NCT06399874 Pilot Trial Comparing Nightmare Deconstruction and Reprocessing vs. NightWare Wristband https://clinicaltrials.gov/study/NCT06399874 RECRUITING Nightmares Associated With Chronic Post-Traumatic Stress Disorder BEHAVIORAL: Nightmare Deconstruction and Reprocessing

NCT06161974 Study of Olutasidenib and Temozolomide in HGG https://clinicaltrials.gov/study/NCT06161974 NOT_YET_RECRUITING High Grade Glioma

NCT04680065 GDNF Gene Therapy for Multiple System Atrophy https://clinicaltrials.gov/study/NCT04680065 RECRUITING Multiple System Atrophy BIOLOGICAL: AAV2-GDNF gene therapy

NCT06232720 User Site Testing Study to Evaluate Usability of the Q300‚Ñ¢ Device Under "Real-life Conditions" in a Reproductive Laboratory Environment Use https://clinicaltrials.gov/study/NCT06232720 RECRUITING to Aid in Sperm Selection for ICSI DEVICE: Q300 QART Medical QART Medical

NCT06462820 SAINT for MDD in an Inpatient Setting Follow-on https://clinicaltrials.gov/study/NCT06462820 RECRUITING Major Depressive Disorder

NCT05655520 A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease https://clinicaltrials.gov/study/NCT05655520 RECRUITING Huntington's Disease DRUG: SAGE-718 Sage Therapeutics

NCT05703620 REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. https://clinicaltrials.gov/study/NCT05703620 RECRUITING Chronic Kidney Diseases

NCT05735574 Determining Cost of Explant of Neurmodulation Device Due to Infection https://clinicaltrials.gov/study/NCT05735574 NOT_YET_RECRUITING Neuropathic Pain

NCT06475274 A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery https://clinicaltrials.gov/study/NCT06475274 RECRUITING Kidney Injury Following Open-Chest Cardiac Surgery DRUG: RMC-035

NCT05787574 A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition https://clinicaltrials.gov/study/NCT05787574 RECRUITING Primary Immune Regulatory Disorder

NCT05583474 OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects https://clinicaltrials.gov/study/NCT05583474 RECRUITING Open Angle Glaucoma or Ocular Hypertension DRUG: OPC-1085EL

NCT05489874 A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient https://clinicaltrials.gov/study/NCT05489874 RECRUITING COVID-19 Patient Shanghai Vinnerna Biosciences Co., Ltd.

NCT05860374 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05860374 RECRUITING Sarcoma